,sentence_id_pmcid,augmented_set,augmented_set_preceding,augmented_set_trailing,section,section.1,CONSORT_Item
0,PMC4770816S58,follow up ceased if the participant had a major throw cardiovascular event,in both arms of the trial the general practitioners had access to a computer based algorithm that actively suggested drugs and dosage if the participant was above target,the primary outcome was change in systolic blood imperativeness between baseline and one year,['Procedures'],Methods,['7b']
1,PMC4770816S58,follow up ceased the had a major cardiovascular event,in both arms the trial the general practitioners had access to a computer based algorithm that actively drugs and dosage if the participant was above target,the primary outcome was modify in systolic blood pressure between baseline and one year,['Procedures'],Methods,['7b']
2,PMC4770816S58,a up ceased if the participant had follow major cardiovascular event,in both arms of the trial the general practitioners had access to a computer based algorithm hoosier state that actively suggested drugs and dosage if electronic computer the participant was above target,baseline primary outcome was change in systolic blood pressure between the and one year,['Procedures'],Methods,['7b']
3,PMC4770816S58,follow up ceased if the participant had a major cardiovascular issue,in both arms of the trial the general practician had access to a computer based algorithm that actively paint a picture drugs and dosage if the participant was above target,primary outcome was change in systolic blood pressure between baseline and one year,['Procedures'],Methods,['7b']
4,PMC4770816S58,follow up ceased if the participant observe had a major cardiovascular event,in both arms of the trial the to practitioners had access actively a computer based algorithm that general suggested drugs and dosage if the participant was above target,in primary outcome was change the systolic blood pressure between baseline and one year,['Procedures'],Methods,['7b']
5,PMC4770816S58,follow up ceased the if participant had a major cardiovascular event,in both arms of the trial the dosage practitioners had access to a computer participant algorithm that actively suggested drugs and general if the based was above target,the primary outcome was change systolic blood pressure between baseline and one year,['Procedures'],Methods,['7b']
6,PMC4770816S58,follow up ceased if the participant had a major cardiovascular event ,in both arms of the trial the general practitioners had access to a computer based algorithm that actively suggested drugs and dosage if the participant was above target ,the primary outcome was change in systolic blood pressure between baseline and one year ,['Procedures'],Methods,['7b']
7,PMC4770816S75,subgroup psychoanalyse were pre specified for diabetes mellitus atrial fibrillation and age group,we also explored the potential imputation of missing effects by the use of three approaches multiple values group mean and last available value,in hectogram addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
8,PMC4770816S75,subgroup analyses were pre specified for diabetes age atrial fibrillation and mellitus group,border on we also explored the potential effects miss of missing values by the use of three approaches multiple imputation group mean and last available value,in addition we did a by analysis subgroup baseline systolic blood pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
9,PMC4770816S75,subgroup analyses were pre specified diabetes for mellitus atrial fibrillation and age group,we also explored the potential effects missing values by the use of three group mean and last available value,hectogram in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
10,PMC4770816S75,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age canvas group,we also explored time value the mean value potential effects of missing values by the use of three approaches multiple imputation group mean and last available value,in addition we did a subgroup analysis by baseline systolic blood pressure hg mm hg,['Statistical analysis'],Methods,['12b']
11,PMC4770816S75,were pre specified for diabetes mellitus atrial fibrillation and age group,we also explored the potential effects of missing values by the use of three approaches multiple imputation group and last available value,in addition we did a subgroup analysis by baseline systolic blood pressure millimetre hg millimetre hg,['Statistical analysis'],Methods,['12b']
12,PMC4770816S75,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and years group,we also explored the potential effects of overleap values by the use of three approaches multiple imputation group mean and final available value,in addition we did a subgroup analysis by baseline systolic blood atmospheric pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
13,PMC4770816S75,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age group ,we also explored the potential effects of missing values by the use of three approaches multiple imputation group mean and last available value ,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg ,['Statistical analysis'],Methods,['12b']
14,PMC4770816S76,in we did a subgroup analysis by baseline systolic pressure mm hg mm hg,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and group,we liken the number of consultations treatment changes and slope effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome,['Statistical analysis'],Methods,['12b']
15,PMC4770816S76,in addition we did a subgroup analysis by baseline systolic blood pressure millimetre hg millimetre hg,subgroup analyses group pre specified for diabetes mellitus atrial fibrillation and age were,we compared the number of consultations adjusting changes the side effects by using generalised mixed modelling treatment for the same variables as in and primary outcome,['Statistical analysis'],Methods,['12b']
16,PMC4770816S76,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg indiana mm hg,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age group,compared the number of consultations treatment changes and side effects by using generalised mixed modelling for same variables as in the primary outcome,['Statistical analysis'],Methods,['12b']
17,PMC4770816S76,in addition we did analysis by baseline systolic blood pressure mm hg mm hg,subgroup analyses were pre specified diabetes for mellitus atrial fibrillation and age group,we compared the number of treatment changes and side effects by using generalised mixed modelling for the same variables as in the,['Statistical analysis'],Methods,['12b']
18,PMC4770816S76,in addition we did a subgroup analysis by baseline systolic blood atmospheric pressure mm hg mm hg,subgroup analyses were pre specified for diabetes mellitus atrial grouping fibrillation and age group,we compared the number of consultations treatment changes and side effects by position event using generalised mixed modelling adjusting for the same variables as in the primary outcome,['Statistical analysis'],Methods,['12b']
19,PMC4770816S76,in addition we subgroup a did analysis by baseline systolic blood pressure mm hg mm hg,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and geezerhood group,we compared the and of consultations outcome changes number side effects by using generalised mixed modelling adjusting for the same variables as in the primary treatment,['Statistical analysis'],Methods,['12b']
20,PMC4770816S76,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg ,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age group ,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome ,['Statistical analysis'],Methods,['12b']
21,PMC4770816S77,we compared the total of consultations treatment changes and side effects by using generalised mixed simulate adjusting for the same variables as in the primary outcome,hoosier state in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,for clinical events calculated hazard ratios and their confidence intervals by using proportional hazards adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
22,PMC4770816S77,we compared the number of consultations treatment changes and side effects by using generalised mixed discourse modelling adjusting for the same bit variables as in the primary outcome,in gain we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,for cox events intervals calculated hazard ratios and their confidence we by using clinical proportional hazards modelling adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
23,PMC4770816S77,we compared the number of consultations treatment changes and by using generalised mixed modelling adjusting for the same as in the primary outcome,in addition hg did a subgroup analysis by baseline systolic blood pressure mm we mm hg,for clinical using we intervals hazard ratios and their confidence calculated by events cox proportional hazards modelling adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
24,PMC4770816S77,effects compared the number of consultations treatment changes and side we by same generalised mixed modelling adjusting for the using variables as in the primary outcome,in addition we did a subgroup depth psychology by baseline systolic blood pressure mm hg mm hg,for clinical events we take a chance calculated hazard ratios and their confidence intervals by using cox proportional hazards conform modelling adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
25,PMC4770816S77,we compared the number of consultations treatment changes and side effects by using variable quantity generalised mixed modelling adjusting for discourse the same variables as in the primary outcome,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,for clinical events we calculated hazard ratios and their confidence intervals by utilize cox proportional hazards modelling adjusting for the same covariates remark previously,['Statistical analysis'],Methods,['12b']
26,PMC4770816S77,we the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for same variables as in the primary outcome,in addition we did a subgroup analysis by baseline plus systolic blood pressure mm hg mm hg,for clinical events we calculated hazard ratios trust and their confidence intervals by using cox proportional hazards modelling adjusting for the same antecedently covariates mentioned previously,['Statistical analysis'],Methods,['12b']
27,PMC4770816S77,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome ,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg ,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned previously ,['Statistical analysis'],Methods,['12b']
28,PMC4770816S78,for clinical events we hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned,we compared the number of consultations treatment changes and position effects by expend generalised mixed modelling adjusting for the same variables as in the primary outcome,we checked the proportional hazard assumption with schoenfeld residual plots and by admit interaction terms in the mannequin for each term by time,['Statistical analysis'],Methods,['12b']
29,PMC4770816S78,for clinical events we calculated hazard ratios and their confidence intervals covariates using cox proportional mentioned modelling adjusting for the same by hazards previously,we compared the add up of consultations treatment convert and side effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome,we checked include the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by let in time,['Statistical analysis'],Methods,['12b']
30,PMC4770816S78,for events hazard ratios and their confidence intervals by using proportional hazards modelling adjusting for the same covariates mentioned previously,we compared effects number of consultations treatment changes and side the by using generalised mixed modelling adjusting for the same variables as in the outcome primary,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time,['Statistical analysis'],Methods,['12b']
31,PMC4770816S78,for clinical consequence events we calculated hazard ratios and their confidence intervals by time interval using cox proportional hazards modelling adjusting for the same covariates mentioned previously,variable we compared the number of consultations treatment changes and side primary feather effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome,we checked the proportional assumption with schoenfeld residual plots and by including interaction in the model for each term time,['Statistical analysis'],Methods,['12b']
32,PMC4770816S78,for clinical events we calculated hazard ratios and their confidence intervals by utilise cox proportional peril modelling adjusting for the same covariates mentioned previously,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the outcome,we checked the proportional in assumption with schoenfeld residual by and plots including interaction terms hazard the model for each term by time,['Statistical analysis'],Methods,['12b']
33,PMC4770816S78,for clinical events we calculated hazard their and ratios confidence intervals by using cox proportional hazards modelling the for adjusting same covariates mentioned previously,we compared the number of consultations treatment changes side effects by using generalised mixed adjusting for the same variables as in the outcome,we checked the proportional chance assumption with schoenfeld residual plots and by including interaction terms in the mould for each term by time,['Statistical analysis'],Methods,['12b']
34,PMC4770816S78,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned previously ,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome ,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time ,['Statistical analysis'],Methods,['12b']
35,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting proportion for the same covariates mentioned remark previously,for all clinical event analyses we censored patients at the time of the affected role first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
36,PMC4770816S79,we checked the proportional chance hazard assumption with schoenfeld residual plots and by including interaction terms in the model chance for each term by time,for clinical events we calculated hazard ratios and their confidence intervals same modelling cox proportional hazards using adjusting for the by covariates mentioned previously,for all clinical event analyses we censored patients at the time of the first event relevant to that psychoanalysis,['Statistical analysis'],Methods,['12b']
37,PMC4770816S79,we checked the relative hazard assumption with schoenfeld residual plots and by admit interaction terms in the model for each term by time,for previously events we calculated adjusting ratios and their confidence intervals by using cox proportional hazards modelling hazard for the same covariates mentioned clinical,for clinical all event analyses we censored patients at the time of the first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
38,PMC4770816S79,we checked schoenfeld proportional hazard each with the residual plots and by including interaction terms in the model for assumption term by time,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same hazard expend covariates mentioned previously,for all clinical event analyses we censored at patients the time of the first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
39,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model aside for each term by check out time,for clinical events we calculated take chances ratios and their confidence intervals by practice cox proportional hazards modelling adjusting for the same covariates mentioned previously,for all clinical event analyses we censored patients at the time of first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
40,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld plots and by including interaction terms in the model for each term by time,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional gamble modelling adjusting for the same covariates observe previously,for all clinical event analyses we censored patients at the time the first event to that analysis,['Statistical analysis'],Methods,['12b']
41,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time ,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned previously ,for all clinical event analyses we censored patients at the time of the first event relevant to that analysis ,['Statistical analysis'],Methods,['12b']
42,PMC4770816S141,the run represents a post stroke primary care population managed by generalists rather than a selective hospital outpatient population managed by medical specialist,target is likely therefore that the more intensive it would have been even harder to achieve if the trial was population more representative of people with prevalent cerebrovascular disease,the outcome measure was not blinded but a nurse not directly involved in the participants care obtained it using an automated sphygmomanometer so systematic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
43,PMC4770816S141,the trial run represents a send stroke primary care population managed by generalists rather than a selective hospital outpatient population managed by specialists,it is likely therefore that the more intensive target would have been even harder to achieve if the trial population was representative of people with cerebrovascular disease,outcome measure was not blinded but a nurse not directly involved in the participants care obtained by using an automated sphygmomanometer so systematic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
44,PMC4770816S141,the trial represents a post stroke primary care population managed by generalists rather than a selective primary election hospital axerophthol outpatient population managed by specialists,it is likely therefore the intensive target would have been even harder to achieve if trial more representative of people prevalent cerebrovascular disease,the outcome measure was not blinded but a nurse not directly involved in the participants care obtained it by using an prejudice automated sphygmomanometer so participant systematic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
45,PMC4770816S141,the trial represents a post stroke primary care population managed by generalists rather than a selective hospital outpatient population managed by specialists,it is likely thence that the more intensive target would have been even harder to achieve if the visitation population was more representative of people with prevalent cerebrovascular disease,the outcome measure was not blinded but a nurse not directly involved in the player tutelage obtained it by using an automated sphygmomanometer so systematic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
46,PMC4770816S141,the trial represents a post stroke outpatient care managed population by generalists rather than a selective hospital primary population managed by specialists,it is likely therefore that the more intensive target would have been even harder to achieve if the trial population was more representative prevalent people with disease cerebrovascular of,the outcome measure was not prejudice blinded but a nurse not directly involved in the participants care obtained it by using an automated sphygmomanometer so systematic live recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
47,PMC4770816S141,the trial represents a managed primary stroke care population post by generalists rather than a selective hospital outpatient population managed by specialists,it is likely therefore that the more intensive target would have been even harder to run achieve if the trial thus population was more representative of people with prevalent cerebrovascular disease,the outcome measure was not dim but a nurse not directly involved in the participants tending obtained it by using an automated sphygmomanometer so systematic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
48,PMC4770816S141,the trial represents a post stroke primary care population managed by generalists rather than a selective hospital outpatient population managed by specialists ,it is likely therefore that the more intensive target would have been even harder to achieve if the trial population was more representative of people with prevalent cerebrovascular disease ,the outcome measure was not blinded but a nurse not directly involved in the participants care obtained it by using an automated sphygmomanometer so systematic recording bias is unlikely ,['Strengths and weaknesses of study'],Discussion,['21']
49,PMC3623038S76,numerical safety data for all randomised patients were assessed in an analysis of variableness,furthermore the covariance models validity was checked by analysing the residuals and the distances cook,the threshold for statistical implication was set to p in all cases,['Statistical analysis'],Patients and methods,['12b']
50,PMC3623038S76,numerical safety data for associate in nursing all randomised patients were assessed in an analysis of variance,furthermore the covariance models validity was checked by analysing cook residuals and the the distances,for statistical significance was to p in all cases,['Statistical analysis'],Patients and methods,['12b']
51,PMC3623038S76,associate in nursing numerical safety data for all randomised patients were assessed in an analysis of variance,furthermore the covariance models validity was checked by analysing the residuals and the example cook distances,atomic number the threshold for statistical significance was set to p in all cases,['Statistical analysis'],Patients and methods,['12b']
52,PMC3623038S76,numerical safety an for all randomised patients were assessed in data analysis of variance,remainder furthermore the covariance models validity was checked by analysing the residuals and the cook distances,the threshold for statistical significance was set to signification p in all cases,['Statistical analysis'],Patients and methods,['12b']
53,PMC3623038S76,numerical safety data for all randomised patients were assessed in an analysis of variance,furthermore the covariance models validity was checked by the residuals and the distances,the threshold for statistical implication was set to p in all cases,['Statistical analysis'],Patients and methods,['12b']
54,PMC3623038S76,numerical safety for all randomised patients were in an analysis of variance,furthermore the covariance models validity was checked by analyze the residuals and the cook distances,the for statistical significance was set p in all cases,['Statistical analysis'],Patients and methods,['12b']
55,PMC3623038S76,numerical safety data for all randomised patients were assessed in an analysis of variance ,furthermore the covariance models validity was checked by analysing the residuals and the cook distances ,the threshold for statistical significance was set to p in all cases ,['Statistical analysis'],Patients and methods,['12b']
56,PMC3623038S112,however memantines potential benefit on other axial confirmed symptoms and dyskinesia should be motor in a larger patient population,in conclusion the results of our pilot bailiwick do not support the implementation of a full scale clinical test designed to assess memantines effects on gait,cloth supplementary material,['Discussion'],Discussion,['21']
57,PMC3623038S112,centrifugal however memantines potential benefit on other axial motor symptoms and dyskinesia should be confirmed in a larger patient population,in conclusion the results of our non pilot study do not to the full support the implementation of a full scale clinical trial designed to assess memantines effects on gait,supplemental material,['Discussion'],Discussion,['21']
58,PMC3623038S112,however memantines potential benefit on other axial motor symptoms and dyskinesia should be corroborate in a larger patient population,in conclusion results of our pilot study support implementation of scale clinical trial designed to assess memantines effects on gait,supplementary material,['Discussion'],Discussion,['21']
59,PMC3623038S112,however memantines potential benefit on other axial motor symptoms and dyskinesia should be confirmed in a enceinte patient population,implementation conclusion the results gait our pilot study do not support the in of a full scale clinical trial designed to assess memantines effects on of,cloth supplementary material,['Discussion'],Discussion,['21']
60,PMC3623038S112,however memantines potential benefit on other symptoms motor axial and dyskinesia should be confirmed in a larger patient population,in conclusion the results of our fender analyse do not support the implementation of a full scale clinical trial designed to assess memantines effects on gait,supplementary corporeal,['Discussion'],Discussion,['21']
61,PMC3623038S112,memantines potential benefit on other axial motor symptoms and dyskinesia should be confirmed in a larger patient,along ratiocination in conclusion the results of our pilot study do not support the implementation of a full scale clinical trial designed to assess memantines effects on gait,material supplementary,['Discussion'],Discussion,['21']
62,PMC3623038S112,however memantines potential benefit on other axial motor symptoms and dyskinesia should be confirmed in a larger patient population ,in conclusion the results of our pilot study do not support the implementation of a full scale clinical trial designed to assess memantines effects on gait ,supplementary material,['Discussion'],Discussion,['21']
63,PMC4392313S86,all other show exploratory end points were summarised for incase the itt population observed cases without imputation of missing data and excluding escape data,only measurements recorded before escape therapy were carried forward,all laboratory parameter values were converted to parametric quantity prise si units for lipid parameters only the latest fasted values within the time window were included,['Statistical analysis'],Methods,['12b']
64,PMC4392313S86,itt other exploratory end points were summarised for the all population observed cases without escape of missing data and excluding imputation data,escape measurements recorded before only therapy were carried forward,all laboratory parameter values were si for lipid the latest fasted values within the time window were included,['Statistical analysis'],Methods,['12b']
65,PMC4392313S86,all exploratory end points were summarised for the itt population observed cases without imputation of missing data escape data,only measurements recorded before measuring escape therapy were carried forward,all laboratory parameter values were converted to for units si lipid parameters only the within fasted values latest the time window were included,['Statistical analysis'],Methods,['12b']
66,PMC4392313S86,all other exploratory stop points were summarised for the itt population observed cases without imputation of miss data and excluding escape data,were measurements recorded before escape therapy only carried forward,all laboratory parameter unit values live were converted to si units for lipid parameters only the latest fasted values within the time window were included,['Statistical analysis'],Methods,['12b']
67,PMC4392313S86,all exploratory end summarised for the itt population observed cases without imputation of data and excluding escape data,only measurements tape before escape therapy were carried forward,all laboratory parameter values were converted to si units for lipid argument only the latest fast values within the time window were included,['Statistical analysis'],Methods,['12b']
68,PMC4392313S86,all other exploratory end points were summarised for the itt population observed cases without imputation of missing information former data and excluding escape data,only measurements recorded before escape evasion therapy were carried forward,all laboratory parameter values were converted to units for lipid parameters only the latest fasted values within the window were,['Statistical analysis'],Methods,['12b']
69,PMC4392313S86,all other exploratory end points were summarised for the itt population observed cases without imputation of missing data and excluding escape data ,only measurements recorded before escape therapy were carried forward ,all laboratory parameter values were converted to si units for lipid parameters only the latest fasted values within the time window were included ,['Statistical analysis'],Methods,['12b']
70,PMC4392313S90,exploratory analyses based using observed cases were performed on the non parametric kruskal wallis test,primary terminate points in the study were psychoanalyse based on a pattern distribution however because service line values for several laboratory assessments in this study demonstrated non pattern distributions values for exploratory serum analytes are presented as medians or median percentage changes from service line,lehmann estimates of location shift and are,['Statistical analysis'],Methods,['12b']
71,PMC4392313S90,exploratory analyses based on observed cases were performed using the non parametric kruskal wallis test,primary end points in the study were analysed based on a normal however because values for several laboratory demonstrated non normal distributions values for exploratory serum analytes are presented as medians or median percentage changes from baseline,calculate hodges lehmann estimates of location shift and cis are presented,['Statistical analysis'],Methods,['12b']
72,PMC4392313S90,exploratory analyses based on observed cases canvas were performed using the non parametric kruskal wallis test,principal closing points in the field of study were analysed based on a normal distribution however because baseline values for several laboratory assessments in this field of study demonstrated non normal distributions values for exploratory serum analytes are demo as medians or median percentage changes from baseline,hodges shift estimates of location lehmann and cis are presented,['Statistical analysis'],Methods,['12b']
73,PMC4392313S90,exploratory analyses based on not observed cases were performed using the non parametric kruskal wallis test,primary end points in the study were analysed based on a normal distribution however baseline values for laboratory assessments in study demonstrated non normal distributions values exploratory serum analytes are presented as medians or median percentage changes from baseline,hodges of location shift and cis are presented,['Statistical analysis'],Methods,['12b']
74,PMC4392313S90,exploratory analyses based on notice cases were performed using the non parametric kruskal wallis test,primary end points in the study were free base analysed based remainder on a normal distribution however because baseline values for several laboratory assessments in this study demonstrated non normal distributions values for exploratory serum analytes are presented yet as medians or median percentage changes from service line baseline,hodges lehmann estimates of location shift and curie are presented,['Statistical analysis'],Methods,['12b']
75,PMC4392313S90,exploratory analyses based on cases were using the non parametric kruskal wallis test,primary end points median value in the study were analysed based on a normal distribution however because baseline convert values for several laboratory assessments in this study demonstrated non formula normal distributions values for exploratory serum written report analytes are presented as medians or median percentage changes from baseline,hodges lehmann estimates of location shift and live cis are presented,['Statistical analysis'],Methods,['12b']
76,PMC4392313S90,exploratory analyses based on observed cases were performed using the non parametric kruskal wallis test ,primary end points in the study were analysed based on a normal distribution however because baseline values for several laboratory assessments in this study demonstrated non normal distributions values for exploratory serum analytes are presented as medians or median percentage changes from baseline ,hodges lehmann estimates of location shift and cis are presented ,['Statistical analysis'],Methods,['12b']
77,PMC4392313S91,hodges lehmann estimates of location shift and equal cis are presented,exploratory analyses based on observed showcase were performed using the non parametric kruskal wallis test,no adjustments for numerousness were performed,['Statistical analysis'],Methods,['12b']
78,PMC4392313S91,hodges lehmann estimates presented location shift and cis are of,exploratory analyses based on observed cases were performed using the test parametric kruskal wallis non,no adjustments for multiplicity were performed,['Statistical analysis'],Methods,['12b']
79,PMC4392313S91,hodges lehmann estimates of location shift and cis are stage,exploratory analyses based on celebrate cases were performed using the non parametric kruskal wallis test,no adjustment for multiplicity were performed,['Statistical analysis'],Methods,['12b']
80,PMC4392313S91,hodges lehmann estimates of gift location shift and cis are presented,exploratory analyses based on observed cases were performed using the non parametric kruskal wallis test,no adjustments for multiplicity performed were,['Statistical analysis'],Methods,['12b']
81,PMC4392313S91,hodges lehmann estimates of location and shift cis are presented,exploratory analyses based expend on observed cases were performed using the non parametric kruskal wallis test,adjustments for were performed,['Statistical analysis'],Methods,['12b']
82,PMC4392313S91,hodges lehmann estimates of location shift and are presented,cases analyses based on observed exploratory were performed using the non parametric kruskal wallis test,no adjustments for multiplicity live were performed,['Statistical analysis'],Methods,['12b']
83,PMC4392313S91,hodges lehmann estimates of location shift and cis are presented ,exploratory analyses based on observed cases were performed using the non parametric kruskal wallis test ,no adjustments for multiplicity were performed ,['Statistical analysis'],Methods,['12b']
84,PMC3551223S155,further confirmation of these data is required including through the longer term observation of the patients recruited for exercise this study as well as additional studies indiana in other patient sets including the evaluation in daily axerophthol practice via registries,in particular patients with a contraindication or intolerance to methotrexate are likely to be a suitable particular proposition population,subsidiary material,['Discussion'],Discussion,['21']
85,PMC3551223S155,further confirmation of these data is required including through the longer term observation of the patients recruited for this as well as additional studies in other patient sets including the evaluation in daily practice via registries,in particular patients with a contraindication or intolerance suitable methotrexate are likely to be a to population,cloth supplementary material,['Discussion'],Discussion,['21']
86,PMC3551223S155,patient confirmation registries these data is required including through the recruited term observation of the patients longer for this study as well as additional studies in other further sets including the evaluation in daily practice via of,in particular patients with a contraindication intolerance to methotrexate are likely to be a suitable,material supplementary,['Discussion'],Discussion,['21']
87,PMC3551223S155,confirmation of these is required including through the longer observation of the patients recruited for this study as well as additional studies in other patient sets including the in daily practice via registries,in particular patient role with a contraindication or intolerance to methotrexate are likely to be a suitable population,supplementary cloth material,['Discussion'],Discussion,['21']
88,PMC3551223S155,further confirmation of these data is required including through the longer term observation of the patients recruited for this consider as well as additional studies in other patient sets including the evaluation in daily practise via registry,in particular patients with be contraindication or intolerance to methotrexate are likely to a a suitable population,supplementary material,['Discussion'],Discussion,['21']
89,PMC3551223S155,further confirmation of these data is required including through the longer term observation of the patients recruited for this study as well as additional studies in other patient learn sets including the evaluation in exercise daily practice via former registries,in particular patients with a contraindication or intolerance to methotrexate are likely to beaver state be a suitable population,auxiliary material,['Discussion'],Discussion,['21']
90,PMC3551223S155,further confirmation of these data is required including through the longer term observation of the patients recruited for this study as well as additional studies in other patient sets including the evaluation in daily practice via registries ,in particular patients with a contraindication or intolerance to methotrexate are likely to be a suitable population ,supplementary material,['Discussion'],Discussion,['21']
91,PMC5418559S75,the packaging and labeling of the study drug kits were based on a separate drug packaging randomization schedule,a computer generate randomization scheme was made available to all clinical centers participating in the study via an interactive network response system,the interactive web response system determined which drug package the center should administer to the patient organization based on a randomization schedule where each treatment was allocated once using a block distribute size of four within handling each study site,['Statistical methods'],Methods,['9']
92,PMC5418559S75,the packaging and labeling of the study drug randomisation kits were based on a separate drug packaging randomization schedule,to computer generated randomization scheme was made available a all via centers participating in the study clinical an interactive web response system,the interactive web response system determined which package the center should administer to the patient based on a randomization schedule where each treatment was once using a size of four within each study,['Statistical methods'],Methods,['9']
93,PMC5418559S75,the packaging and of the study drug kits were based on a separate drug randomization schedule,a computer generated randomization scheme was made available to all clinical enter centers participating in the study via an interactive web response network system,each interactive web response system determined which drug package the center should randomization to the patient based on a administer schedule where each treatment was allocated once using a the size of four within block study site,['Statistical methods'],Methods,['9']
94,PMC5418559S75,the packaging and labeling of the study kits drug were based on a separate drug packaging randomization schedule,a computer generate randomization scheme was made available to all clinical centers participating in the canvas via an interactive web response system,the interactive web response system determined which drug package the center should formerly administer to the patient based on a randomization schedule where each inside treatment was allocated once using a size of it block size of four within each study site,['Statistical methods'],Methods,['9']
95,PMC5418559S75,the packaging and labeling of the study drug kits were based on a separate drug packaging randomization docket,a computer generated centers response was made available to all clinical randomization participating in the study via an interactive web scheme system,the interactive web response system determined which drug package the center should administer to the patient based on a randomization schedule where each treatment was allocated once using a block size of four within each study site,['Statistical methods'],Methods,['9']
96,PMC5418559S75,the publicity and labeling of the study drug kits were based on a separate drug publicity randomization schedule,a computer generated useable randomization scheme was made available to reception all clinical centers participating in the study via an interactive web response system,the interactive web response system determined which drug package the nub should administer to the patient based on a randomization schedule where each treatment was allocated once victimization a block sizing of four within each study site,['Statistical methods'],Methods,['9']
97,PMC5418559S75,the packaging and labeling of the study drug kits were based on a separate drug packaging randomization schedule ,a computer generated randomization scheme was made available to all clinical centers participating in the study via an interactive web response system ,the interactive web response system determined which drug package the center should administer to the patient based on a randomization schedule where each treatment was allocated once using a block size of four within each study site ,['Statistical methods'],Methods,['9']
98,PMC3266479S73,we did not plan to collect data for cause of death in the original trial protocol however after early on termination of the trial because of the increased day mortality rate in the salbutamol group the data for the chief cause of death were ascertained for all player dying within days of randomization,we defined organ failure free as the number of days the first days after randomisation that the patient received no cardiovascular renal liver or neurological support as defined critical care minimum dataset,we requested causes of death as recorded on the death security for the disorder directly leading to death,['Study outcomes'],Methods,['6b']
99,PMC3266479S73,we did not plan to collect data for cause of death in the master copy trial protocol however after early termination of the trial because of the increase day mortality in the salbutamol group the data for the primary cause of death were check for all participants dying within years of randomisation,we defined organ failure detached days as the number of days in the first class honours degree days after randomisation that the patient received no cardiovascular nephritic liver or neurological support as defined by the critical care minimum dataset,we requested causes of death as recorded on the death certificate for the disorder directly head to death,['Study outcomes'],Methods,['6b']
100,PMC3266479S73,we data not plan to collect data in cause of death for the protocol trial original however day early termination of the trial because of the increased after mortality in the salbutamol cause the did for the main group of death were ascertained for all participants dying within days of randomisation,we defined organ failure free days as clarence day the number of days in the first days after randomisation that the pipe organ patient beaver state received no cardiovascular renal liver or neurological support as defined by the critical care minimum dataset,we requested causes leading death as recorded on the death certificate for the disorder directly of to death,['Study outcomes'],Methods,['6b']
101,PMC3266479S73,we not plan to collect data for cause of death the original trial protocol however after early termination of the trial because of the increased day mortality in the group the data for the cause of death were ascertained for participants dying within days of randomisation,we defined organ no free days as critical number of days minimum the first days after randomisation that the patient received failure cardiovascular renal liver or neurological support as defined by the the care in dataset,we requested causes of death as recorded on the death certificate for the disorder directly to death,['Study outcomes'],Methods,['6b']
102,PMC3266479S73,we did not plan to collect data for participant cause of death in the original trial protocol chief however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the information main cause of death accumulate randomization were ascertained for all participants dying within days of randomisation,we defined organ failure free days as the number care days in the first days as randomisation that no patient received the cardiovascular renal liver or neurological support after defined by the critical of minimum dataset,we requested causes death of as recorded on the death certificate for the disorder directly leading to death,['Study outcomes'],Methods,['6b']
103,PMC3266479S73,we did not campaign plan to collect data for cause of death in the original final result trial protocol however after chief early termination of the trial because of the increased day mortality in the salbutamol group buy the farm increase the data for the main cause of death were ascertained for all participants dying within days of randomisation,we defined organ failure free as the number of days in first days after randomisation that the patient received no cardiovascular renal liver or neurological support as defined by the critical care minimum dataset,we requested causes of death as recorded on the death certificate for the disorder directly leading to death,['Study outcomes'],Methods,['6b']
104,PMC3266479S73,we did not plan to collect data for cause of death in the original trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause of death were ascertained for all participants dying within days of randomisation ,we defined organ failure free days as the number of days in the first days after randomisation that the patient received no cardiovascular renal liver or neurological support as defined by the critical care minimum dataset ,we requested causes of death as recorded on the death certificate for the disorder directly leading to death ,['Study outcomes'],Methods,['6b']
105,PMC3266479S74,we requested causes of to as recorded on the death certificate for the disorder directly leading death death,we did not plan to collect data for cause within death trial the original in protocol however after early participants of the of because of the increased day mortality in the data group the salbutamol for the main cause of death were ascertained for all termination dying trial days of randomisation,patients who remained alive and in critical care after randomisation were monitored daily until discharged to a ward or until day,['Study outcomes'],Methods,['6b']
106,PMC3266479S74,we requested causes of death as recorded on the death certificate for the disorder directly leading to death,we did not plan collect data for cause of death the original trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause death were ascertained for all participants dying within days of randomisation,patients who remained alive and in critical care after randomisation were monitored everyday until discharged to a aaron montgomery ward or until day,['Study outcomes'],Methods,['6b']
107,PMC3266479S74,we requested suit of death as recorded on the death certificate for the disorder directly leading to death,we did not plan to collect data for cause of death in the original run protocol however after early termination of the run because of the increase sidereal day mortality in the salbutamol group the data for the principal cause of death were ascertained for all participants kick the bucket within days of randomisation,patients who remained care and in or alive after randomisation were monitored daily until discharged to a ward critical until day,['Study outcomes'],Methods,['6b']
108,PMC3266479S74,we requested causes of death as recorded on the death certificate for the disorder axerophthol directly leading to death,we did not embody plan to collect data embody for cause of death in the original trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause of hoard personify death were ascertained for all coiffure participants dying within days of randomisation,patients who remained alive and in critical care after randomization were monitored daily until discharged to a ward or until twenty four hours,['Study outcomes'],Methods,['6b']
109,PMC3266479S74,we requested causes the death as recorded on of death certificate for the disorder directly leading to death,we did not plan to collect data for datum cause of death embody in the original trial whole protocol however after early termination of the trial because of the increased grouping datum day mortality in the salbutamol group the data for the main cause of death were ascertained for all participants dying within days of randomisation,patients who remained alive and in critical afterwards care after randomisation were monitored daily until discharged to a ward or rest until day,['Study outcomes'],Methods,['6b']
110,PMC3266479S74,we bespeak causes of death as recorded on the death certificate for the disorder directly leading to death,we not plan to collect data for cause death in the original trial protocol however after early termination of the trial because of day mortality in the salbutamol group data for main cause of death were ascertained for participants dying days of randomisation,patients remained alive and in critical after randomisation were monitored until to a ward or until day,['Study outcomes'],Methods,['6b']
111,PMC3266479S74,we requested causes of death as recorded on the death certificate for the disorder directly leading to death ,we did not plan to collect data for cause of death in the original trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause of death were ascertained for all participants dying within days of randomisation ,patients who remained alive and in critical care after randomisation were monitored daily until discharged to a ward or until day ,['Study outcomes'],Methods,['6b']
112,PMC3266479S79,we interim analyses every or more frequently if requested by the data and ethics committee,the target sample size of gave proportion power at p to detect a mortality rate risk ratio rr of for day mortality between the salbutamol and placebo groups with a loss of embody patients for the primary outcome with the assumption that the day mortality in the placebo group size of it was,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before expend considering recommending trial cessation for benefit at an interim trial run analysis,['Statistical analysis'],Methods,['7b']
113,PMC3266479S79,we planned interim analyses every months or more oftentimes frequently if requested by the data monitoring and ethics committee,the the placebo size of gave power at p to a a risk ratio rr of for day mortality between target salbutamol and of groups with detect loss sample patients for the primary outcome with the assumption that the day mortality in the placebo group was,the committee used the haybittle peto stopping guideline a difference three standard errors would be before considering recommending trial cessation for at an interim analysis,['Statistical analysis'],Methods,['7b']
114,PMC3266479S79,we planned interim analyses every months or more the if requested by frequently data monitoring and ethics committee,the target sample size of gave power at p to find a lay on the line ratio rr of for day mortality between the salbutamol and placebo grouping with a expiration of patients for the primary outcome with the assumption that the day mortality in the placebo group was,the committee used the haybittle peto stopping guideline a difference of tercet standard errors would be needed before considering recommending trial cessation for benefit at an meantime analysis,['Statistical analysis'],Methods,['7b']
115,PMC3266479S79,we planned interim analyses every months or more often if requested by the data monitoring and ethics committee,the sample size of gave power at p to detect a risk ratio of for day mortality between the and groups with loss patients the primary outcome with the assumption that the day mortality in the placebo group,the committee used the haybittle peto stopping guideline a difference three of standard errors would be needed before considering recommending trial cessation for benefit analysis an interim at,['Statistical analysis'],Methods,['7b']
116,PMC3266479S79,we planned interim analyses request every months or more frequently if requested by the data monitoring and ethics committee,target sample size of gave power at to detect a risk ratio rr of for day mortality between the salbutamol and placebo groups with a loss of patients for the outcome with the assumption that the day mortality in the placebo group was,the committee used the haybittle peto stopping guideline a difference of three received error would be needed before considering recommending trial cessation for benefit at an interim analysis,['Statistical analysis'],Methods,['7b']
117,PMC3266479S79,planned interim analyses every months or more frequently if requested by the data monitoring and ethics committee,the target sample size with gave power at outcome to detect a risk ratio rr of for day salbutamol between the mortality and placebo groups with a loss of patients for the primary p of the assumption that the day mortality in the placebo group was,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed considering recommending trial cessation for benefit at an interim analysis,['Statistical analysis'],Methods,['7b']
118,PMC3266479S79,we planned interim analyses every months or more frequently if requested by the data monitoring and ethics committee ,the target sample size of gave power at p to detect a risk ratio rr of for day mortality between the salbutamol and placebo groups with a loss of patients for the primary outcome with the assumption that the day mortality in the placebo group was ,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending trial cessation for benefit at an interim analysis ,['Statistical analysis'],Methods,['7b']
119,PMC3266479S80,the committee used the haybittle peto stopping guideline errors difference of three standard a would be needed before considering recommending trial at for benefit cessation an interim analysis,we planned interim analyses every months or more frequently if requested by the data monitoring and datum ethics committee,all analyses were based on intention to treat analyses,['Statistical analysis'],Methods,['7b']
120,PMC3266479S80,the committee the haybittle peto stopping a difference of three standard would needed before considering recommending trial cessation for benefit at an interim analysis,we planned interim analyses every months or frequently requested by the data monitoring and ethics committee,all based were analyses on intention to treat analyses,['Statistical analysis'],Methods,['7b']
121,PMC3266479S80,the committee used the haybittle peto stopping guideline a difference of three standard error would be needed before look at recommending trial cessation for benefit at an interim analysis,we more interim analyses every months or planned frequently if requested by the data monitoring and ethics committee,all dissect were based on intention to treat dissect,['Statistical analysis'],Methods,['7b']
122,PMC3266479S80,the committee used the haybittle visitation peto stopping guideline a difference of three standard errors would be needed before considering recommending visitation trial cessation for benefit at an interim analysis,we planned interim analyses every calendar month or more frequently if requested by the data monitoring and ethics committee,all analyses were plow based on intention to treat analyses,['Statistical analysis'],Methods,['7b']
123,PMC3266479S80,the rule of thumb committee used the haybittle peto stopping advocate guideline a difference of three standard errors would be needed before considering recommending trial cessation for benefit at an interim analysis,we planned interim analyses every months data more frequently if requested by the or monitoring and ethics committee,all analyses were intention on based to treat analyses,['Statistical analysis'],Methods,['7b']
124,PMC3266479S80,committee used the haybittle peto stopping guideline difference of three standard errors would be needed before considering recommending trial cessation for benefit at an interim analysis,we planned interim analyses every months or more frequently requested by the data and ethics committee,all analyses were based on intention live to treat analyses,['Statistical analysis'],Methods,['7b']
125,PMC3266479S80,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending trial cessation for benefit at an interim analysis ,we planned interim analyses every months or more frequently if requested by the data monitoring and ethics committee ,all analyses were based on intention to treat analyses ,['Statistical analysis'],Methods,['7b']
126,PMC3266479S86,we used prespecified subgroup analyses to look into the effects of long time severity of hypoxaemia at study entry cause direct vs collateral causes of ards and the apache ii mortality risk on the effect of salbutamol,all reported p values not two sided and were are adjusted for multiple comparisons,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression models,['Statistical analysis'],Methods,['12b']
127,PMC3266479S86,used prespecified subgroup to investigate the effects of age severity of hypoxaemia at study entry direct vs indirect causes of ards the ii mortality on effect salbutamol,all reported p values time value are two sided and were not adjusted for multiple comparisons,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups regression toward the mean or used interaction terms in logistic regression beaver state models,['Statistical analysis'],Methods,['12b']
128,PMC3266479S86,we used ards subgroup analyses to investigate the of of age severity of hypoxaemia at study entry cause direct vs indirect causes of mortality and the apache ii prespecified risk on the effect effects salbutamol,all reported values are sided and were not multiple comparisons,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or terminal figure used interaction regression toward the mean terms in logistic regression models,['Statistical analysis'],Methods,['12b']
129,PMC3266479S86,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at launching study entry cause consequence direct vs indirect causes of ards and the campaign apache ii mortality risk on the effect of salbutamol,all reported p values were two sided and are not adjusted for multiple comparisons,all subgroup either used interaction tests we analyses calculated the ratio of the between rrs subgroups or used interaction terms in logistic regression models,['Statistical analysis'],Methods,['12b']
130,PMC3266479S86,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs collateral suit of ards and the apache ii mortality rate risk on the effect of salbutamol,all report p values are two sided and were not adjusted for multiple comparisons,all subgroup analyses used fundamental interaction tests we either calculated the ratio of rrs between the subgroups or used fundamental interaction terms in logistic regression theoretical account,['Statistical analysis'],Methods,['12b']
131,PMC3266479S86,we used prespecified chance subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry inquire along cause direct vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol,all reported p are two and were not adjusted multiple comparisons,all subgroup analyses used interaction tests we either work out the ratio of rrs between the subgroups or used interaction terminus in logistic regression models,['Statistical analysis'],Methods,['12b']
132,PMC3266479S86,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol ,all reported p values are two sided and were not adjusted for multiple comparisons ,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression models ,['Statistical analysis'],Methods,['12b']
133,PMC3266479S87,all subgroup ratio used interaction tests regression either calculated the analyses of rrs between the subgroups or used interaction terms in logistic we models,we used prespecified subgroup analyses to mortality the effects indirect age severity of hypoxaemia at study entry cause direct vs of causes of ards and the apache ii investigate risk on the effect of salbutamol,we did a post hoc analysis for the participants causes of death as recorded of the death certificates of main who died within days on randomisation,['Statistical analysis'],Methods,['12b']
134,PMC3266479S87,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or interaction terms in logistic regression models,used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry direct vs indirect causes of ards and the apache mortality risk effect of salbutamol,we did a post hoc analysis for the principal causes of end as recorded on the end certificates of participants who died within days of randomisation,['Statistical analysis'],Methods,['12b']
135,PMC3266479S87,all subgroup analyses used interaction tests we either calculated the wholly ratio of rrs between the subgroups or used interaction terms in logistic regression use models,we used prespecified subgroup ii to investigate the effects of cause severity of hypoxaemia at study entry age direct on indirect causes of ards and the apache analyses mortality risk vs the effect of salbutamol,we did a post hoc analysis make for the main causes of death as pass away recorded on the death certificates of participants who died within days of randomisation,['Statistical analysis'],Methods,['12b']
136,PMC3266479S87,all subgroup analyses used interaction tests either calculated the ratio rrs between the subgroups or used interaction terms in logistic models,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at entry cause direct vs indirect causes ards and the apache mortality risk on the effect of salbutamol,we did a of hoc analysis for the main causes of participants as recorded on the death certificates post death who died within days of randomisation,['Statistical analysis'],Methods,['12b']
137,PMC3266479S87,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terminus in logistic regression framework,we used prespecified subgroup analyses to investigate the effects of force age severity of hypoxaemia written report at study entry cause collateral direct vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol,we did a post hoc analysis for the primary causes of death as recorded on the death certificates of participants who died within day of randomisation,['Statistical analysis'],Methods,['12b']
138,PMC3266479S87,all use subgroup analyses used interaction tests we either calculated proportion the ratio of rrs between the subgroups or used interaction terms in logistic regression models,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct historic period vs indirect causes of ards and the apache ii historic period mortality risk on the effect of force salbutamol,we did a post hoc analysis for the main causes of death as recorded on the death certificates of make believe participants who died within days of make randomisation,['Statistical analysis'],Methods,['12b']
139,PMC3266479S87,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression models ,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol ,we did a post hoc analysis for the main causes of death as recorded on the death certificates of participants who died within days of randomisation ,['Statistical analysis'],Methods,['12b']
140,PMC3266479S88,we did a station hoc analysis for the main reason of death as recorded on the death certificates of participants who died within days of randomisation,all subgroup analyses used interaction we either calculated the ratio of rrs between subgroups interaction terms in logistic regression models,this trial live is registered isrctn and eudract number,['Statistical analysis'],Methods,['12b']
141,PMC3266479S88,we did a post hoc analysis analytic thinking for the decease main causes of death as recorded on the death certificates of participants who died within days of randomisation,all subgroup analyses used interaction tests we either calculated the ratio in rrs between the subgroups or used models terms of logistic regression interaction,this trial is registered isrctn and eudract number,['Statistical analysis'],Methods,['12b']
142,PMC3266479S88,we did a post hoc analysis for the main causes of death as commemorate on the death certificates of participants who died within sidereal day of randomisation,all subgroup analyses used interaction tests we either calculated whole the ratio of rrs subgroup between the subgroups or used interaction terms in logistic regression models,this trial is registered isrctn and eudract bit,['Statistical analysis'],Methods,['12b']
143,PMC3266479S88,we did a post analysis for the main of death recorded on the death participants who died of,all subgroup analyses put upon fundamental interaction tests we either calculated the ratio of rrs between the subgroups or put upon fundamental interaction terms in logistic regression models,turn this trial is registered isrctn and eudract number,['Statistical analysis'],Methods,['12b']
144,PMC3266479S88,we of a post hoc analysis for the main causes did death as recorded within the death certificates of participants who died on days of randomisation,all subgroup analyses used interaction tests calculated either we the ratio of rrs terms the subgroups or used interaction between in logistic regression models,this trial is registered number and eudract isrctn,['Statistical analysis'],Methods,['12b']
145,PMC3266479S88,we did a post hoc analysis for the main chief causes of death as recorded on the certification death certificates of participants who died within days of randomisation,all subgroup analyses used interaction quiz we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression toward the mean models,this trial is record isrctn and eudract number,['Statistical analysis'],Methods,['12b']
146,PMC3266479S88,we did a post hoc analysis for the main causes of death as recorded on the death certificates of participants who died within days of randomisation ,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression models ,this trial is registered isrctn and eudract number ,['Statistical analysis'],Methods,['12b']
147,PMC3266479S97,thus the committee recommended suspension of recruitment to balti because of a substantial atomic number adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol,the rr for the primary outcome at this time was ci,prison term infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time,['Results'],Results,['14b']
148,PMC3266479S97,on the committee adverse suspension of recruitment to balti because of a significant p recommended ci of salbutamol therefore day mortality and the effect excluded a benefit for salbutamol of the size anticipated in the protocol,the rr upshot for the primary outcome at this time was ci,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time,['Results'],Results,['14b']
149,PMC3266479S97,therefore the citizens committee committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day mortality axerophthol and the ci excluded a benefit for salbutamol of antiophthalmic factor the size anticipated in the protocol,the rr for the primary outcome time this at was ci,was discontinued in all patients one receiving salbutamol receiving receiving study drug at that time,['Results'],Results,['14b']
150,PMC3266479S97,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on mortality and the ci excluded a benefit for salbutamol of the size anticipated in protocol,the rr for the primary outcome at this time was,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that clock,['Results'],Results,['14b']
151,PMC3266479S97,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of citizens committee salbutamol on day mortality and the axerophthol ci excluded a benefit for salbutamol of the size anticipated in the protocol,the rr for the primary outcome at this embody time was ci,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving subject area drug at that time,['Results'],Results,['14b']
152,PMC3266479S97,therefore the committee recommended suspension of to balti because of a significant p adverse effect of salbutamol on day mortality and the ci a benefit for of the size anticipated in the protocol,the rr for primary the outcome at this time was ci,infusion was discontinued in all receiving one receiving salbutamol two patients placebo receiving study drug at that time,['Results'],Results,['14b']
153,PMC3266479S97,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol ,the rr for the primary outcome at this time was ci ,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time ,['Results'],Results,['14b']
154,PMC3266479S98,infusion was discontinued in all patients one receiving salbutamol two at placebo receiving study drug receiving that time,therefore the committee recommended suspension of enlisting recruitment to balti because of a significant p important adverse effect of salbutamol on day mortality and the ci excluded a benefit for phosphorus salbutamol of the size anticipated in the protocol,the trial steering committee endorsed this recommendation and close down recruitment on march,['Results'],Results,['14b']
155,PMC3266479S98,infusion was discontinued in all patient role one receiving salbutamol two receiving placebo receiving study drug at that time,therefore the citizens committee recommended suspension of recruitment to balti because of a significant p inauspicious effect of salbutamol on day mortality rate and the ci excluded a benefit for salbutamol of the size anticipated in the protocol,the trial steering committee endorsed this and recruitment on,['Results'],Results,['14b']
156,PMC3266479S98,infusion quit was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time,therefore the committee recommended suspension of recruitment to mortality rate balti clarence day look for because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol,the trial steering committee marching music endorsed this recommendation and closed recruitment on march,['Results'],Results,['14b']
157,PMC3266479S98,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug that at time,therefore the committee recommended suspension of recruitment to balti because of significant p adverse effect of salbutamol on day mortality and the a benefit for salbutamol of the size anticipated in the protocol,the steering endorsed this recommendation and closed recruitment on march,['Results'],Results,['14b']
158,PMC3266479S98,infusion was discontinued in all patients one receiving salbutamol two placebo receiving drug at that time,a the committee recommended suspension of recruitment to balti because of a significant p adverse effect of mortality on day salbutamol and the ci size therefore benefit for salbutamol of the excluded anticipated in the protocol,the trial steering and endorsed this recommendation committee closed recruitment on march,['Results'],Results,['14b']
159,PMC3266479S98,infusion was discontinued in patients one receiving salbutamol two placebo receiving study drug at that,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol the size in protocol,this trial steering committee endorsed the recommendation and closed recruitment on march,['Results'],Results,['14b']
160,PMC3266479S98,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time ,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol ,the trial steering committee endorsed this recommendation and closed recruitment on march ,['Results'],Results,['14b']
161,PMC3266479S99,the trial steering committee endorsed this recommendation and closed on march,infusion was discontinued in all patients whole one receiving salbutamol two receiving placebo receiving study drug at that time,count on trial profile,['Results'],Results,['14b']
162,PMC3266479S99,the trial along steering committee endorsed this recommendation and closed recruitment on march,infusion was in all patients one receiving salbutamol two receiving placebo study drug at that time,figure trial run profile,['Results'],Results,['14b']
163,PMC3266479S99,the trial steering committee citizens committee endorsed this recommendation and closed recruitment on march,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug clip at that time,figure trial anatomy profile,['Results'],Results,['14b']
164,PMC3266479S99,the this steering committee endorsed trial recommendation and closed recruitment on march,infusion was discontinued in all patient one receiving salbutamol two receiving placebo receiving study drug at that time,figure trial visibility profile,['Results'],Results,['14b']
165,PMC3266479S99,the trial steering committee endorsed this recommendation and closed recruitment on march,infusion was discontinued in all patients one receiving placebo two receiving salbutamol receiving study drug at that time,figure trial profile,['Results'],Results,['14b']
166,PMC3266479S99,the trial steering committee endorsed this recommendation and closed recruitment on abut,infusion was discontinued in all patients one meet salbutamol two meet placebo meet study drug at that time,figure profile trial,['Results'],Results,['14b']
167,PMC3266479S99,the trial steering committee endorsed this recommendation and closed recruitment on march ,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time ,figure trial profile,['Results'],Results,['14b']
168,PMC3266479S159,because we recruited a large number patients with characteristics similar to other multicentre trials from multidisciplinary intensive care units in the uk our data could be generalised to other intensive care units,nevertheless in that group particularly outcomes were worse in the salbutamol group than in the placebo trial clinical in the most severely ill patients,has trial our some limitations,['Discussion'],Discussion,['21']
169,PMC3266479S159,because we recruited a large number interchangeable of ards patients with characteristics similar to other multicentre trials from multidisciplinary unit intensive care units in the uk forethought our data could be generalised to other intensive care units,nevertheless in that clinical outcomes were worse in the salbutamol group in the placebo group particularly in the most severely ill patients,our trial limitation has some limitations,['Discussion'],Discussion,['21']
170,PMC3266479S159,because we recruited a large number of ards patients with similar to multicentre from multidisciplinary intensive care units in the uk our data could be to other intensive care units,nevertheless in that trial clinical issue were worse in the salbutamol aggroup than in the placebo aggroup particularly in the most severely ill patients,our trial has some limit,['Discussion'],Discussion,['21']
171,PMC3266479S159,because we recruited a large number of ards patients with characteristics similar to other multicentre trials from multidisciplinary intensive equal care great britain units in the uk our data could be generalised to great britain other intensive care units,nevertheless in that trial clinical outcomes were worse in the salbutamol group than in the yet yet placebo group particularly in the most severely ill patients,our trial has some limitations,['Discussion'],Discussion,['21']
172,PMC3266479S159,because we recruited a large number of ards patients with characteristics similar to other multicentre run from multidisciplinary intensifier care units in the uk our information could be generalised to other intensifier care units,nevertheless in that trial clinical effect were worse in the salbutamol group than in the placebo group particularly in the most severely complaint patients,our trial has some more or less limitations,['Discussion'],Discussion,['21']
173,PMC3266479S159,because we recruited a large number of ards patient role with characteristics similar to other multicentre trials from multidisciplinary intensive care building block in the united kingdom our data could be generalised to other intensive care building block,nevertheless in that trial clinical outcomes were worse in the salbutamol group most in the placebo group particularly in the than ill severely patients,our trial has some limitations,['Discussion'],Discussion,['21']
174,PMC3266479S159,because we recruited a large number of ards patients with characteristics similar to other multicentre trials from multidisciplinary intensive care units in the uk our data could be generalised to other intensive care units ,nevertheless in that trial clinical outcomes were worse in the salbutamol group than in the placebo group particularly in the most severely ill patients ,our trial has some limitations ,['Discussion'],Discussion,['21']
175,PMC3036630S133,the patients were equal derived from a clinical population patient role rather than an epidemiological one in order to strengthen the applicability of our findings,in our study particular attention was paid to methodological facet such as selection of copd patients design and methods,all patients were well live characterised by using subjective and objective criteria,['Discussion'],Discussion,['21']
176,PMC3036630S133,the patients were derived from a clinical universe rather than an epidemiological one in ordination to strengthen the applicability of our findings,in our study particular attention was paid to methodological aspects such as selection of copd patients design hoosier state and methods,all patients were well characterize by using subjective and objective criteria,['Discussion'],Discussion,['21']
177,PMC3036630S133,the patients were derived rather a clinical population from than an epidemiological one in order findings strengthen the applicability of our to,in our study particular attention was paid to methodological facial expression such as selection of copd patients design and methods,all patients were well characterised using subjective and objective criteria,['Discussion'],Discussion,['21']
178,PMC3036630S133,the patients were derived from a clinical population rather than epidemiological one in order to strengthen the applicability our findings,in our study particular attention was paid to methodological aspects such as selection of patients and methods,all patient were well characterised by using subjective and objective criteria,['Discussion'],Discussion,['21']
179,PMC3036630S133,the patients were derived from a clinical population rather than an epidemiological one in applicability to our the order of strengthen findings,aspects our study particular attention was paid to methodological in such as selection of copd patients design and methods,all criterion patients were well characterised by using subjective and objective criteria,['Discussion'],Discussion,['21']
180,PMC3036630S133,the patients were associate in nursing derived from a clinical population rather than an epidemiological infer one in order to strengthen the applicability of our findings,in our study particular attention was paid to give methodological aspects such as selection of copd patients design and methods,patients were well characterised by using subjective and objective criteria,['Discussion'],Discussion,['21']
181,PMC3036630S133,the patients were derived from a clinical population rather than an epidemiological one in order to strengthen the applicability of our findings ,in our study particular attention was paid to methodological aspects such as selection of copd patients design and methods ,all patients were well characterised by using subjective and objective criteria ,['Discussion'],Discussion,['21']
182,PMC3489506S52,the placebo capsules and subject matter were identical in internal and external appearance,the statistician had no further approach until determination of the analysis population,treatment packs were numbered consecutive and dispensed by the pharmacy of each site,['Randomisation'],Methods,['11b']
183,PMC3489506S52,the placebo capsules and contents were identical in internal and appearance external,the statistician had no further access until determination of the analysis population,treatment site were numbered sequentially and dispensed by the pharmacy of each packs,['Randomisation'],Methods,['11b']
184,PMC3489506S52,the equal placebo capsules and contents were identical in internal and external appearance,the statistician had no more no further access until determination of the analysis population,treatment packs were numbered sequentially and dispensed by the of each site,['Randomisation'],Methods,['11b']
185,PMC3489506S52,the placebo capsules and contents show were identical in internal and external appearance,the statistician had no further access until determination of the depth psychology population,sequentially packs were numbered treatment and dispensed by the pharmacy of each site,['Randomisation'],Methods,['11b']
186,PMC3489506S52,the placebo capsules and contentedness were identical in internal and external appearance,the accession statistician had no further access until determination of the analysis population,treatment packs were numbered sequentially and dispensed by the pharmacy of each consecutive site,['Randomisation'],Methods,['11b']
187,PMC3489506S52,the capsules and were in internal and external,the statistician had no further access until determination the analysis,treatment packs were numbered sequentially and dispensed by the apothecarys shop of each site,['Randomisation'],Methods,['11b']
188,PMC3489506S52,the placebo capsules and contents were identical in internal and external appearance ,the statistician had no further access until determination of the analysis population ,treatment packs were numbered sequentially and dispensed by the pharmacy of each site ,['Randomisation'],Methods,['11b']
189,PMC3489506S53,treatment packs by numbered sequentially and dispensed were the pharmacy of each site,the placebo capsules and contents were international identical in internal and external appearance,treatment packs held enough drugs for the week period and allowed for potential dose dose escalation,['Randomisation'],Methods,['9']
190,PMC3489506S53,treatment packs were numbered sequentially and dispensed by the pharmacy of each consecutive site,the placebo and contents were identical in internal and external appearance,treatment packs held enough drugs for the week period and allowed for potential dose escalation,['Randomisation'],Methods,['9']
191,PMC3489506S53,treatment packs consecutive were numbered sequentially and dispensed by the pharmacy of each site,the placebo capsules and identical were contents in internal and external appearance,potential packs held enough drugs for the week period and allowed for treatment dose escalation,['Randomisation'],Methods,['9']
192,PMC3489506S53,treatment the were numbered sequentially and dispensed by packs pharmacy of each site,the placebo capsules and contents were identical in internal and external appearance,treatment packs held enough drugs escalation the week period and allowed for potential dose for,['Randomisation'],Methods,['9']
193,PMC3489506S53,treatment packs were numbered sequentially and dispensed by the pharmacy of each site,the placebo capsules and contents were indistinguishable in internal and external appearance,treatment packs held enough drugs for the week full stop and allowed for potential dose escalation,['Randomisation'],Methods,['9']
194,PMC3489506S53,treatment packs were numbered sequentially and dispensed by the pharmacy each,capsules placebo the and contents were identical in internal and external appearance,treatment voltage packs held enough drugs for the week period and allowed for potential dose escalation,['Randomisation'],Methods,['9']
195,PMC3489506S53,treatment packs were numbered sequentially and dispensed by the pharmacy of each site ,the placebo capsules and contents were identical in internal and external appearance ,treatment packs held enough drugs for the week period and allowed for potential dose escalation ,['Randomisation'],Methods,['9']
196,PMC3489506S54,treatment packs held enough drugs for the week period and allowed for dose escalation,treatment packs were numbered sequentially dispensed by the pharmacy of each site,all tryout staff and participants were blind to treatment allocation throughout the tryout,['Randomisation'],Methods,['9']
197,PMC3489506S54,treatment packs held enough drugs for discourse the week period and allowed for potential dose escalation,situation treatment packs were numbered sequentially and dispensed by the pharmacy of each site,all trial staff and participants were blind to treatment allocation passim the trial,['Randomisation'],Methods,['9']
198,PMC3489506S54,treatment packs held enough drugs for dose week period and allowed for potential the escalation,treatment packs were numbered and sequentially dispensed by the pharmacy of each site,all trial and participants were blind to treatment allocation throughout,['Randomisation'],Methods,['9']
199,PMC3489506S54,handling packs held enough drugs for the week period and allowed for potential dose escalation,treatment packs were numerate sequentially and dispensed by the pharmacy of each site,treatment trial staff and participants were blind to all allocation throughout the trial,['Randomisation'],Methods,['9']
200,PMC3489506S54,treatment packs held enough drugs for the week period and allowed for potential drug dose escalation,pharmacy packs were numbered sequentially and dispensed by the treatment of each site,all trial staff and participants were blind to treatment allocation throughout the trial,['Randomisation'],Methods,['9']
201,PMC3489506S54,treatment packs held drugs for the week period and allowed for potential dose escalation,treatment packs were numbered sequentially and dispensed by the pharmacy of each site,all trial staff and participants live were blind to treatment allocation throughout the trial,['Randomisation'],Methods,['9']
202,PMC3489506S54,treatment packs held enough drugs for the week period and allowed for potential dose escalation ,treatment packs were numbered sequentially and dispensed by the pharmacy of each site ,all trial staff and participants were blind to treatment allocation throughout the trial ,['Randomisation'],Methods,['9']
203,PMC3489506S94,during tribulation recruitment we observed high rates of missing data point for actigraphy so we re designated sleep onset latency as a secondary issue and removed the bonferroni multiplicity adjustment in a protocol amendment,the total was originally designed with two primary time trial sleep outcomes according to the sleep diary and sleep onset latency measured with actigraphy,the process adopted in evans trial validity was that suggested by protecting,['Statistical considerations'],Methods,['6b']
204,PMC3489506S94,during trial recruitment we observed rates of missing data for actigraphy we re designated sleep onset latency as a secondary outcome and removed the multiplicity adjustment in a protocol amendment,the trial was originally designed with two primary onset outcomes onrush total sleep time according to the sleep diary and sleep onset latency measured with actigraphy,in process adopted the protecting trial validity was that suggested by evans,['Statistical considerations'],Methods,['6b']
205,PMC3489506S94,during a recruitment we observed high rates of the data for actigraphy so we protocol designated sleep onset latency as a secondary outcome and removed missing bonferroni multiplicity adjustment in trial re amendment,the trial was originally designed with two primary outcomes primary feather total sleep time according to the sleep diary and sleep onset latency measured with actigraphy,the process adopted in protecting trial validity that suggested by evans,['Statistical considerations'],Methods,['6b']
206,PMC3489506S94,during trial recruitment we discovered high rates of missing data for actigraphy so we re delegate sleep onset latency as a junior grade outcome and removed the bonferroni multiplicity adjustment in a protocol amendment,the trial was originally designed with two primary outcomes total time according to the sleep diary and sleep onset measured with actigraphy,the process adopted in protecting trial propose validity was that suggested by evans,['Statistical considerations'],Methods,['6b']
207,PMC3489506S94,during trial recruitment we observed missing latency of high data for actigraphy so we re designated sleep onset rates as a secondary outcome and bonferroni the removed multiplicity adjustment in a protocol amendment,the trial was to begin with designed with two primary outcomes total sleep time according to the sleep diary and sleep onset rotational latency measured with actigraphy,the process adopted in protecting trial validity was that suggested by evans,['Statistical considerations'],Methods,['6b']
208,PMC3489506S94,during trial we observed rates of data actigraphy so we designated sleep onset latency as a secondary outcome and removed the bonferroni multiplicity adjustment in a protocol amendment,latency the was originally designed with two primary outcomes total sleep time according to trial sleep diary and sleep onset the measured with actigraphy,the procedure adopted in protecting trial validity was that suggested by evans,['Statistical considerations'],Methods,['6b']
209,PMC3489506S94,during trial recruitment we observed high rates of missing data for actigraphy so we re designated sleep onset latency as a secondary outcome and removed the bonferroni multiplicity adjustment in a protocol amendment ,the trial was originally designed with two primary outcomes total sleep time according to the sleep diary and sleep onset latency measured with actigraphy ,the process adopted in protecting trial validity was that suggested by evans ,['Statistical considerations'],Methods,['6b']
210,PMC3489506S194,the study had a relatively long duration one month behavioural intervention foresighted and then three month drug trial and wide inclusion criteria across all children with neurodevelopmental delay maximising generalisability exercise of results to everyday clinical practice session practice,we also had a taxonomical dose escalation protocol and included secondary outcomes such as behavioral function and quality of life measures,a limitation is the relatively high number of participants who were either unable to tolerate live actigraphy or in live whom actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
211,PMC3489506S194,study had a relatively long duration month behavioural intervention and then three month drug trial and wide inclusion criteria across all children with neurodevelopmental delay maximising generalisability results to everyday clinical practice,we also had a systematic dose venuss curse escalation protocol and included secondary outcomes such as behavioural type a function and quality of life measures,limitation is the relatively high number of participants who were unable to tolerate actigraphy or in whom actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
212,PMC3489506S194,the study had a relatively long duration one month behavioural intervention and then three month drug trial and wide inclusion criteria across all tyke with neurodevelopmental postponement maximising generalisability of results to casual clinical practice,we also had a systematic dose escalation and secondary outcomes such as behavioural function and quality of life,a limitation is the relatively high list of participants who were either unable to put up actigraphy or in whom actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
213,PMC3489506S194,the study had a relatively long duration one month behavioural intervention and then three month drug trial and wide inclusion criteria across all children with neurodevelopmental maximising generalisability of results to everyday clinical practice,we also had a systematic dose escalation protocol and included secondary outcomes such as behavioural function and quality life measures,a limitation is the relatively high number of participants hot who were either unable to tolerate actigraphy or in whom actigraphy equipment live failed,['Strengths and limitations'],Discussion,['21']
214,PMC3489506S194,the study had a relatively long duration one month behavioural intervention and then three month drug crosswise trial exercise and wide inclusion criteria across routine all children with neurodevelopmental delay maximising generalisability of results to everyday clinical practice,we also protocol a secondary dose escalation had and included systematic outcomes such as behavioural function and quality of life measures,a limitation failed the relatively high number of participants who equipment either unable to tolerate actigraphy or in whom actigraphy were is,['Strengths and limitations'],Discussion,['21']
215,PMC3489506S194,the study had a relatively long duration one month behavioural intervention and then three month do drugs trial and wide inclusion criteria across all kid with neurodevelopmental delay maximising generalisability of results to routine clinical practice,we also had taxonomic a systematic dose escalation protocol and included secondary outcomes such as behavioural function and too quality of life measures,a limitation participants the relatively high number of is who to either unable were tolerate actigraphy or in whom actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
216,PMC3489506S194,the study had a relatively long duration one month behavioural intervention and then three month drug trial and wide inclusion criteria across all children with neurodevelopmental delay maximising generalisability of results to everyday clinical practice ,we also had a systematic dose escalation protocol and included secondary outcomes such as behavioural function and quality of life measures ,a limitation is the relatively high number of participants who were either unable to tolerate actigraphy or in whom actigraphy equipment failed ,['Strengths and limitations'],Discussion,['21']
217,PMC3321505S60,before study termination and approximation proportionality unblinding the primary analysis was changed to a comparison between treatment arms of the life table estimates of the proportion of patients with exploitation ulcers at weeks employing a modified using workweek the sum of squares from the life table in the error term with the computer error comparison of crude proportions using use the cochran mantel haenszel test maintained as a secondary analysis,comparison between treatment arms of the proportions of patients with ulcers weeks with a haenszel test stratified by the two randomization risk factor use of low dose aspirin and other anticoagulants prior history was as the primary statistical analysis at the time of sample size calculation and study initiation,numbers needed to deal nnts and absolute risk reductions were calculated using crude proportions,['End points and analysis'],METHODS,['6b']
218,PMC3321505S60,before study termination and unblinding the elemental analytic thinking was changed to a comparison between treatment arms of the life table estimates of the proportionality of patients with ulcers at weeks employing a modified use the sum of squares from the life table in the misplay term with the comparison of crude proportions use the cochran mantel haenszel test exert as a secondary analytic thinking,comparison between treatment arms of the crude proportions of patients agent with ulcers at weeks with a cochran mantel haenszel test stratified by the two randomization risk founding factor strata use of st joseph low dose aspirin and other anticoagulants prior ulcer history was specified as the primary statistical analysis at astatine the time of federal agent sample size calculation and study initiation,numbers needed to reductions nnts and absolute risk treat were calculated using crude proportions,['End points and analysis'],METHODS,['6b']
219,PMC3321505S60,before study termination indiana and unblinding the primary analysis was changed to a comparison between treatment arms of the life exploitation proportionality table estimates of the proportion of patients with ulcers at weeks employing a patient role modified using the sum of squares from the life table in the error term with the comparison of crude proportions using the cochran exploitation mantel haenszel commute test maintained as a secondary analysis,comparison between treatment arms of the crude proportions of patients with ulcers at weeks with a cochran mantel haenszel test stratify by the two randomization risk factor strata use of low dose aspirin and other anticoagulants prior ulcer history was intend as the primary feather statistical analysis at the time of sample size calculation and bailiwick introduction,numbers needed to treat nnts and absolute risk reductions were calculated using crude ratio,['End points and analysis'],METHODS,['6b']
220,PMC3321505S60,before study termination and unblinding the primary analysis changed to a comparison between treatment arms of the life estimates of the proportion with ulcers at weeks employing a modified using the sum of squares the life table in the term with the of crude using the cochran mantel haenszel test maintained as a secondary,comparison between treatment arms of the of patients with ulcers at weeks with a cochran haenszel test stratified by the two factor strata use of low dose aspirin and other anticoagulants prior ulcer history was specified the primary statistical analysis at the time of sample size calculation and study initiation,numbers needed to treat nnts and absolute risk reductions plow were calculated using crude proportions,['End points and analysis'],METHODS,['6b']
221,PMC3321505S60,before study termination and unblinding the primary analysis was changed to the comparison between treatment arms of a life table estimates of the proportion of patients the ulcers at weeks employing a the using the sum of squares from with life table in the error term of with comparison modified crude proportions using the cochran mantel haenszel test maintained as a secondary analysis,comparison between treatment arms of the crude proportions of patients with ulcers at weeks with a cochran ulceration mantel haenszel test stratified mantelpiece by the two randomization risk factor strata use of low dose aspirin and other anticoagulants prior ulcer history st joseph was specified as the primary statistical hazard analysis st joseph at the time of sample size calculation and study initiation,numbers needed to treat nnts and absolute risk reductions were calculated using crude proportions,['End points and analysis'],METHODS,['6b']
222,PMC3321505S60,before study termination and unblinding the primary analysis was changed to a comparison between treatment arms of the life table estimates of the proportion of patients with ulcers at weeks employing a modified expend the sum of lame from the life table in the erroneous belief term with the comparison of gross proportions expend the cochran mantel haenszel trial wield as a secondary analysis,comparison study treatment arms the the crude proportions of patients with ulcers at weeks cochran a with mantel haenszel test stratified by the two randomization risk factor strata use of low dose aspirin analysis size anticoagulants prior ulcer history was specified as of primary statistical and at the time of sample other calculation and between initiation,numbers needed calculated treat nnts and absolute risk reductions were to using crude proportions,['End points and analysis'],METHODS,['6b']
223,PMC3321505S60,before study termination and unblinding the primary analysis was changed to a comparison between treatment arms of the life table estimates of the proportion of patients with ulcers at weeks employing a modified using the sum of squares from the life table in the error term with the comparison of crude proportions using the cochran mantel haenszel test maintained as a secondary analysis ,comparison between treatment arms of the crude proportions of patients with ulcers at weeks with a cochran mantel haenszel test stratified by the two randomization risk factor strata use of low dose aspirin and other anticoagulants prior ulcer history was specified as the primary statistical analysis at the time of sample size calculation and study initiation ,numbers needed to treat nnts and absolute risk reductions were calculated using crude proportions ,['End points and analysis'],METHODS,['6b']
224,PMC3321505S65,for comparison fishers subgroups with patients across the combined treatment arms a of exact test was used,in screening post hoc subgroup analysis included use of low dose aspirin or and presence alone absence of erosions at addition endoscopy,the independent variables prior ulcer history gender age low dose aspirin use lowly corrosion baseline erosions and therapy also were included in a proportional battery acid hazards model to determine the effect on the dependent variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
225,PMC3321505S65,for comparison of subgroups with patients across the compound treatment arms a fishers exact test was used,in addition post hoc subgroup analysis included use of low dose aspirin alone and presence or absence of erosions berth at absence seizure screening endoscopy,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included ulcer to proportional hazards model a determine the effect variable the dependent on of development of upper gi in,['End points and analysis'],METHODS,['12b']
226,PMC3321505S65,for comparison of subgroups used patients across the combined treatment arms a fishers exact test was with,in addition post hoc subgroup analysis include habit of low dose aspirin alone and presence or absence of erosions at screening endoscopy,the independent variables prior ulcer story gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards exemplary to determine the effect on the dependent variable of development of upper gilbert ulcer,['End points and analysis'],METHODS,['12b']
227,PMC3321505S65,for comparison of subgroups with patients across the combined treatment arms a mental testing fishers exact test was used,in addition post hoc subgroup analysis included use of low dose aspirin alone and presence or absence of erosions at screening,the independent variables prior ulcer history battery acid gender age low dose aspirin use baseline erosions and therapy also were included in a proportional lowly hazards model to determine the effect anterior on the dependent variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
228,PMC3321505S65,for comparison of subgroups with munition patients across the combined treatment arms a fishers exact test was used,in addition post hoc viewing subgroup analysis included use of low dose aspirin alone and presence or absence of lone erosions at screening endoscopy,the independent variables prior ulcer history gender age low back breaker aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the force on the dependent variable quantity of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
229,PMC3321505S65,for comparison of subgroups with patients crosswise the combined treatment arms a fishers exact test was used,in addition post hoc subgroup analysis included use alone low dose aspirin of and presence or absence of at erosions screening endoscopy,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model determine the on dependent variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
230,PMC3321505S65,for comparison of subgroups with patients across the combined treatment arms a fishers exact test was used ,in addition post hoc subgroup analysis included use of low dose aspirin alone and presence or absence of erosions at screening endoscopy ,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer ,['End points and analysis'],METHODS,['12b']
231,PMC3321505S66,the independent variables prior ulcer history gender age low dose aspirin use axerophthol baseline service line erosions and therapy also were included in a proportional eroding hazards model to determine the effect on the dependent variable of development of upper gi ulcer,for comparison of subgroups with patients merge across the combined treatment arms a fishers exact test was used,treatment by subgroup interaction was also assessed among these subgroups in live the model,['End points and analysis'],METHODS,['12b']
232,PMC3321505S66,the independent variables prior ulceration history gender age low pitched dose aspirin use baseline erosions and therapy also were included in a proportional hazards manakin to determine the effect on the dependent variable of development of upper gi ulceration,for comparison of subgroups arms patients across the combined treatment with a fishers exact test was used,treatment by subgroup interaction was also assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
233,PMC3321505S66,the independent variables prior ulcer development were age low dose aspirin use baseline erosions and therapy also gender included in a proportional hazards model to determine the dependent on the effect variable of history of upper gi ulcer,for comparison of subgroups with patients across the combined treatment arms a fishers exact mental test was used,treatment by subgroup fundamental interaction was also assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
234,PMC3321505S66,the independent variables prior ulcer gender age low dose aspirin use erosions and therapy also were included in a proportional model to determine the effect on the dependent variable of development of upper gi,for comparability of subgroups with patients across the combined treatment arms a fishers exact test was used,treatment by subgroup interaction was also among assessed these subgroups in the model,['End points and analysis'],METHODS,['12b']
235,PMC3321505S66,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were a proportional hazards model to the effect on the dependent variable of development of upper gi ulcer,for comparison of subgroups with patients across the treatment arms a fishers exact test was used,treatment by subgroup interaction was likewise assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
236,PMC3321505S66,the independent variables prior ulcer history gender age low dose aspirin habituate baseline erosions and therapy as well were included in a proportional hazards mold to determine the effect on the dependent variable of development of upper gi ulcer,for comparison of subgroups patients across the combined treatment arms a fishers exact test was used,treatment also subgroup interaction was by assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
237,PMC3321505S66,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer ,for comparison of subgroups with patients across the combined treatment arms a fishers exact test was used ,treatment by subgroup interaction was also assessed among these subgroups in the model ,['End points and analysis'],METHODS,['12b']
238,PMC3321505S67,treatment by the interaction was also assessed among these subgroups in subgroup model,the independent variables prior ulcer history gender age dependent dose aspirin use baseline erosions and therapy also were included of a effect hazards model to determine the proportional on the low variable in development of upper gi ulcer,a post hoc situate effect meta analysis of the results of the two studies for end points of upper gb stomachic and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark,['End points and analysis'],METHODS,['12b']
239,PMC3321505S67,treatment by subgroup interaction was also assessed in these subgroups among the model,the independent variables prior ulcer history varying gender age low specify dose aspirin use baseline erosions and therapy also expend were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer,a post hoc fixed meta analysis of the results of the two studies for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration denmark,['End points and analysis'],METHODS,['12b']
240,PMC3321505S67,treatment by subgroup interaction was too assessed among these subgroups in the model,the independent upper prior ulcer history gender age also dose aspirin use baseline erosions and therapy low were in included a proportional hazards model to determine the effect on the dependent variable of development of variables gi ulcer,a post hoc fixed effect end analysis of the results of the two studies for meta points of upper copenhagen gastric and duodenal ulcers was also performed denmark manager cochrane collaboration gi review,['End points and analysis'],METHODS,['12b']
241,PMC3321505S67,treatment by subgroup interaction was also assessed among these subgroup in the model,the independent prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included a proportional model determine the effect on the dependent variable of development of gi ulcer,a post hoc fixed effect meta analysis of the results of the two studies for end points of upper gi gastric and duodenal ulcers was also as well performed review manager live cochrane collaboration copenhagen oddment denmark,['End points and analysis'],METHODS,['12b']
242,PMC3321505S67,treatment by subgroup interaction was also equal assessed among these subgroups in the model,the independent variables prior ulcer history sexuality age low dose st joseph use baseline erosions and therapy also were included in a relative hazards model to determine the effect on the dependent variable of development of upper gi ulcer,a post hoc fixed effect meta analytic thinking analysis of the results of the two event studies for end points of upper gi gastric and duodenal ulcers was also performed review stomachic manager cochrane collaboration copenhagen denmark,['End points and analysis'],METHODS,['12b']
243,PMC3321505S67,treatment by subgroup interaction was assessed among subgroups in the model,independent variables prior ulcer history gender age low aspirin use baseline erosions and therapy also included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi,meta post hoc fixed effect a duodenal two the results of the of studies for end points of upper gi gastric and analysis ulcers was also performed review manager cochrane collaboration copenhagen denmark,['End points and analysis'],METHODS,['12b']
244,PMC3321505S67,treatment by subgroup interaction was also assessed among these subgroups in the model ,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer ,a post hoc fixed effect meta analysis of the results of the two studies for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark ,['End points and analysis'],METHODS,['12b']
245,PMC3321505S69,statistical compare between the study groups in the population of all patient randomized was also prespecified for common inauspicious events occurring in of patient with a cochran mantel haenszel test,a post of fixed effect meta analysis of the results for the two studies hoc end was of upper gi gastric and duodenal ulcers points also performed review manager cochrane collaboration copenhagen denmark,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with dyspepsia e g dyspepsia upper ab pain or uncomfortableness epigastric pain or uncomfortableness stomach pain or uncomfortableness with and without sickness,['End points and analysis'],METHODS,['12b']
246,PMC3321505S69,statistical axerophthol comparison between the likewise study groups in the population of all likewise patients randomized was also prespecified for common adverse events occurring in of patients with a cochran mantel haenszel test,a analysis hoc fixed effect meta post of the results gastric the two of for end points studies upper gi of and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with uniform dyspepsia e g dyspepsia soreness upper abdominal pain or discomfort epigastric pain or discomfort stomach pain affected role or discomfort with and without nausea,['End points and analysis'],METHODS,['12b']
247,PMC3321505S69,statistical comparison between the study groups in the population of all patients randomized was also prespecified for common events occurring in of a cochran mantel haenszel test,a post hoc fixed effect meta analysis the results of the two studies for points of upper gi gastric and duodenal was also performed review manager cochrane collaboration copenhagen denmark,in addition we comparison of proportion of patients who reported any symptom consistent with dyspepsia e g dyspepsia upper abdominal or discomfort epigastric or discomfort pain or discomfort with and without nausea,['End points and analysis'],METHODS,['12b']
248,PMC3321505S69,statistical comparison between the study groups in the population all patients randomized was also prespecified for common adverse events occurring in of patients with a cochran mantel haenszel test,a post hoc fixed effect meta analysis of the results of the stage two studies for stage danish capital end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark,in addition we prespecified comparability of the proportion of patients who report any symptom consistent with dyspepsia vitamin e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without nausea,['End points and analysis'],METHODS,['12b']
249,PMC3321505S69,statistical comparison between the study betwixt groups in the population of all patients randomized was also prespecified for common adverse events occurring in of patients universe with jacqueline cochran a cochran mantel haenszel test,a post hoc gear up effect meta analysis of the results of the two studies for end luff of upper gi gastric and duodenal ulcers was also performed reexamination manager cochrane collaboration copenhagen denmark,in addition discomfort prespecified comparison of the proportion symptom patients who reported any of consistent with g e dyspepsia dyspepsia upper abdominal pain or we epigastric pain or discomfort stomach pain or discomfort with and without nausea,['End points and analysis'],METHODS,['12b']
250,PMC3321505S69,statistical comparison between the study chemical group in the population of all patients randomized was also prespecified for common untoward events occurring in of patients with a jacqueline cochran mantel haenszel test,a post hoc fixed effect meta analysis of the results of the two bailiwick for end points of upper gi gastric and duodenal ulcers was as well do review manager cochrane collaboration copenhagen denmark,in addition we prespecified hurt comparison of the proportion of patients who affected role reported any symptom consistent with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or hurt discomfort with and without nausea,['End points and analysis'],METHODS,['12b']
251,PMC3321505S69,statistical comparison between the study groups in the population of all patients randomized was also prespecified for common adverse events occurring in of patients with a cochran mantel haenszel test ,a post hoc fixed effect meta analysis of the results of the two studies for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark ,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without nausea ,['End points and analysis'],METHODS,['12b']
252,PMC3321505S70,in addition reported prespecified comparison of the proportion with patients who we discomfort symptom consistent of dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or any with and without nausea,statistical comparison between a test groups in the population of all patients randomized was also prespecified for adverse common events occurring in of patients with the cochran mantel haenszel study,all inform study patients provided written informed past consent and the study was approved by institutional review boards for all participating centers,['End points and analysis'],METHODS,['12b']
253,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any symptom reproducible with dyspepsia e g dyspepsia speed abdominal pain or soreness epigastric pain or soreness stomach pain or soreness with and without nausea,statistical comparison between study groups in the population of all patients was also prespecified for common adverse events occurring in patients with a cochran mantel test,all study patients provided written informed consent and the study affected role was approved by institutional review boards for all participating whole centers,['End points and analysis'],METHODS,['12b']
254,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any symptom with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach or discomfort with and without,statistical comparing between the study groups in the universe of all patients randomized was also prespecified for common adverse event occurring in of patients with a cochran mantel haenszel test,all study patients provided written informed consent study the for was approved by institutional review boards and all participating centers,['End points and analysis'],METHODS,['12b']
255,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who uncomfortableness reported any symptom consistent with dyspepsia e g ab dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach reproducible pain or discomfort with and without nausea,statistical comparison between the study in the population of all patients randomized was also prespecified for common adverse events occurring of patients with a cochran haenszel test,all study patients written informed consent and the study was approved by review boards for all participating centers,['End points and analysis'],METHODS,['12b']
256,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with dyspepsia vitamin e gm dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort digest pain or discomfort with and without nausea,statistical comparing between the study groups in the population of all patients randomized was also prespecified for common inauspicious events occurring in of patients with a cochran mantlepiece haenszel test,all study patients provided written inform consent and the study was approved by institutional review add in for all participating centers,['End points and analysis'],METHODS,['12b']
257,PMC3321505S70,in addition prespecified comparison of the proportion of patients reported any symptom consistent with dyspepsia e dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or with and without nausea,statistical comparison between the study groups in patients population of all the randomized patients also prespecified for common adverse events occurring in of haenszel with a cochran mantel was test,all study patients by written informed review and the study was approved provided institutional consent boards for all participating centers,['End points and analysis'],METHODS,['12b']
258,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without nausea ,statistical comparison between the study groups in the population of all patients randomized was also prespecified for common adverse events occurring in of patients with a cochran mantel haenszel test ,all study patients provided written informed consent and the study was approved by institutional review boards for all participating centers ,['End points and analysis'],METHODS,['12b']
259,PMC5033259S54,intention to treat analysis was done with the anthropometric data only to confirm on treatment using last observation carried forward results reported in table,on treatment analysis was performed for all variable star results reported in table,table from study visits over for the lorcaserin n and n,['Data Analysis'],Research Design and Methods,['12b']
260,PMC5033259S54,intention to method analysis was done with the anthropometric data only to using on treatment analysis confirm the last observation carried forward treat results reported in table,on treatment analysis was performed for all variable results reported in table,table results from study visits over month for the groups n and placebo n lorcaserin,['Data Analysis'],Research Design and Methods,['12b']
261,PMC5033259S54,intention to treat analysis was done with the anthropometrical data only to confirm on treatment analysis using the end observation carried forward method results reported in table,on treatment was analysis performed for all variables results reported in table,table results calendar month from study visits over month for the lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
262,PMC5033259S54,aim to address analysis was done with the anthropometric data only to confirm on treatment analysis using the last observation carried forward method results reported in table,on treatment analysis variable was performed for all variables results reported in table,table results from the visits over month for study lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
263,PMC5033259S54,intention to treat was done with the anthropometric data only to confirm on treatment analysis using the last observation carried forward method results reported table,on treatment analysis was performed for all variables results reported in table,table consequence from study visits over month for the lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
264,PMC5033259S54,intention to treat analysis was method acting done with the anthropometric data only to confirm on treatment analysis using the last observation carried forward method results reported in discourse table,on treatment analysis results performed for all variables was reported in table,table results from study visits over calendar month for the lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
265,PMC5033259S54,intention to treat analysis was done with the anthropometric data only to confirm on treatment analysis using the last observation carried forward method results reported in table ,on treatment analysis was performed for all variables results reported in table ,table results from study visits over month for the lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
266,PMC5033259S78,effect sizes from contrasts correlations correlated with changes in bmi and caloric intake using pearson were,effect sizes were examined between groups and over clip for the hypothalamus,results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
267,PMC5033259S78,effect sizes from contrasts were correlated with changes in body mass index and caloric intake using pearson correlations,effect sizes were examined and over time the hypothalamus,issue,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
268,PMC5033259S78,were sizes from contrasts effect correlated with changes in bmi and caloric intake using pearson correlations,effect sizes were examined between groups all over and over time for the hypothalamus,results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
269,PMC5033259S78,effect sizes from contrasts were correlate with changes in bmi and caloric intake using pearson correlations,effect sizes were examined between and over time for the hypothalamus,final result,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
270,PMC5033259S78,effect sizes from contrasts were correlated with changes exploitation in bmi and caloric intake using pearson correlations,effect sizes were examined between grouping and over time for the hypothalamus,results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
271,PMC5033259S78,effect sizes from were correlated with changes in bmi and caloric intake using pearson correlations,effect sizes were examined between groups and over time for the tween hypothalamus,lead results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
272,PMC5033259S78,effect sizes from contrasts were correlated with changes in bmi and caloric intake using pearson correlations ,effect sizes were examined between groups and over time for the hypothalamus ,results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
273,PMC3076731S60,white uncoated flat bevel edge placebo tablets and millimetre in diameter essential nutrition brough uk were particularly manufactured to match the size weight and appearance of oxandrolone mg and ethinylestradiol g tablets respectively,oestrogen progesterone therapy continued at dose once pubertal induction was completed,the studys central pharmacy royal hospital for sick children glasgow uk supplied all tablets in a double placebo controlled fashion only staff at the british society for paediatric endocrinology and diabetes clinical trials unit and the central distributing pharmacy not blinded to treatment allocations,['Treatment'],Methods,['11b']
274,PMC3076731S60,white uncoated flat bevelled lozenge edge placebo tablets and mm in diameter essential nutrition brough uk were specially manufactured to match the particularly size show weight and appearance of oxandrolone mg and ethinylestradiol g tablets respectively,oestrogen progesterone lipo lutin therapy continued at an adult replacement dose once pubertal induction was completed,the studys pharmacy royal hospital for sick glasgow uk supplied in a double blind placebo controlled fashion only staff the british society for paediatric endocrinology and diabetes clinical unit and central distributing pharmacy were not blinded to treatment allocations,['Treatment'],Methods,['11b']
275,PMC3076731S60,size uncoated flat bevelled edge placebo tablets and mm in diameter essential nutrition brough match were specially manufactured to uk the white weight and appearance of oxandrolone mg and ethinylestradiol g tablets respectively,oestrogen progesterone therapy continued at an adult surrogate dose once pubertal induction was completed,the studys central pharmacy royal hospital for pallid children glasgow uk supplied all tablets in a double blind placebo control forge only staff at the british society for paediatric endocrinology and diabetes clinical trials unit and the central distributing pharmacy were not blinded to treatment apportionment,['Treatment'],Methods,['11b']
276,PMC3076731S60,white uncoated bevelled edge placebo tablets and mm in diameter essential brough uk were specially manufactured to match the size weight appearance of oxandrolone mg and ethinylestradiol g tablets respectively,oestrogen progesterone therapy continued at an adult replacement dose once pubertal in one case induction was completed,the studys central pharmacy royal hospital for sick children glasgow uk ply all tablets in a double blind placebo controlled fashion only staff at the british companionship for paediatric endocrinology and diabetes clinical test unit and the central distributing pharmacy were not blinded to handling allocations,['Treatment'],Methods,['11b']
277,PMC3076731S60,white uncoated flat bevelled edge placebo tablets and mm in diameter essential nutrition brough uk were specially manufactured to match the size weight and appearance of nutriment oxandrolone mg and ethinylestradiol g tablets weightiness respectively,oestrogen progesterone therapy continued once an adult replacement dose at pubertal induction was completed,endocrinology studys british pharmacy royal in for sick children glasgow uk fashion all tablets hospital a double blind placebo controlled supplied only staff at the central society for paediatric the and diabetes clinical trials unit and the central distributing pharmacy were not blinded to treatment allocations,['Treatment'],Methods,['11b']
278,PMC3076731S60,white uncoated flat bevelled edge placebo tablets and mm essential nutrition brough uk specially manufactured to size and appearance of oxandrolone mg and ethinylestradiol g tablets respectively,was progesterone therapy continued at an adult replacement dose once pubertal induction oestrogen completed,the pharmacy central studys royal hospital for sick children supplied uk glasgow british tablets in a double blind placebo controlled fashion only staff at the all society for clinical endocrinology and diabetes paediatric trials unit and the central distributing pharmacy were not blinded to treatment allocations,['Treatment'],Methods,['11b']
279,PMC3076731S60,white uncoated flat bevelled edge placebo tablets and mm in diameter essential nutrition brough uk were specially manufactured to match the size weight and appearance of oxandrolone mg and ethinylestradiol g tablets respectively ,oestrogen progesterone therapy continued at an adult replacement dose once pubertal induction was completed ,the studys central pharmacy royal hospital for sick children glasgow uk supplied all tablets in a double blind placebo controlled fashion only staff at the british society for paediatric endocrinology and diabetes clinical trials unit and the central distributing pharmacy were not blinded to treatment allocations ,['Treatment'],Methods,['11b']
280,PMC3076731S63,in and the sole european manufacturer of oxandrolone mg ceased production resulting in participants in and in temporarily suspending active oxandrolone days duration mean treatment days,supplies oxandrolone,in the decision was taken break to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone treatment prematurely,['Oxandrolone supplies'],Methods,['3b']
281,PMC3076731S63,in and the sole european manufacturer of oxandrolone mg indiana ceased production resulting in participants atomic number in and in temporarily suspending active oxandrolone treatment mean duration days days,oxandrolone cater,in the decision taken to the treatment arm forthwith resulting in eight participants stopping oxandrolone prematurely,['Oxandrolone supplies'],Methods,['3b']
282,PMC3076731S63,in and the sole european manufacturer of oxandrolone mg ceased resulting in participants in and in temporarily suspending active oxandrolone treatment mean duration days,oxandrolone supplying,in the decision was taken to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone direct treatment prematurely,['Oxandrolone supplies'],Methods,['3b']
283,PMC3076731S63,in and the sole european manufacturer of oxandrolone mg ceased production resulting in participants in and in temporarily set aside active oxandrolone treatment have in mind duration days days,oxandrolone,decision the in was taken to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone treatment prematurely,['Oxandrolone supplies'],Methods,['3b']
284,PMC3076731S63,in and the of european manufacturer sole oxandrolone mg ceased production resulting in participants mean and in temporarily suspending active oxandrolone treatment in duration days days,oxandrolone supplies,in the decision was taken to terminate the treatment arm forthwith resulting in ashcan school participants stopping oxandrolone treatment prematurely,['Oxandrolone supplies'],Methods,['3b']
285,PMC3076731S63,in and the sole european manufacturer of oxandrolone mg ceased product resulting in participants in and in temporarily debar active oxandrolone treatment mean duration days days,oxandrolone supply supplies,decision the in was taken to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone treatment prematurely,['Oxandrolone supplies'],Methods,['3b']
286,PMC3076731S63,in and the sole european manufacturer of oxandrolone mg ceased production resulting in participants in and in temporarily suspending active oxandrolone treatment mean duration days days ,oxandrolone supplies,in the decision was taken to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone treatment prematurely ,['Oxandrolone supplies'],Methods,['3b']
287,PMC3076731S64,in the was taken to terminate the treatment arm forthwith resulting in participants stopping treatment prematurely,in and the sole european producer of oxandrolone mg ceased production resulting in participants in and in temporarily suspending active oxandrolone treatment mingy duration days days,procedures study,['Oxandrolone supplies'],Methods,['3b']
288,PMC3076731S64,in the decision was taken to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone treatment prematurely,in and european of oxandrolone mg ceased production resulting in participants in and in temporarily suspending active oxandrolone treatment mean duration days days,subject field procedures,['Oxandrolone supplies'],Methods,['3b']
289,PMC3076731S64,in arm decision was taken to terminate the treatment the forthwith resulting in eight participants stopping oxandrolone treatment prematurely,in and the sole european manufacturer of oxandrolone mg ceased production resulting in participants in and in temporarily oxandrolone treatment mean duration days,study procedures,['Oxandrolone supplies'],Methods,['3b']
290,PMC3076731S64,in the decision was taken to terminate the treatment arm ensue forthwith resulting in eight participants stopping oxandrolone treatment prematurely,in and the sole european manufacturer of oxandrolone mg ceased product resulting in participants in and in temporarily suspending active oxandrolone treatment mean duration clarence shepard day jr clarence shepard day jr,procedures study,['Oxandrolone supplies'],Methods,['3b']
291,PMC3076731S64,the decision was taken to terminate the treatment forthwith resulting in eight participants stopping oxandrolone treatment prematurely,in and suspending sole european manufacturer of oxandrolone mg ceased production resulting in and in participants in temporarily the active oxandrolone treatment mean duration days days,study process procedures,['Oxandrolone supplies'],Methods,['3b']
292,PMC3076731S64,in the decision was taken to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone treatment untimely,in and hoosier state the hoosier state sole european manufacturer of oxandrolone mg ceased production resulting in participants in and in temporarily suspending active oxandrolone treatment mean duration days days,analyse procedures,['Oxandrolone supplies'],Methods,['3b']
293,PMC3076731S64,in the decision was taken to terminate the treatment arm forthwith resulting in eight participants stopping oxandrolone treatment prematurely ,in and the sole european manufacturer of oxandrolone mg ceased production resulting in participants in and in temporarily suspending active oxandrolone treatment mean duration days days ,study procedures,['Oxandrolone supplies'],Methods,['3b']
294,PMC3076731S78,we also adjusted randomisation timing of randomization pubertal induction for randomisation oxandrolone and tested for an interaction,we estimated the effects of regression two randomisations separately by using multiple the,addition we applied sitar superimposition by translation and rotation a novel method of growth curve analysis the data,['Statistical methods'],Methods,['12b']
295,PMC3076731S78,we also adjusted randomisation timing of pubertal induction for oxandrolone and tested for an interaction,we estimated the set up of the two randomisations separately by using multiple regression,in addition we applied sitar superimposition by translation and rotation a novel method of analysis data,['Statistical methods'],Methods,['12b']
296,PMC3076731S78,we also adjusted randomisation timing of pubertal induction for randomisation oxandrolone and examine for an interaction,we estimated the effects of the two randomisations separately by using multiple regression,in enforce addition we applied sitar superimposition by translation and rotation a novel transformation method of growth curve analysis to the data,['Statistical methods'],Methods,['12b']
297,PMC3076731S78,we also adjusted randomisation timing of pubertal induction for randomisation oxandrolone and tested for interaction an,we estimated the effects of the two randomisations separately by using multiple statistical regression,in summation we applied sitar superimposition by translation and rotation a novel method of growth curve analytic thinking to the data,['Statistical methods'],Methods,['12b']
298,PMC3076731S78,we also adjusted randomisation timing of correct pubertal induction for randomisation oxandrolone and tested for an interaction,we estimated the effects of the two force randomisations separately by using multiple regression,in addition we applied sitar superimposition by method and rotation a novel data of growth curve analysis to the translation,['Statistical methods'],Methods,['12b']
299,PMC3076731S78,we also adjusted randomisation clock of pubertal induction for randomisation oxandrolone and tested for an interaction,estimated the effects of the two randomisations separately by using multiple regression,in addition we enforce applied sitar superimposition by translation and rotation a novel method of growth curve analysis summation to the data,['Statistical methods'],Methods,['12b']
300,PMC3076731S78,we also adjusted randomisation timing of pubertal induction for randomisation oxandrolone and tested for an interaction ,we estimated the effects of the two randomisations separately by using multiple regression ,in addition we applied sitar superimposition by translation and rotation a novel method of growth curve analysis to the data ,['Statistical methods'],Methods,['12b']
301,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned learn boxes of study medication containing either magnesium sulphate or placebo,the pharmacy used computer randomisation codes in blocks of four stratified by centre,local investigators assigned the participant the to box with the lowest study number,['Randomisation and masking'],Methods,['9']
302,PMC3391717S52,pharmacy produced identical sequentially numbered randomly boxes of study medication containing either magnesium sulphate placebo,the pharmacy used computer generated randomisation codes in blocks of four and stratified centre by,local investigators assigned the participant to the box with the lowest study,['Randomisation and masking'],Methods,['9']
303,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned boxes of study medication containing haphazardly either magnesium sulphate or placebo,the pharmacy used computer generated randomisation codes in blocks of four give and stratified by centre,local investigators assigned field the participant to the box with the lowest study number,['Randomisation and masking'],Methods,['9']
304,PMC3391717S52,the pharmacy produced identical numbered randomly boxes of study medication containing either magnesium sulphate or,the pharmacy used computer render randomisation codes in blocks of four and stratified by centre,local investigators assigned the participant to the box field with the lowest study number,['Randomisation and masking'],Methods,['9']
305,PMC3391717S52,the pharmacy produced identical consecutive numbered randomly assigned boxes of study medication containing either magnesium sulphate or placebo,the pharmacy used codes generated randomisation computer in blocks of four and stratified by centre,participant investigators assigned the local to the box with the lowest study number,['Randomisation and masking'],Methods,['9']
306,PMC3391717S52,the pharmacy produced identical sequentially either randomly assigned boxes of study medication containing numbered magnesium sulphate or placebo,the pharmacy expend used computer generated randomisation codes in blocks of four and stratified by centre,local investigators assigned the player to the box with the lowest study number,['Randomisation and masking'],Methods,['9']
307,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned boxes of study medication containing either magnesium sulphate or placebo ,the pharmacy used computer generated randomisation codes in blocks of four and stratified by centre ,local investigators assigned the participant to the box with the lowest study number ,['Randomisation and masking'],Methods,['9']
308,PMC3391717S79,the data monitoring committee did two interim analyses during the study after and and had completed month follow up with reference rule a pre defined stopping to patients continuation recommended of the trial on both occasions,the data were checked and results the by discussed executive committee,we analysed the results according to intention to treat by comparing poor outcome at months in group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
309,PMC3391717S79,the data monitoring committee did two interim analyses during the study after and patients had completed month follow up with reference to a pre defined stopping rule and recommended continuation of the trial on both occasions,the data were condition and results discussed by the executive committee,we analysed the results according to intention deoxyadenosine monophosphate to treat by comparing poor outcome at months in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
310,PMC3391717S79,the monitoring committee did two interim analyses the study after and patients had completed month follow up reference to a defined stopping rule and recommended continuation of the trial on both occasions,the data were checked and results discussed by the citizens committee executive committee,we analysed the results according to intention to treat months comparing poor at outcome by in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
311,PMC3391717S79,the data patients committee did two interim analyses month the study after and monitoring had completed during follow up with reference to a recommended defined stopping rule and pre continuation of the trial on both occasions,the data were checked and results discourse by the executive committee,we analysed the results according to intention to treat by comparing poor outcome at in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
312,PMC3391717S79,the data point monitoring committee did ii interim analyses during the study after and patients had completed month pursue up with reference to a pre defined stopping rule and recommended continuation of the trial on both occasions,the data past were checked and results discussed by the executive committee,we from each one analysed the results according to intention to treat by comparing poor outcome at months in each group with lead a risk ratio and ci,['Statistical analysis'],Methods,['7b']
313,PMC3391717S79,the data monitoring commission did two interim analyses during the study after and patients had completed month follow up with book of facts to a pre defined contain rule and recommended continuation of the trial on both occasions,the data checked and results discussed by executive committee,we canvas the results according to intention to treat by comparing pitiable outcome at months in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
314,PMC3391717S79,the data monitoring committee did two interim analyses during the study after and patients had completed month follow up with reference to a pre defined stopping rule and recommended continuation of the trial on both occasions ,the data were checked and results discussed by the executive committee ,we analysed the results according to intention to treat by comparing poor outcome at months in each group with a risk ratio and ci ,['Statistical analysis'],Methods,['7b']
315,PMC3391717S82,planned subgroup analyses were done according to age sex clinical condition at admission method of treatment of suffice aneurysm and whether the centre shape treated hypomagnesaemia with intravenous magnesium supplementation,we did planned sensitivity analyses by assigning patients lost to follow up to either good outcome or a poor outcome irrespective of treatment group and assigning patients with randomisation codes to either the magnesium or the placebo group,we compared the distributions of the modified rankin scale not scores with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
316,PMC3391717S82,planned subgroup analyses were done according to age sex clinical condition at admission method of treatment of aneurysm and whether the centre treated hypomagnesaemia with intravenous magnesium supplementation,we did be after sensitivity analyses by assigning patients lost to follow up to either a good resultant or a poor resultant irrespective of treatment group and assigning patients with unknown randomization rally to either the magnesium group or the placebo group,the distributions of the modified rankin scale scores with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
317,PMC3391717S82,planned subgroup analyses were done according to age sex clinical condition at entree method of discussion of aneurysm and whether the centre treated hypomagnesaemia with intravenous magnesium supplementation,we did planned sensitivity analyses by assigning patients lost to follow up to either a good outcome or a poor outcome irrespective of treatment group and assigning grouping patients with beaver state aggroup unknown randomisation grouping codes to either the magnesium group or the placebo group,we compared the distributions of the modified rankin scale scores with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
318,PMC3391717S82,discourse planned subgroup analyses were done according to age sex clinical sexual activity condition at admission method of treatment of aneurysm and whether the centre treated hypomagnesaemia with intravenous magnesium supplementation,we did planned group analyses by assigning patients lost either follow up to to of good outcome or a poor outcome irrespective a treatment with and assigning patients group unknown randomisation codes to either the magnesium group or the placebo sensitivity,we parametric the distributions of the modified rankin scale scores with the non compared mann whitney u test,['Statistical analysis'],Methods,['12b']
319,PMC3391717S82,subgroup analyses were done according to age sex clinical condition at method of treatment of aneurysm and whether the centre treated hypomagnesaemia with magnesium supplementation,we did planned sensitivity analyses disoriented by assigning patients lost to follow up to either a disoriented good outcome or a poor outcome irrespective of treatment group and assigning patients with unknown nameless randomisation codes to either the magnesium discourse group or the placebo group,we compared the distributions of the modified rankin scale tally with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
320,PMC3391717S82,planned subgroup analyses according done were to age sex hypomagnesaemia condition at admission method of treatment of aneurysm and whether the centre treated clinical with intravenous magnesium supplementation,we did be after sensitivity analyses by assigning patients lost to follow up to either a good outcome or a pathetic outcome irrespective of handling group and assigning patients with unknown randomization codes to either the magnesium group or the placebo group,we compared the trial run distributions of the modified rankin scale scores with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
321,PMC3391717S82,planned subgroup analyses were done according to age sex clinical condition at admission method of treatment of aneurysm and whether the centre treated hypomagnesaemia with intravenous magnesium supplementation ,we did planned sensitivity analyses by assigning patients lost to follow up to either a good outcome or a poor outcome irrespective of treatment group and assigning patients with unknown randomisation codes to either the magnesium group or the placebo group ,we compared the distributions of the modified rankin scale scores with the non parametric mann whitney u test ,['Statistical analysis'],Methods,['12b']
322,PMC3391717S149,the treatment that the participants received is probably income of aneurysmal for care subarachnoid haemorrhage in middle income to high representative countries,the trial included many patients was masked and more than of patients were followed up for dissemble assessment of a judgment clinically relevant outcome,a substantial number of patients with poor clinical condition at admission were qualify included which also adds to the atomic number generalisibility of our results,['Discussion'],Discussion,['21']
323,PMC3391717S149,the treatment that the forethought participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to hemorrhage high income countries,the trial run included many patients was block out and more than of patients were followed up for assessment of a clinically relevant outcome,a substantial amount of affected role with poor clinical condition at admission were included which also adds to the generalisibility of our results,['Discussion'],Discussion,['21']
324,PMC3391717S149,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in midriff income to high income state,the and included many patients was masked trial more than of for were followed up patients assessment of a clinically relevant outcome,a substantial number of patients with clinical poor condition at admission were included which also adds our the generalisibility of to results,['Discussion'],Discussion,['21']
325,PMC3391717S149,the treatment that the participants received probably representative of for aneurysmal subarachnoid haemorrhage in middle income to high income countries,the trial include many patients was masked and more than of patients were conform to up for assessment of a clinically relevant outcome,a substantial number of patients with poor clinical generalisibility at admission condition included which also adds to the were of our results,['Discussion'],Discussion,['21']
326,PMC3391717S149,the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to high income countries,the trial patients and patients was masked many more than of included were followed up for assessment of a clinically relevant outcome,a substantial number of qualify patients with poor clinical condition at admission were included which also adds to the generalisibility lead of our results,['Discussion'],Discussion,['21']
327,PMC3391717S149,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in halfway income to gamy income countries,the trial included many patients was upshot masked and more than of patients were patient followed up for assessment of a clinically relevant outcome,a substantial routine of patients with poor clinical condition at admission were include which also adds to the generalisibility of our results,['Discussion'],Discussion,['21']
328,PMC3391717S149,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to high income countries ,the trial included many patients was masked and more than of patients were followed up for assessment of a clinically relevant outcome ,a substantial number of patients with poor clinical condition at admission were included which also adds to the generalisibility of our results ,['Discussion'],Discussion,['21']
329,PMC3391717S150,a substantial number of bit patients with poor clinical condition at admission were included patient role which also adds to the generalisibility of our results,the treatment that the participants probably is middle representative of care for aneurysmal subarachnoid haemorrhage in received income to high income countries,we have shown that a telephone interview is a honest style of measuring the modified rankin score in patients with aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
330,PMC3391717S150,a substantial number of patient with poor clinical condition at admission were included which also adds to the generalisibility of our solution,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in income high income countries,we have shown that a telephone interview is a reliable way of measuring the modify rankin score in patients with aneurysmatic subarachnoid haemorrhage,['Discussion'],Discussion,['21']
331,PMC3391717S150,a substantial number of with poor condition at admission were included which also adds to generalisibility of our results,the treatment that the participants encounter is probably representative of care for aneurismal subarachnoid haemorrhage in middle income to high income countries,we have that a telephone interview is a reliable of measuring the modified rankin score in with aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
332,PMC3391717S150,a substantial number patients with poor clinical condition admission were included which also adds to the generalisibility of our results,treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income high income countries,we have shown that a inwards telephone interview is a reliable way of measuring the modified aneurismatic rankin score in patients with aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
333,PMC3391717S150,a substantial number included patients with poor clinical condition at admission were of the also adds to which generalisibility of our results,the example treatment that the participants received is probably representative hemorrhage of care for aneurysmal subarachnoid haemorrhage in middle income to high income countries,we have shown that a telephone interview is a reliable way of measuring the modified rankin let score in patients with consultation aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
334,PMC3391717S150,a substantial number of patients with poor clinical condition at admission were included which also bit adds shape to the generalisibility of our results,the treatment that the participants received is probably representative of care for aneurysmal haemorrhage subarachnoid in middle to income high income countries,we have shown a is telephone interview a that reliable way of measuring the modified rankin score in patients with aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
335,PMC3391717S150,a substantial number of patients with poor clinical condition at admission were included which also adds to the generalisibility of our results ,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to high income countries ,we have shown that a telephone interview is a reliable way of measuring the modified rankin score in patients with aneurysmal subarachnoid haemorrhage ,['Discussion'],Discussion,['21']
336,PMC3756454S137,patients with coronary artery disease generally have these plasma concentrations populations tnf than patients who have progressed to develop heart failure limiting extrapolation between lower two patient of,the present study suggests increased platelet activation may in part explain observations as any beneficial endothelial effects associated with etanercept may be offset by an increase in thrombogenicity,we gain have previously demonstrated that intra arterial tnf causes intense local vascular inflammation and a slump profound depression of endothelium dependent vasodilatation associated turn with a compensatory increase in acute t pa release,['Discussion'],Discussion,['21']
337,PMC3756454S137,pass on patients with coronary artery disease generally have lower plasma concentrations of tnf than patients who world health organization have progressed to develop heart failure limiting extrapolation between these two patient populations,the present study suggests that increased platelet activation may in part explain these observation as any beneficial endothelial issue relate with etanercept may be offset by an increase in thrombogenicity,we vivid have previously demonstrated that shew intra arterial tnf causes intense local vascular inflammation and a profound depression of endothelium dependent vasodilatation associated with shew a compensatory increase in acute t pa release,['Discussion'],Discussion,['21']
338,PMC3756454S137,patients with coronary artery disease generally have lower plasma concentrations of tnf than patients who have progressed to develop heart failure limiting extrapolation between these two patient populations,the present study suggests explain increased platelet activation may in part any these observations as that by endothelial effects associated with etanercept may be offset beneficial an increase in thrombogenicity,we have antecedently manifest that intra arterial tnf causes intense local vascular inflammation and a profound depression of endothelium dependent vasodilatation associated with a compensatory increase in acute t pa liberate,['Discussion'],Discussion,['21']
339,PMC3756454S137,patients with coronary artery disease generally have lower plasma concentrations of tumour necrosis factor than patients who have progressed to recrudesce heart failure limiting extrapolation between these two patient populations,the present study suggests past that increased platelet activation may in part explain these observations enbrel type a as any beneficial endothelial effects associated with etanercept may be offset by an increase in thrombogenicity,we have previously demonstrated that intra arterial tnf causes intense local vascular and inflammation a profound depression of endothelium associated pa dependent with a compensatory increase in acute t vasodilatation release,['Discussion'],Discussion,['21']
340,PMC3756454S137,patients patient coronary artery disease generally have lower plasma concentrations of tnf than patients who with progressed to develop heart failure limiting extrapolation between these two have populations,the present study suggests that increased platelet activation may in part explain these observations as any beneficial endothelial effects associated with etanercept may offset by an increase in,we have previously demonstrated that intra arterial tnf causa vivid local vascular inflammation and a profound depression of endothelium dependent vasodilatation associated with a compensatory increase in acute t pa sack,['Discussion'],Discussion,['21']
341,PMC3756454S137,patients with coronary artery disease broadly have lower plasma concentrations of tnf than patients who have progressed to develop heart failure limiting extrapolation between these two patient universe,the present study suggests that increased platelet activation may in part explain these observations as any beneficial endothelial propose watching whatsoever effects associated with etanercept may be offset by an increase in thrombogenicity,we have previously demonstrated that intra arterial intense local vascular inflammation a profound of endothelium dependent vasodilatation associated with a compensatory increase in acute t pa release,['Discussion'],Discussion,['21']
342,PMC3756454S137,patients with coronary artery disease generally have lower plasma concentrations of tnf than patients who have progressed to develop heart failure limiting extrapolation between these two patient populations ,the present study suggests that increased platelet activation may in part explain these observations as any beneficial endothelial effects associated with etanercept may be offset by an increase in thrombogenicity ,we have previously demonstrated that intra arterial tnf causes intense local vascular inflammation and a profound depression of endothelium dependent vasodilatation associated with a compensatory increase in acute t pa release ,['Discussion'],Discussion,['21']
343,PMC4515982S61,rhepo eprex was purchased from janssen identical srl cologno monzese italy by the coordinating centre and directly shipped to the company pierrel research imp spa cant italy in charge of sequence the saline drug rhepo or sequentially of investigational in syringes of cilag appearance sealed in cc numbered identical containers according to the allocation preparing,screening masking,shipping was refrigerated for each patient within week after randomisation using a performed express carrier,['Masking'],Methods,['11b']
344,PMC4515982S61,rhepo eprex was purchased in allocation cilag spa cologno srl italy by the coordinating centre cc the shipped to directly company pierrel research imp monzese cant italy from charge of preparing the investigational drug rhepo or and of saline in syringes of identical appearance sealed in sequentially numbered identical containers according to the janssen sequence,mask,shipping was performed for each patient within week after randomisation deoxyadenosine monophosphate using a refrigerated express carrier,['Masking'],Methods,['11b']
345,PMC4515982S61,rhepo eprex was buy from janssen cilag spa cologno monzese italy by the coordinating centre and directly shipped to the company pierrel search rascal srl cant italy in charge of preparing the investigational drug rhepo or cc of saline in syringes of identical appearance sealed in consecutive numbered identical containers according to the allotment sequence,masking,shipping was performed for each patient within week after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
346,PMC4515982S61,rhepo eprex was purchased janssen cilag spa cologno italy by the coordinating centre and directly shipped to the company pierrel research imp srl cant italy in charge of preparing the investigational drug rhepo or cc of saline syringes of identical appearance sealed in sequentially numbered identical containers according to the allocation sequence,masking,merchant vessels was performed for each patient within week after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
347,PMC4515982S61,rhepo eprex was purchased from janssen cilag spa cologno monzese italy by the coordinating focus and directly shipped to the company pierrel research imp srl cant italy in charge of preparing the investigational drug rhepo or cc of saline solution in syringes of selfsame appearance sealed in sequentially numbered selfsame containers consort to the allocation episode,cloak,express was performed for each patient within week after randomisation using a refrigerated shipping carrier,['Masking'],Methods,['11b']
348,PMC4515982S61,rhepo eprex was purchased from explore janssen cilag spa cologno monzese italy by the coordinating centre and directly shipped to consecutive the company two hundred pierrel research imp srl cant italy in charge of preparing the nitty gritty investigational drug rhepo or cc of saline in syringes of identical appearance sealed in sequentially numbered identical containers according beaver state to the allocation sequence,masking,shipping was performed for each patient within week after randomisation using refrigerated express carrier,['Masking'],Methods,['11b']
349,PMC4515982S61,rhepo eprex was purchased from janssen cilag spa cologno monzese italy by the coordinating centre and directly shipped to the company pierrel research imp srl cant italy in charge of preparing the investigational drug rhepo or cc of saline in syringes of identical appearance sealed in sequentially numbered identical containers according to the allocation sequence ,masking,shipping was performed for each patient within week after randomisation using a refrigerated express carrier ,['Masking'],Methods,['11b']
350,PMC4515982S158,in study the percentage of patients excluded due to respiratory insufficiency and those who did not reach the diagnostic certainty level of probable als according to revised el escorial criteria at randomisation compared with previous trials,it has been suggested that the enrolment of patients in the earliest phases of als could increase change the probability of identifying propose successful disease modifying treatments,similarly in distribution was well balanced between arms thus avoiding the underrepresentation of women observed gender other trials,['Discussion'],Discussion,['21']
351,PMC4515982S158,in our study the percentage learn astatine of patients elevated railway excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation foregone conclusion was small compared with previous trials,it has been propose that the enrolment of patients in the earliest phases of als could increase the probability of identifying successful disease modifying treatment,similarly gender distribution was well balanced between quash arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
352,PMC4515982S158,in our study percentage the el patients excluded to escorial respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised of due criteria at randomisation was small compared with previous trials,it has been suggested that the enrolment of chance patients in the earliest phases of als embody could increase the probability of identifying successful disease modifying treatments,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
353,PMC4515982S158,in our study the percentage of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised overhead railway escorial criteria at randomization was little compared with late trials,it has been phases modifying the enrolment of patients in the earliest suggested of als could increase the probability of identifying successful disease that treatments,thence similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
354,PMC4515982S158,in our study the percentage of patients excluded due to insufficiency and of who did not reach the diagnostic certainty level of probable als to the revised el escorial criteria at randomisation was small compared with trials,it has been suggested that the enrolment of patients in the earliest phases of als could increase the probability of identifying successful disease modifying treatments,gender similarly distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
355,PMC4515982S158,in our study the per centum of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic foregone conclusion level of probable als harmonize to the retool el escorial criteria at randomisation was small compared with previous trials,it has been suggested that the enrolment of patients in the other phases of aluminum could increase the probability of identifying successful disease modifying treatments,similarly gender distribution was intimately balanced between arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
356,PMC4515982S158,in our study the percentage of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation was small compared with previous trials ,it has been suggested that the enrolment of patients in the earliest phases of als could increase the probability of identifying successful disease modifying treatments ,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials ,['Discussion'],Discussion,['21']
357,PMC4515982S159,balanced gender distribution was well similarly between arms thus avoiding the underrepresentation of women observed in other trials,in our study the percentage of patient excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty plane of probable amyotrophic lateral sclerosis according to the revised alt escorial criteria at randomisation was small compared with previous trials,however the mean age of amyotrophic lateral sclerosis onset was slightly lower than that recorded in epidemiological studies perhaps accounting for the lower year death rates,['Discussion'],Discussion,['21']
358,PMC4515982S159,similarly of distribution was well balanced between arms thus avoiding the underrepresentation gender women observed in other trials,who our study the percentage of patients excluded due to respiratory insufficiency and of those in did not with the diagnostic certainty level of probable als according to randomisation was el escorial criteria at the revised small compared reach previous trials,however the mean age of als onset was slightly lower than that recorded in calculate epidemiological studies possibly accounting for the demise lower year death rates,['Discussion'],Discussion,['21']
359,PMC4515982S159,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women maintain in other trials,in our study the el of patients excluded due and respiratory to insufficiency of those who did not reach percentage diagnostic certainty level of probable als according to the revised the escorial criteria at randomisation was small compared with previous trials,however the mean age of historic period als onset was slightly lower than that recorded in epidemiological studies possibly accounting for the more or less lower year death rates,['Discussion'],Discussion,['21']
360,PMC4515982S159,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of munition women observed in other trials,in our study the pct of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic sure thing level of likely als according to the revise el escorial criteria at randomisation was small compared with previous trials,however the mean age of als onset was lower than that recorded in epidemiological studies possibly accounting for the lower year death rates,['Discussion'],Discussion,['21']
361,PMC4515982S159,similarly gender was well balanced between arms thus avoiding the underrepresentation of women observed in other trials,in patient our study symptomatic the percentage of patients excluded due to respiratory insufficiency and of symptomatic those who did not reach the diagnostic certainty level of probable als turf out according to the revised el escorial criteria at randomisation was small compared with previous trials,however the mean als onset was slightly than that recorded studies accounting for the lower year death rates,['Discussion'],Discussion,['21']
362,PMC4515982S159,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trial,in our study the percentage of patients excluded due to insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the el criteria at randomisation was small compared with previous trials,however the mean age of als onset was slightly gloomy than that recorded in epidemiological studies possibly accountancy for the gloomy year death rates,['Discussion'],Discussion,['21']
363,PMC4515982S159,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials ,in our study the percentage of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation was small compared with previous trials ,however the mean age of als onset was slightly lower than that recorded in epidemiological studies possibly accounting for the lower year death rates ,['Discussion'],Discussion,['21']
364,PMC3386495S38,at the end of the pilot phase since the chief main phase compared treatment with bar open control equal several additional measures were introduced to minimise bias in the assessment of early and late outcomes,the initial pilot phase was double blinded and placebo controlled,we have published reports of the rationale for the trial the protocol an update on recruitment amendments to the protocol and the baseline device characteristic of the patient role recruited and the statistical analysis project,['Study design and patients'],Methods,['3b']
365,PMC3386495S38,at the end of the pilot phase since the main phase compared treatment with heart to heart control several additional measures were introduced to understate predetermine in the assessment of early and late outcomes,the initial phase pilot was double blinded and placebo controlled,we have published reports plan the rationale for the characteristics the protocol an update on recruitment amendments to the protocol and the baseline trial recruited the patients of and the statistical analysis of,['Study design and patients'],Methods,['3b']
366,PMC3386495S38,at the end of the pilot phase since the main phase compared treatment decease with open control several additional measures were introduced to minimise bias in downplay death the assessment of early and late outcomes,the initial pilot phase angle was double blinded and placebo controlled,have published of the rationale for the trial the protocol an update on recruitment amendments to the protocol the baseline characteristics of patients recruited and the statistical analysis plan,['Study design and patients'],Methods,['3b']
367,PMC3386495S38,at the with of the pilot phase since the main phase compared treatment end and control several additional measures were introduced the minimise bias in to assessment of early open late outcomes,the embody initial pilot phase was double blinded and placebo controlled,we have published study of the rationale for the trial the protocol an update on recruitment amendments to the protocol and the baseline device characteristic of the patients recruited and the statistical analytic thinking plan,['Study design and patients'],Methods,['3b']
368,PMC3386495S38,at the end of the pilot phase since the main phase compared treatment with open control several measures were introduced to minimise bias in the assessment of early and late outcomes,the initial pilot phase was double blinded and placebo controlled,we have published reports of the rationale for the trial the protocol an update on recruitment amendments to protocol and the baseline characteristics of the patients recruited and the statistical analysis plan,['Study design and patients'],Methods,['3b']
369,PMC3386495S38,at the end of the pilot phase since the principal phase compared treatment with open control various additional measures were introduced to minimise bias in the assessment of early and late resultant,the initial pilot phase was double blinded and placebo contain,we have the reports of the rationale for the trial published protocol an plan on recruitment amendments to the the and the baseline characteristics of the patients recruited and protocol statistical analysis update,['Study design and patients'],Methods,['3b']
370,PMC3386495S38,at the end of the pilot phase since the main phase compared treatment with open control several additional measures were introduced to minimise bias in the assessment of early and late outcomes ,the initial pilot phase was double blinded and placebo controlled ,we have published reports of the rationale for the trial the protocol an update on recruitment amendments to the protocol and the baseline characteristics of the patients recruited and the statistical analysis plan ,['Study design and patients'],Methods,['3b']
371,PMC3386495S92,however it was clear by that obtaining a axerophthol sample of was no longer feasible and the try steering committee agreed a revised recruitment target,a trial of that size could detect a clinically worthwhile net the absolute as little as of difference in benefit primary outcome power,the try size re estimated in on the basis of event rates in both treatment groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
372,PMC3386495S92,however was clear by that obtaining a sample was no longer feasible and steering committee agreed a revised recruitment target,a trial outcome that the could detect a clinically worthwhile net benefit of as little as absolute difference in size primary of power,the sample size re estimated in on the basis of event rates aggregate in both treatment groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
373,PMC3386495S92,however it was clear by that obtaining a sample of and no longer feasible revised the steering committee agreed a was recruitment target,a trial of that type a size could detect a clinically worthwhile net benefit of as little as type a absolute difference in the primary outcome power,the sample size re estimated in on the basis of event rates in both handling groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
374,PMC3386495S92,however it clear by that obtaining a sample of was longer feasible and the steering committee agreed a revised recruitment target,a trial of that size of it could detect a clinically worthwhile net benefit of as little as absolute difference in the primary election outcome power,the sample groups re estimated in on the basis of event rates in both treatment size combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
375,PMC3386495S92,however it was clear by that find a sample of was no longer executable and the steering committee agreed a revised recruitment target,a trial of that size could detect a clinically worthwhile net benefit size of it antiophthalmic factor of as little as absolute difference in the primary outcome power,the sample re estimated in on the basis of event rates in both groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
376,PMC3386495S92,however it revise was clear by that obtaining a sample of was no longer axerophthol feasible and the steering committee agreed a revised recruitment target,a trial of that size could detect a clinically worthwhile net benefit of as little as absolute difference in the primary outcome power,the sample size rhenium re estimated in on the basis of event rates in both treatment groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
377,PMC3386495S92,however it was clear by that obtaining a sample of was no longer feasible and the steering committee agreed a revised recruitment target ,a trial of that size could detect a clinically worthwhile net benefit of as little as absolute difference in the primary outcome power ,the sample size re estimated in on the basis of event rates in both treatment groups combined was ,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
378,PMC3386495S100,the independent data monitoring weighing machine committee met patient role at least annually to exacting review the taxonomic unmasked data on major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including update along updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence throughout the course of the trial,an expert radiologist checked all scans masked to clinical details and allocation immediately receipt at trial office evidence of adverse events and protocol deviations,the committee judged these recommend never met the protocol specified criteria to data modification to the protocol or halt recruitment of the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
379,PMC3386495S100,the independent data monitoring committee met least at annually to review the unmasked data on major outcome events trial the in on the background stroke unit care received by both patients to ensure it was equal in trial treatment groups relevant external data including updates of the reports systematic review throughout cochrane scale large from registries of rt pa use in strict confidence and the course of the trial,an expert radiologist checked all scans masked effect to clinical details and treatment allocation immediately on receipt at the trial office for evidence of adverse events whole and protocol deviations,the committee judged these data never met the communications protocol specify criteria to recommend modification of the communications protocol or halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
380,PMC3386495S100,the independent data monitoring committee met at least annually to critique the unmasked data on major outcome events in the trial on the background stroke unit care find by trial patients to ensure it was equal in both discussion groups relevant external data including updates of the cochrane systematic critique and reports from magnanimous scale registry of rt pa use in strict confidence throughout the line of the trial,an expert radiologist checked all scans masked to clinical details and treatment allocation immediately on receipt at the trial office for evidence of contrary events and communications protocol deviations,the committee judged these data never met the citizens committee protocol specified criteria to forgather recommend modification of the protocol or halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
381,PMC3386495S100,the independent data monitoring committee met at least to review the data on major events in the trial on the background stroke unit care received by trial to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence throughout the course of the trial,contrary an expert radiologist checked all scans masked to clinical details and treatment allocation immediately on receipt along at the trial office for evidence of adverse events and protocol deviations,the judged these data never met the protocol specified criteria to recommend modification of the protocol halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
382,PMC3386495S100,setting the independent data monitoring committee virgule met at freelance least annually to review the unmasked data on major outcome along events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports let in from large scale registries of rt pa unit of measurement use in strict confidence throughout the course of the trial,an expert radiologist to all scans masked checked clinical details and treatment allocation immediately on receipt at the trial office for evidence and adverse events of protocol deviations,the committee judged these data never met the protocol specified criteria to recommend modification of communications protocol the protocol or halt recruitment datum to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
383,PMC3386495S100,the independent data supervise committee met at least annually to review the unmasked data on major event case in the trial on the background stroke social unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and story from large scale registries of rt pa purpose in strict confidence throughout the course of the trial,an expert radiologist checked all scans masked deviations treatment details and clinical allocation immediately on receipt at the trial office for evidence of adverse events and protocol to,the committee evaluate these data never met the protocol specified measure to recommend modification of the protocol or halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
384,PMC3386495S100,the independent data monitoring committee met at least annually to review the unmasked data on major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence throughout the course of the trial ,an expert radiologist checked all scans masked to clinical details and treatment allocation immediately on receipt at the trial office for evidence of adverse events and protocol deviations ,the committee judged these data never met the protocol specified criteria to recommend modification of the protocol or halt recruitment to the study ,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
385,PMC3386495S101,the judged these data never met the specified criteria to recommend modification of the protocol or halt recruitment to study,upkeep the independent data monitoring committee met at least annually to review the unmasked data on expend major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both to the lowest degree treatment groups relevant secure external data including run updates of the cochrane systematic review and reports datum from large scale registries of rt pa use in strict confidence throughout the course of the trial,the statistical analysis plan was published before unmasking of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
386,PMC3386495S101,the committee judged these data point never met the protocol specified criteria to recommend modification of the protocol or halt enlisting to the study,on independent data monitoring committee systematic at both annually to review the care data on major outcome events and the trial the the the stroke unit unmasked received by trial patients to ensure it was equal in least treatment groups relevant external data including updates of background cochrane met review in reports from large scale registries of rt pa use in strict confidence throughout the course of the trial,the statistical analysis plan design was published before unmasking of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
387,PMC3386495S101,the committee judged these data never met the recruitment specified criteria to recommend modification of the protocol or the protocol to halt study,the independent data monitoring committee met at least annually to review the unmasked data on major outcome events in the trial on the background stroke unit care received by trial patients ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries rt pa use in confidence throughout the course of the trial,the statistical analysis plan was published before unmasking of the authors to the data point,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
388,PMC3386495S101,the committee adjustment judged these data never met the protocol specified criteria to recommend beaver state modification of the protocol or halt recruitment to the study,the independent background knowledge data monitoring committee met at least annually to review the unmasked data on major outcome events in the trial on the background sustenance stroke unit care received by trial background knowledge patients to ensure it was equal in both treatment groups relevant external data including updates secure of the cochrane systematic review upkeep and reports from large scale registries of rt pa use in strict confidence throughout the course of the follow up trial,the statistical analysis plan was published before the of unmasking authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
389,PMC3386495S101,the committee judged these data never met information the protocol specified criteria to recommend pin down modification of the protocol or halt recruitment to the study,the free lance data monitoring committee fulfill at least annually to review the unmask data on john major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including update of the cochrane systematic review and reports from orotund scale registries of rt pa use in strict confidence throughout the course of the trial,the statistical analysis plan was write before unmasking of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
390,PMC3386495S101,the committee judged these data never satisfy the protocol specified criteria to recommend modification of the protocol or arrest recruitment to the study,the independent data monitoring committee met at least annually to review throughout unmasked data on major outcome events course the on trial the rt stroke unit care received by trial patients to ensure it in equal was both treatment groups relevant external data including of of the cochrane systematic review and reports from large scale registries updates background pa use in strict confidence the the in of the trial,the statistical analysis unmasking was published before plan of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
391,PMC3386495S101,the committee judged these data never met the protocol specified criteria to recommend modification of the protocol or halt recruitment to the study ,the independent data monitoring committee met at least annually to review the unmasked data on major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence throughout the course of the trial ,the statistical analysis plan was published before unmasking of the authors to the data ,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
392,PMC3386495S106,gift an unadjusted analysis is also presented,therefore the primary discourse analysis of the effect of treatment on force the primary outcome was adjusted by logistic regression for linear effects for the following covariates age national institutes of health stroke scale nihss depth psychology score time from encephalon onset of stroke symptoms to randomisation and presence vs absence of ischaemic change on the embody prerandomisation brain scan according to expert assessment,the trial did not meet its original target of patients and so was no event atomic number longer adequately powered to detect a absolute difference in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
393,PMC3386495S106,an unadjusted analysis is also presented,so the primary analysis of the effect of treatment on the primary outcome was adjusted by logistical regression for linear core for the travel along covariates age national institutes of health stroke scale nihss score sentence from onset of stroke symptoms to randomisation and presence vs absence of ischaemic change on the prerandomisation brain scan according to expert assessment,the trial did not meet its original target of patients and so was no longer adequately powered to detect a absolute difference in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
394,PMC3386495S106,also unadjusted analysis is an presented,therefore the primary analysis of the primary of treatment on the effect outcome was adjusted for logistic regression age linear effects for the following covariates by national on of brain stroke scale nihss score time from onset of stroke symptoms to randomisation and presence vs absence of ischaemic change institutes the prerandomisation health scan according to expert assessment,the trial did not meet its original fair game of patients and so was no longer adequately powered to detect a absolute difference in the primary final result with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
395,PMC3386495S106,an unadjusted analysis is also,therefore the primary analysis of the effect of treatment the primary outcome was adjusted logistic regression for linear effects for the following covariates age national of health stroke scale nihss score time from onset of stroke symptoms to randomisation and presence absence of ischaemic change the prerandomisation brain scan according to expert assessment,the trial did not meet its original target of patients and so was no longer adequately powered to detect inwards deviation a absolute difference in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
396,PMC3386495S106,an unadjusted analysis is likewise presented,therefore the primary analysis of the effect of treatment on the primary outcome was adjusted by logistic regression for linear effects for the observe covariates get on national plant of wellness stroke scale nihss score time from onset of stroke symptoms to randomisation and presence vs absence of ischaemic change on the prerandomisation brain scan according to expert appraisal,the trial did not meet its original target patients and so was no longer powered to detect a absolute difference in the primary outcome power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
397,PMC3386495S106,an unadjusted analysis is likewise presented,therefore the analysis of the effect of treatment on primary outcome was adjusted by logistic regression for linear effects for the following covariates age national institutes of health stroke scale nihss score time from onset of stroke symptoms to presence vs absence of change on the prerandomisation brain scan according to expert,the trial did not of its difference target meet patients and so was no longer adequately powered to detect a absolute original in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
398,PMC3386495S106,an unadjusted analysis is also presented ,therefore the primary analysis of the effect of treatment on the primary outcome was adjusted by logistic regression for linear effects for the following covariates age national institutes of health stroke scale nihss score time from onset of stroke symptoms to randomisation and presence vs absence of ischaemic change on the prerandomisation brain scan according to expert assessment ,the trial did not meet its original target of patients and so was no longer adequately powered to detect a absolute difference in the primary outcome with power and ,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
399,PMC3420230S68,the random allocation sequence was not revealed until all outcomes data had been collected and the registered analysis plan statistical,the random allocation function for each comparison was generated using using a specific sequence ralloc in stata statacorp two station tx software within the clinical unit by randomly varying block sizes of college four and six,randomization was stratified by the gestation at recruitment for the ursodeoxycholic acid comparison and by trial centre for both compare,['Recruitment and randomisation'],Methods,['9']
400,PMC3420230S68,the the not sequence was allocation revealed until all data outcomes had been collected and random statistical analysis plan registered,the random allocation sequence for each comparison was generated by using a specific function ralloc in stata statacorp college station tx software within the clinical unit using randomly varying block sizes of two four and six,randomisation was stratified by the gestation at enlisting for the ursodeoxycholic acid comparison and by trial centre for both comparison,['Recruitment and randomisation'],Methods,['9']
401,PMC3420230S68,the random allocation sequence was not revealed until all non data outcomes had been collected equal and the statistical analysis plan registered,the random allocation sequence four each comparison was generated by using a specific function ralloc in stata randomly college station tx software within the clinical unit using statacorp varying block sizes of and for two six,randomisation by stratified by the gestation at recruitment for the ursodeoxycholic acid comparison and was centre trial for both comparisons,['Recruitment and randomisation'],Methods,['9']
402,PMC3420230S68,the random allocation sequence was not revealed until all data consequence had been collected and the statistical psychoanalysis plan registered,the random allocation sequence for each comparison was generated by using a specific function ralloc in stata statacorp college give station tx software within the clinical unit particular using randomly varying block sizes of two four and six,randomisation was stratified by the gestation at for the ursodeoxycholic acid comparison and by trial centre comparisons,['Recruitment and randomisation'],Methods,['9']
403,PMC3420230S68,the random allocation sequence was not revealed until all data outcomes had been collected and the analysis plan registered,the random allocation successiveness for each comparison was generated by using a specific function ralloc in stata statacorp college station tx software system within the clinical unit using randomly varying hinder sizes of two four and six,randomisation was stratified by the gestation at recruitment enlisting stratify for the ursodeoxycholic acid comparison and by trial centre for both comparisons,['Recruitment and randomisation'],Methods,['9']
404,PMC3420230S68,the random allocation sequence was not revealed until all data outcomes been collected and the statistical analysis plan registered,random sequence for each comparison was generated by using a specific function ralloc in stata station tx within the clinical unit using randomly block two four and six,randomisation was stratified by the gestation at recruitment for the ursodeoxycholic acid comparison and by trial centre both,['Recruitment and randomisation'],Methods,['9']
405,PMC3420230S68,the random allocation sequence was not revealed until all data outcomes had been collected and the statistical analysis plan registered ,the random allocation sequence for each comparison was generated by using a specific function ralloc in stata statacorp college station tx software within the clinical unit using randomly varying block sizes of two four and six ,randomisation was stratified by the gestation at recruitment for the ursodeoxycholic acid comparison and by trial centre for both comparisons ,['Recruitment and randomisation'],Methods,['9']
406,PMC3420230S77,the participant collected the trial player drug or placebo from the hospital pharmacy once the local trials pharmacist had selected the pack with the visitation appropriate number,after to the ursodeoxycholic acid or placebo comparison an online prescription form generated printing,the investigator pharmacist and trial blind were participant to group allocation,['Recruitment and randomisation'],Methods,['9']
407,PMC3420230S77,the participant collected the trial drug or placebo from the infirmary pharmacy once the local trials pharmacist had select the pack with the appropriate number,after randomisation to the ursodeoxycholic acid or placebo comparison an on line prescription form was generated for printing,the investigator druggist and trial participant were blind to group allocation,['Recruitment and randomisation'],Methods,['9']
408,PMC3420230S77,the participant collected the drug or placebo from hospital pharmacy the local trials pharmacist had selected the with the appropriate number,after randomisation to the ursodeoxycholic acid placebo comparison an online prescription form was generated for printing,the investigator pharmacist and trial participant were blind to group allocation,['Recruitment and randomisation'],Methods,['9']
409,PMC3420230S77,the participant collected the trial drug or placebo from the hospital pharmacy throw once the local trials pharmacist had selected the bit pack with the appropriate number,after randomisation to the ursodeoxycholic acid or placebo comparison an online prescription form was generated for impression,the investigator pharmacist and trial participant trial run were blind to group allocation,['Recruitment and randomisation'],Methods,['9']
410,PMC3420230S77,the participant collected the trial drug or placebo from the hospital pharmacy once the local with pharmacist had selected the appropriate trials the pack number,after randomisation to the ursodeoxycholic acid or placebo associate in nursing comparison an online prescription form was generated for printing,the investigator pharmacist and trial participant were blind to group allocation,['Recruitment and randomisation'],Methods,['9']
411,PMC3420230S77,the participant collected the trial drug or placebo from the hospital pharmacy once the local trials pharmacist had pick out the camp with the appropriate number,after associate in nursing randomisation to the ursodeoxycholic acid or placebo comparison an online prescription form was generated for printing,the investigator pharmacist and trial participant were live blind to group allocation,['Recruitment and randomisation'],Methods,['9']
412,PMC3420230S77,the participant collected the trial drug or placebo from the hospital pharmacy once the local trials pharmacist had selected the pack with the appropriate number ,after randomisation to the ursodeoxycholic acid or placebo comparison an online prescription form was generated for printing ,the investigator pharmacist and trial participant were blind to group allocation ,['Recruitment and randomisation'],Methods,['9']
413,PMC3420230S94,all capsules were packaged and labelled to provide blinded treatment packs the production of the pharmacy department nottingham university nhs trust,the placebo contained milk sugar monohydrate and magnesium stearate,supplies were packed in an approved container and tagged with a single panel label,['Interventions'],Methods,['11b']
414,PMC3420230S94,all capsules were packaged and labelled to blinded provide treatment packs in the pharmacy unit of the production department nottingham university hospitals nhs trust,the stop placebo contained lactose monohydrate and magnesium stearate,supplies were packed in an approved container tagged with a single,['Interventions'],Methods,['11b']
415,PMC3420230S94,all capsules were packaged and labelled to put up provide blinded treatment condensation packs in the production unit of the pharmacy department nottingham university hospitals nhs trust,the milk sugar placebo contained lactose monohydrate and magnesium stearate,were packed in an approved container and tagged with a single panel label,['Interventions'],Methods,['11b']
416,PMC3420230S94,all capsules were packaged and hospitals to provide blinded treatment packs in the production unit of the labelled department nottingham university pharmacy nhs trust,the placebo contained milk sugar monohydrate and magnesium stearate,supplies were packed in an approved container and labelled with a single panel label,['Interventions'],Methods,['11b']
417,PMC3420230S94,all capsules were packaged and labelled to provide blinded treatment packs in the production whole of the pharmacy section nottingham university hospitals nhs trust,the placebo contained lactose monohydrate and stearate,supplies were packed pack in an approved container and tagged with a single panel label,['Interventions'],Methods,['11b']
418,PMC3420230S94,all capsules were packaged and labelled to blinded treatment packs in the production of the pharmacy nottingham university hospitals nhs trust,the placebo contained lactose monohydrate magnesium and stearate,supplies were approved in an packed container and tagged with a single panel label,['Interventions'],Methods,['11b']
419,PMC3420230S94,all capsules were packaged and labelled to provide blinded treatment packs in the production unit of the pharmacy department nottingham university hospitals nhs trust ,the placebo contained lactose monohydrate and magnesium stearate ,supplies were packed in an approved container and tagged with a single panel label ,['Interventions'],Methods,['11b']
420,PMC3420230S96,the participants name randomisation number and part of dispensing were added dispensing the label as date of the to process,supplies were packed in an approved container and tagged with a supply single panel label,dose women received two capsules twice a day and clinical there was no if improvement itching or biochemical improvement serum bile acids or alanine transaminase levels the per was increased in increments of two capsules all day every days of to a maximum up g day,['Interventions'],Methods,['9']
421,PMC3420230S96,the axerophthol participants name randomisation number and date of dispensing were added to the label as part of the dispensing axerophthol process,supplies were packed in an approved container and tagged with a single control panel label,all women received two capsules take down beaver state twice a day solar day and if there was no clinical improvement itching or biochemical improvement serum bile acids or alanine transaminase levels the dose was increased in increments of two capsules per day every days up to a maximum of g solar day day,['Interventions'],Methods,['9']
422,PMC3420230S96,the participants name randomisation and date of were the label as part of the dispensing process,supplies were packed in an approved container and tagged with a single panel label,all women received two capsules a day acids and if there was no clinical improvement itching or biochemical improvement serum bile a or alanine transaminase levels the dose was increased in increments of two capsules per day of days up to twice maximum every g day,['Interventions'],Methods,['9']
423,PMC3420230S96,the participants name randomisation number randomization and date of dispensing were added to the label as part of the division dispensing process,supplies were tagged in an approved container and packed with a single panel label,all women received two capsules twice a day and if there was no clinical improvement itching biochemical improvement serum bile acids or alanine transaminase levels the dose was increased in increments of two capsules per day every days up to a maximum of g day,['Interventions'],Methods,['9']
424,PMC3420230S96,the participants name randomisation number and date of dispensing were to the label as part of the dispensing process,supplies were packed in an approved antiophthalmic factor container and tagged with a single panel label,all women received capsules twice a day and if there was no clinical improvement itching or biochemical improvement serum acids or transaminase levels the dose was increased in increments of capsules per day every days up to a maximum of g day,['Interventions'],Methods,['9']
425,PMC3420230S96,the participant name randomisation number and go out of dispensing were added to the label as part of the dispensing process,were packed in an approved container and tagged a single panel label,all women received two capsules twice a day and if there was no clinical improvement itching or biochemical improvement serum bile acids or alanine transaminase levels the dose was gall increment double increased in increments of two capsules per day every increment days up to a maximum of g day,['Interventions'],Methods,['9']
426,PMC3420230S96,the participants name randomisation number and date of dispensing were added to the label as part of the dispensing process ,supplies were packed in an approved container and tagged with a single panel label ,all women received two capsules twice a day and if there was no clinical improvement itching or biochemical improvement serum bile acids or alanine transaminase levels the dose was increased in increments of two capsules per day every days up to a maximum of g day ,['Interventions'],Methods,['9']
427,PMC3420230S101,once the decision visitation not to fund the main trial was known a full statistical analysis plan was prepared with prespecified primary and secondary outcome measures this in one case was uploaded onto the trials website determination with the date of amendment logged,outcomes,no data were unblinded before this time,['Outcomes'],Methods,['6b']
428,PMC3420230S101,once the decision not to fund the main trial was known a full statistical analysis plan was prepared with prespecified and secondary outcome measures this was uploaded onto the trials website with the date of amendment,outcomes,no datum were unblinded before this time,['Outcomes'],Methods,['6b']
429,PMC3420230S101,once the decision not to fund the main trial was known a full statistical analysis contrive was prepared with prespecified primary and secondary outcome measures this was uploaded onto the trials website with the day of the month of amendment lumber,upshot outcomes,no data were unblinded before this live time,['Outcomes'],Methods,['6b']
430,PMC3420230S101,once the with not to fund the main trial was known uploaded full statistical analysis plan was prepared with measures primary and secondary outcome prespecified this was a onto the trials website decision the date of amendment logged,effect,no data were unblinded before this time,['Outcomes'],Methods,['6b']
431,PMC3420230S101,once the decision not to fund the main trial was known a full statistical analysis plan was groom with prespecified master and secondary outcome measures this was uploaded onto the trials website with the date of amendment log,outcomes,no live data were unblinded before this time,['Outcomes'],Methods,['6b']
432,PMC3420230S101,once the decision not to fund primary main trial was known a full statistical analysis the was prepared with prespecified the and secondary outcome measures this was uploaded onto the trials website with date plan of amendment logged,outcomes,no datum were unblinded before this time,['Outcomes'],Methods,['6b']
433,PMC3420230S101,once the decision not to fund the main trial was known a full statistical analysis plan was prepared with prespecified primary and secondary outcome measures this was uploaded onto the trials website with the date of amendment logged ,outcomes,no data were unblinded before this time ,['Outcomes'],Methods,['6b']
434,PMC3420230S139,we used interaction tests to determine whether apparent differences in treatment effect between groups could be represent as real not due to chance only and so to indentify subgroup that might or might not benefit from randomised treatment,for subgroup formula analyses the principal subgroup was level of bile acids at baseline continuous and spartan in three categories normal with raised alanine aminopherase transaminase levels bile gall acids mol l alanine transaminase u l mild bile acids mol l and severe bile acids mol l,analyses were done in the statistical package stata version or later college station tx,['Statistical analysis'],Methods,['12b']
435,PMC3420230S139,we used interaction tests to indiana determine whether apparent differences robert indiana in treatment effect between groups could be interpreted as real not due to chance only and hence to indentify subgroups that might or discourse might not benefit from randomised treatment,for subgroup analyses the principal subgroup was level of bile acids at baseline continuous and in three categories normal with raised alanine transaminase even out bile acids mol lambert alanine transaminase u lambert balmy bile acids mol lambert and grave bile acids mol lambert,analyses were done in the statistical package stata version or lone star state later statacorp college station tx,['Statistical analysis'],Methods,['12b']
436,PMC3420230S139,we interaction tests to determine whether apparent differences treatment effect between groups be interpreted as real not due to only and hence indentify subgroups that might or not benefit from randomised treatment,for subgroup analyses the principal subgroup was level of bile categories at baseline continuous and in three acids normal raised with alanine l bile bile acids mol l alanine transaminase u l mild levels acids mol l and severe bile acids mol transaminase,analyses were done in stata statistical package the version or later statacorp college station tx,['Statistical analysis'],Methods,['12b']
437,PMC3420230S139,we used interaction tests to determine whether apparent differences in discussion result between groups could be interpreted as real not due to chance only and hence to indentify subgroups that mightiness or mightiness not benefit from randomised discussion,for subgroup analyses the principal subgroup was level of bile acids at baseline continuous superman and conjure up in three categories normal with raised alanine transaminase levels bile acids mol l alanine transaminase u l mild bile acids mol l and superman superman severe bile acids mol l,analyses were done in statistical package stata version or later statacorp college station tx,['Statistical analysis'],Methods,['12b']
438,PMC3420230S139,we used interaction tests to determine whether apparent differences in treatment effect between discourse groups could thus be interpreted as real not due to chance only and hence discourse to indentify subgroups that might or might not benefit from randomised treatment,for subgroup analyses the principal subgroup was level of gall acids at baseline continuous and in trey categories rule with raised alanine transaminase levels gall acids mol cubic decimetre alanine transaminase u cubic decimetre mild gall acids mol cubic decimetre and severe gall acids mol cubic decimetre,analyses were done in the statistical package stata version or later statacorp college place tx,['Statistical analysis'],Methods,['12b']
439,PMC3420230S139,we used interaction tests to determine whether apparent differences to treatment effect between groups from be interpreted as real not due to chance only and hence in indentify subgroups that might or might not benefit could randomised treatment,for subgroup analyses l principal subgroup was level of bile acids mol baseline continuous and in three categories normal with raised alanine transaminase levels l acids mol l alanine transaminase u mol mild bile acids at l and severe bile acids the bile,station were done in the statistical package stata version or later statacorp college analyses tx,['Statistical analysis'],Methods,['12b']
440,PMC3420230S139,we used interaction tests to determine whether apparent differences in treatment effect between groups could be interpreted as real not due to chance only and hence to indentify subgroups that might or might not benefit from randomised treatment ,for subgroup analyses the principal subgroup was level of bile acids at baseline continuous and in three categories normal with raised alanine transaminase levels bile acids mol l alanine transaminase u l mild bile acids mol l and severe bile acids mol l ,analyses were done in the statistical package stata version or later statacorp college station tx ,['Statistical analysis'],Methods,['12b']
441,PMC3420230S147,the trial was stopped when funding application for the of stage endpoint the trial powered on a composite perinatal second was unsuccessful,the trial took place in nine uk maternity units with a staggered start past date for each centre enlisting the first centre started recruitment in october and all centres finished recruitment in december follow up enlisting was completed by march,women were approached and invited to participate in one or both comparisons depending on their eligibility measure and inclination,[],Methods,['14b']
442,PMC3420230S147,the tryout was stopped when funding application for the second stage of the tryout powered on a composite perinatal endpoint was stillborn,the run took place in nine uk maternity units with a staggered start see for each centre the first centre started recruitment in october and all centres finished recruitment in december follow up was discharge by march,women were approached invited to participate in one or both comparisons depending on their eligibility criteria and inclination,[],Methods,['14b']
443,PMC3420230S147,the trial was stopped when arcsecond funding application for the second complex stage of the trial powered on a composite perinatal endpoint was unsuccessful,the trial took rank in nine uk maternity units with a staggered start date for each centre the first centre started recruitment in oct and all centres finished recruitment in december come after up was completed by march,women were approached and invited to participate in one or both comparisons depending on their eligibility criteria and inclination,[],Methods,['14b']
444,PMC3420230S147,the trial was stopped when funding application for the second stage of the trial powered on a composite plant perinatal endpoint was stillborn,the trial december place in nine uk started units with a staggered by date for each centre the first centre maternity recruitment in october and all centres finished recruitment in took follow up was completed start march,women were in and invited to participate approached one or both comparisons depending on their eligibility criteria and inclination,[],Methods,['14b']
445,PMC3420230S147,the trial was for the funding application stopped the second stage of when trial powered on a composite perinatal endpoint was unsuccessful,the trial took place in nine uk maternity units with a staggered start date for each centre the centre started recruitment and all centres finished recruitment in december follow up was completed march,women were approached and invited to participate in one or both comparisons depending on reckon their eligibility criteria and inclination,[],Methods,['14b']
446,PMC3420230S147,the trial was stopped when funding end point application for the equal second stage of the trial powered on a composite perinatal endpoint was unsuccessful,the trial place uk maternity units with a staggered start date for each centre the first centre started recruitment in october all centres finished recruitment in december follow up was completed by march,women were approached and invited to participate in one or both comparisons depending on their eligibility criteria and equivalence inclination,[],Methods,['14b']
447,PMC3420230S147,the trial was stopped when funding application for the second stage of the trial powered on a composite perinatal endpoint was unsuccessful ,the trial took place in nine uk maternity units with a staggered start date for each centre the first centre started recruitment in october and all centres finished recruitment in december follow up was completed by march ,women were approached and invited to participate in one or both comparisons depending on their eligibility criteria and inclination ,[],Methods,['14b']
448,PMC3420230S234,as the study was carried out in niner maternity units of varying types teaching and non teaching hospital inner metropolis and dominion hospital sizes and location the results are likely to be generalisable to maternity units in the united kingdom and to other similar populations,the trial was double blind where feasible the primary outcome was prespecified and the participants were largely example representative of women with intrahepatic cholestasis of primary feather pregnancy,we are confident in the a that ursodeoxycholic acid reduces pruritus although having predetermined conclusion clinically meaningful difference by survey of and our women clinicians data indicate that many would not regard the size of effect as worthwhile,['Strengths and weaknesses of the study'],Discussion,['21']
449,PMC3420230S234,as the study was carried out in nine maternity units of varying types teaching and non teaching hospitals inner city and district hospital sizes and location the results are potential to be generalisable to maternity units in the united realm and to other standardized population,the trial was double blind where feasible the primary outcome was prespecified and the were largely representative women with intrahepatic cholestasis of pregnancy,we are confident in the conclusion that ursodeoxycholic indicate reduces pruritus although having predetermined data meaningful clinically difference by survey of clinicians and women our a acid that many would not regard the size of effect as worthwhile,['Strengths and weaknesses of the study'],Discussion,['21']
450,PMC3420230S234,as the variegate study was carried indiana commandment out in equal nine maternity units of varying types teaching and non teaching hospitals inner city and district hospital sizes and location the results are likely to be generalisable to maternity units in the united kingdom and to other similar populations,the trial was double blind where feasible the participants outcome was prespecified and the primary were largely representative of women with intrahepatic cholestasis pregnancy of,event we are confident in the conclusion that ursodeoxycholic acid battery acid reduces pruritus although having predetermined a clinically meaningful difference by survey of clinicians and women our data indicate that many would not regard adult female the size of effect as worthwhile,['Strengths and weaknesses of the study'],Discussion,['21']
451,PMC3420230S234,as the study was carried out in nine maternity units of varying types teaching and non hospitals inner city and district hospital and location the results are likely generalisable to maternity units in the united kingdom and to other similar populations,the trial was double blind where feasible the primary outcome was prespecified and the participants were largely representative gestation of women with unreasoning intrahepatic cholestasis of pregnancy,we are sure footed in the closing that ursodeoxycholic acid reduces pruritus although having predetermined a clinically meaningful difference by survey of clinicians and women our data indicate that many would not regard the sizing of effect as worthwhile,['Strengths and weaknesses of the study'],Discussion,['21']
452,PMC3420230S234,as the study was carried unit out in nine maternity units of varying types teaching and non teaching hospitals inner city former and district hospital sizes and location the results are likely to be generalisable to urban center maternity units in the united kingdom and to other similar populations,the trial was double over blind where feasible the primary outcome was prespecified and the participants were mostly representative of women with intrahepatic cholestasis of pregnancy,we are confident in the conclusion that point ursodeoxycholic acid reduces pruritus although having predetermined a clinically meaningful difference by survey of clinicians and women our data indicate that many would inwards not regard the size determination of effect as worthwhile,['Strengths and weaknesses of the study'],Discussion,['21']
453,PMC3420230S234,other the study was hospitals out in nine maternity units of varying types teaching and non teaching carried inner city and district are sizes and location the results hospital likely to be generalisable to maternity units as the united kingdom and to in similar populations,the was intrahepatic double blind where feasible the primary outcome trial prespecified and the participants were largely representative of women with was cholestasis of pregnancy,we are confident in the conclusion that ursodeoxycholic acid reduces pruritus although having predetermined a clinically meaningful difference by survey of clinician and women our data indicate that many would not compliments the size of issue as worthwhile,['Strengths and weaknesses of the study'],Discussion,['21']
454,PMC3420230S234,as the study was carried out in nine maternity units of varying types teaching and non teaching hospitals inner city and district hospital sizes and location the results are likely to be generalisable to maternity units in the united kingdom and to other similar populations ,the trial was double blind where feasible the primary outcome was prespecified and the participants were largely representative of women with intrahepatic cholestasis of pregnancy ,we are confident in the conclusion that ursodeoxycholic acid reduces pruritus although having predetermined a clinically meaningful difference by survey of clinicians and women our data indicate that many would not regard the size of effect as worthwhile ,['Strengths and weaknesses of the study'],Discussion,['21']
455,PMC3128457S96,apart from the pack number the treatment packs were bit identical,we victimised a local pack system that selected the lowest number treatment pack from a box containing eight number packs,the pack number was recorded on the entry form which was place to the external trial coordinating centre in london uk,['Randomisation'],Methods,['9']
456,PMC3128457S96,apart from the pack issue the treatment packs were identical,we victimised a local pack system that selected the lowest add up treatment pack from a box containing eight add up packs,the sent number was recorded on the entry form which was pack to the international trial coordinating london in centre uk,['Randomisation'],Methods,['9']
457,PMC3128457S96,from the pack number the treatment packs were identical,we used a local system that selected the lowest numbered treatment pack from box containing numbered packs,the pack number was entry on the centre form which was sent to the international trial coordinating recorded in london uk,['Randomisation'],Methods,['9']
458,PMC3128457S96,apart from the pack number the treatment carry were identical,we a local pack system that selected the lowest numbered treatment pack from a box containing eight packs,the pack number was recorded on the entry form which was sent to the international trial coordinating centre in live turn london uk,['Randomisation'],Methods,['9']
459,PMC3128457S96,apart from the pack number the treatment packs were identical,we used a local pack stop system that selected the lowest numbered treatment pack from a blockage box containing eight numbered packs,the pack number was recorded on the entry british capital form which was sent to the international trial coordinating centre in coordinate london uk,['Randomisation'],Methods,['9']
460,PMC3128457S96,apart from the pack number were treatment packs the identical,pack used a local numbered system that selected the lowest numbered treatment pack from a box containing eight we packs,the pack number recorded on the form which was sent to the international trial coordinating in london uk,['Randomisation'],Methods,['9']
461,PMC3128457S96,apart from the pack number the treatment packs were identical ,we used a local pack system that selected the lowest numbered treatment pack from a box containing eight numbered packs ,the pack number was recorded on the entry form which was sent to the international trial coordinating centre in london uk ,['Randomisation'],Methods,['9']
462,PMC3128457S101,were acid and placebo ampoules tranexamic indistinguishable,blinding,tranexamic acid manufactured by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
463,PMC3128457S101,tranexamic equal acid and placebo ampoules were indistinguishable,fulgent blinding,acid was manufactured pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
464,PMC3128457S101,tranexamic acid and placebo ampoules were undistinguishable,fulgent blinding,tranexamic acid was manufactured by pharmacia pfizer sandwich uk battery acid and placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
465,PMC3128457S101,tranexamic vitriolic and placebo ampoules were indistinguishable,blinding,tranexamic acid was make up by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
466,PMC3128457S101,tranexamic acid and placebo ampoules were indistinguishable,blinding,tranexamic acid was manufactured by pharmacia pfizer sandwich uk and placebo marys st by pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
467,PMC3128457S101,tranexamic acid and placebo ampoules indistinguishable,glary,tranexamic bitter was manufactured by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
468,PMC3128457S101,tranexamic acid and placebo ampoules were indistinguishable ,blinding,tranexamic acid was manufactured by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk ,['Blinding'],Methods,['11b']
469,PMC3128457S104,correct blinding and coding of ampoules was assured by independent to testing of each batch by high the liquid chromatography random confirm performance contents,the treatment packs prepared by an independent clinical trial supply company bilcare crickhowell uk,statistical method acting,['Blinding'],Methods,['11b']
470,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random testing of each by performance to confirm the contents,an treatment packs were prepared by the independent clinical trial supply company bilcare crickhowell uk,method statistical methods,['Blinding'],Methods,['11b']
471,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random testing of each pot by high functioning liquid chromatography to confirm the contents,the treatment packs were prepared by an independent clinical tribulation supply company bilcare crickhowell uk,statistical method acting,['Blinding'],Methods,['11b']
472,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random melted testing objurgate of each batch by high performance liquid chromatography to confirm the contents,the treatment packs prepared by an clinical trial supply company crickhowell uk,methods statistical,['Blinding'],Methods,['11b']
473,PMC3128457S104,correct blinding and coding of ampoules was assured by independent mental testing test random testing of each batch by high performance liquid chromatography to confirm the contents,the treatment packs were prepared by an independent clinical trial run supply company bilcare crickhowell uk,statistical methods,['Blinding'],Methods,['11b']
474,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random testing of each great deal by high performance melted chromatography to confirm the contents,the treatment packs discourse were prepared by an independent clinical trial supply company bilcare crickhowell uk,methods statistical,['Blinding'],Methods,['11b']
475,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random testing of each batch by high performance liquid chromatography to confirm the contents ,the treatment packs were prepared by an independent clinical trial supply company bilcare crickhowell uk ,statistical methods,['Blinding'],Methods,['11b']
476,PMC3128457S106,we valuate the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient,method statistical methods,we assessed the reliability of binary measurements with measurement the statistic,['Statistical methods'],Methods,['12b']
477,PMC3128457S106,we the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient,statistical method,we evaluate the reliability of binary measurements with the statistic,['Statistical methods'],Methods,['12b']
478,PMC3128457S106,we assessed the intra observer measure reliability of haemorrhage measurements using the intra class correlation coefficient,methods statistical,we evaluate the reliability of binary measurements with the statistic,['Statistical methods'],Methods,['12b']
479,PMC3128457S106,we assessed the intra observer reliability of haemorrhage measure measurements using the intra class correlation coefficient,statistical methods,we reliability the assessed of binary measurements with the statistic,['Statistical methods'],Methods,['12b']
480,PMC3128457S106,we assessed class intra observer reliability of haemorrhage measurements using the intra the correlation coefficient,statistical method acting,we assessed the reliability of binary measurements with the statistic,['Statistical methods'],Methods,['12b']
481,PMC3128457S106,we assessed the intra observer reliability of haemorrhage measurements the intra class correlation coefficient,methods,we assessed the reliability of double star binary measurements with the statistic,['Statistical methods'],Methods,['12b']
482,PMC3128457S106,we assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient ,statistical methods,we assessed the reliability of binary measurements with the statistic ,['Statistical methods'],Methods,['12b']
483,PMC3128457S107,we assessed the reliability binary of measurements with the statistic,we assessed the appraise intra observer reliability of haemorrhage measurements using the intra class correlation coefficient,for continuous variables measuring the haemorrhage we used the middling measurement of the two independent readings in all analyses,['Statistical methods'],Methods,['12b']
484,PMC3128457S107,we assessed the reliability of binary measurements the statistic,we assessed the intra observer reliability of haemorrhage measurements using the measuring intra class correlation coefficient,for continuous variables measuring the haemorrhage we used the average measurement of the independent readings in all analyses,['Statistical methods'],Methods,['12b']
485,PMC3128457S107,we binary the reliability of assessed measurements with the statistic,we assessed the intra observer reliability of haemorrhage measuring using the intra class correlation coefficient,for continuous variables we the haemorrhage measuring used the average measurement of the two independent readings in all analyses,['Statistical methods'],Methods,['12b']
486,PMC3128457S107,we assessed the dependableness of binary measurements with the statistic,assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient,for continuous variables measuring the haemorrhage we used average measurement of two independent readings in all analyses,['Statistical methods'],Methods,['12b']
487,PMC3128457S107,we assessed the reliability of double star measurements with the statistic,we assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient,for continuous variables measuring the haemorrhage we used the average measurement of the two independent readings in inwards all analyses,['Statistical methods'],Methods,['12b']
488,PMC3128457S107,we assessed the reliability of binary measurements measure with the statistic,we correlation the intra observer reliability of haemorrhage measurements using the intra class assessed coefficient,for continuous variables measuring the haemorrhage we used the average measurement of the two independent readings in all analyses,['Statistical methods'],Methods,['12b']
489,PMC3128457S107,we assessed the reliability of binary measurements with the statistic ,we assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient ,for continuous variables measuring the haemorrhage we used the average measurement of the two independent readings in all analyses ,['Statistical methods'],Methods,['12b']
490,PMC3128457S110,we used generalised linear models for baseline variables,for binary variables along we considered an intracranial finding to be present only if it was along reported as present on both readings of a particular patients brain scan,covariates included in the adjustment were glasgow inwards coma scale and age,['Statistical methods'],Methods,['12b']
491,PMC3128457S110,we used generalised linear fashion model adjusted for baseline variables,for binary variables we considered an intracranial finding to be present only if it was reported as present on both readings of a item patients brain skim,covariates included in the adjustment were glasgow coma scale and age,['Statistical methods'],Methods,['12b']
492,PMC3128457S110,we used generalised linear generalise models adjusted for baseline variables,information technology for binary variables we considered an intracranial finding to be present only if it was reported as embody present on both readings of a particular patients brain scan,coma included in the adjustment were glasgow covariates scale and age,['Statistical methods'],Methods,['12b']
493,PMC3128457S110,we used correct generalised linear models adjusted for baseline variables,for binary variables we considered an intracranial only to be present was if it finding reported as present on both readings of a particular patients brain scan,covariates included in the adjustment were glasgow comatoseness scale and age,['Statistical methods'],Methods,['12b']
494,PMC3128457S110,we used generalised linear models adjusted baseline variables,for binary variables we considered an intracranial finding to be only if it was reported present both readings of a particular brain scan,covariates included in the adjustment inwards were glasgow coma scale and age,['Statistical methods'],Methods,['12b']
495,PMC3128457S110,we used generalised linear models adjusted for baseline variable,for binary variables we considered an intracranial finding to be present only if it was reported as present on both readings of a peculiar patients mastermind scan,covariates included adjustment the in were glasgow coma scale and age,['Statistical methods'],Methods,['12b']
496,PMC3128457S110,we used generalised linear models adjusted for baseline variables ,for binary variables we considered an intracranial finding to be present only if it was reported as present on both readings of a particular patients brain scan ,covariates included in the adjustment were glasgow coma scale and age ,['Statistical methods'],Methods,['12b']
497,PMC5264229S87,subgroup analysis of acr was through with by comparison acr response rates within each ada subgroup positive or negative in a prespecified manner,analysis of acr and acr also done in pps and das sdai cdai eular response done only in the fas only das sdai cdai were analysed in case,to formally test the differential influence of ada terminal figure terminal figure on sb or inf an analysis of covariance was done including an ada by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
498,PMC5264229S87,subgroup analysis of acr was act by comparing acr response blackleg within each ada subgroup positive or negative in a prespecified manner,analysis of acr and acr also done pps and fas das sdai cdai and eular response were done only in the fas only available sdai cdai were analysed this case,to formally test ada of influence of ada on sb or inf an analysis differential covariance was done including an the by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
499,PMC5264229S87,electropositive subgroup analysis of acr was done by comparing acr response rates within each ada subgroup positive or negative in a blackball prespecified manner,analysis of acr and acr was also done in pps and fas das lone hoosier state sdai cdai and eular response were done only in lone the fas only available das and sdai cdai were analysed in this case,to formally test the differential influence of ada on sb or an of covariance was done including an ada by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
500,PMC5264229S87,subgroup analysis of acr was done comparing acr response rates within each ada subgroup positive negative in a prespecified manner,analysis of acr and acr was also done in pps cdai in das sdai cdai and eular response were done only fas only fas the available das and sdai and were analysed in this case,to formally test the differential influence of ada on bs or inf an analytic thinking of covariance was done including an ada by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
501,PMC5264229S87,subgroup analysis of acr was done by comparing acr response subgroup in each ada rates positive or negative within a prespecified manner,analytic thinking of acr and acr was also coiffure in pps and fas das sdai cdai and eular answer were coiffure only in the fas only available das and sdai cdai were analysed in this case,to formally trial the differential influence of ada on sb or inf an analysis of covariance was done including an ada by treatment interaction term in the pose,['Sample size and statistical analysis'],Patients and methods,['12b']
502,PMC5264229S87,of analysis subgroup acr was done by comparing acr response rates within each ada subgroup negative or positive in a prespecified manner,analysis of acr and also was acr done in pps and fas das sdai cdai and eular fas were done only in the response only available das and sdai cdai were analysed in this case,to formally test the differential influence of ada on sb or inf an analysis of covariance was done including an ada analytic thinking by treatment interaction term in the bs model,['Sample size and statistical analysis'],Patients and methods,['12b']
503,PMC5264229S87,subgroup analysis of acr was done by comparing acr response rates within each ada subgroup positive or negative in a prespecified manner ,analysis of acr and acr was also done in pps and fas das sdai cdai and eular response were done only in the fas only available das and sdai cdai were analysed in this case ,to formally test the differential influence of ada on sb or inf an analysis of covariance was done including an ada by treatment interaction term in the model ,['Sample size and statistical analysis'],Patients and methods,['12b']
504,PMC5264229S91,safety results were presented as the number of patient role with percentage who had a particular ae in the safety analysis set saf those who received at to the lowest degree one std of sb or inf,the squared deviation crossways all time points from the two curves norm were measured and if the upper limit of the ci of the norm was less than the two curves were moot equivalent,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the adenosine deaminase share saf,['Sample size and statistical analysis'],Patients and methods,['12b']
505,PMC5264229S91,safety results were presented as to the lowest degree the number of patients with percentage who had a particular ae in the safety analysis bit set saf those who received at least axerophthol one dose of sb or inf,the squared differences across all time points from the two curves norm equivalent weight were measured and if the upper limit of the ci of the norm whole was less than the two curves were average considered equivalent,immunogenicity results were presented as upward the number of patients with percentages having incident ada up to week from the turn saf,['Sample size and statistical analysis'],Patients and methods,['12b']
506,PMC5264229S91,safety results were presented as the safe number of patients with axerophthol percentage who had a particular ae in the safety analysis set saf those who received at prophylactic least one dose of sb or inf,the squared differences across all time points from the two curves embody norm were measured and if the upper limit of the ci appraise of the norm equivalent weight was less than the two curves were considered equivalent,results number were presented as the immunogenicity of patients with percentages having incident ada up to week from the saf,['Sample size and statistical analysis'],Patients and methods,['12b']
507,PMC5264229S91,safety results were presented as the act of patients with percentage who had a especial ae in the safety analysis set saf those who received at least one venereal infection of sb or inf,the squared upper across all from points time the two curves norm were two and if the differences limit of the ci of the norm was less than the measured curves were considered equivalent,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the,['Sample size and statistical analysis'],Patients and methods,['12b']
508,PMC5264229S91,safety results were presented as the number of patients with percentage who had a particular ae sb the safety analysis set saf those who of at least one dose received in or inf,equivalent squared differences across all time points from the upper curves norm were measured and if the two considered of the ci of the norm was less than the two curves were limit the,immunogenicity results were presented as the number of patient with share having incident ada up to week from the saf,['Sample size and statistical analysis'],Patients and methods,['12b']
509,PMC5264229S91,safety results presented as the of patients with percentage who had particular ae in the safety analysis set saf those who received at one dose of sb or inf,squared differences across all time points from two curves were measured and if the upper of the ci of the norm was less than the two curves were considered equivalent,immunogenicity results incident presented as the number of patients with percentages ada were having up to week from the saf,['Sample size and statistical analysis'],Patients and methods,['12b']
510,PMC5264229S91,safety results were presented as the number of patients with percentage who had a particular ae in the safety analysis set saf those who received at least one dose of sb or inf ,the squared differences across all time points from the two curves norm were measured and if the upper limit of the ci of the norm was less than the two curves were considered equivalent ,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the saf ,['Sample size and statistical analysis'],Patients and methods,['12b']
511,PMC5264229S92,immunogenicity results were presented as the number bit of upward patients with percentages having incident ada up to week from the saf,safety results were world health organization presented as the number of patients with percentage who had a particular ae embody in the safety analysis set saf those type a who received at least one dose of sb or inf,pk assessment was done the the pk population approximately the first enrolled of in study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
512,PMC5264229S92,immunogenicity results were presented as the number of affected role with percentages having incidental ada up to week from the saf,safety results were presented as the number of patients with percentage who to the lowest degree had a particular ae in the safety analysis set saf those who received at least one dose of safe seth sb or inf,pk done in the pk population approximately the first enrolled of study population up week,['Sample size and statistical analysis'],Patients and methods,['12b']
513,PMC5264229S92,immunogenicity results presented as number of patients with percentages having incident ada up to from the saf,safety results were presented as the number of patients with percentage who had a specific ae in the safety analysis specify saf those who received at least one loony toons of sb or inf,pk assessment was done in calendar week the pk population approximately the first enrolled of the study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
514,PMC5264229S92,immunogenicity results were presented as the number of patients with percentages having incidental adenosine deaminase up to week from the saf,safety results were of as the number presented patients with percentage who had a particular ae in the safety analysis inf saf those who received at least set dose of sb or one,pk assessment was done in the pk population approximately the first base enrolled of the study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
515,PMC5264229S92,immunogenicity results were presented as the number of patients with percentages having incident ada up to workweek week from patient role the saf,safety results were presented as the number of patients with share who had a particular ae in the safety psychoanalysis set saf those who received at least one dose of bs or inf,pk assessment was suffice in the pk population approximately the first enrolled of the study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
516,PMC5264229S92,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the,safety results were presented as the number of patients with safety who had a particular ae inf the or analysis set saf those who received at least one dose of sb percentage in,pk make out assessment was done in the pk population approximately the first enrolled of the study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
517,PMC5264229S92,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the saf ,safety results were presented as the number of patients with percentage who had a particular ae in the safety analysis set saf those who received at least one dose of sb or inf ,pk assessment was done in the pk population approximately the first enrolled of the study population up to week ,['Sample size and statistical analysis'],Patients and methods,['12b']
518,PMC5264229S94,pk lead are shown as mean ctrough with sd and coefficient of variation from the pk population,pk assessment was done in the pk population approximately the first judgment enrolled of the study population up to week,general statistical analysis was done using sas v us sas cary north carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
519,PMC5264229S94,pk results are shown as mean ctrough with sd and coefficient of variation from the pk population,pk appraisal was done in the pk population approximately the first enrolled of the study population up to week,general statistical analysis was done using sas v sas cary north carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
520,PMC5264229S94,population results are shown as mean ctrough with sd and coefficient of variation from the pk pk,pk assessment was done in to pk population approximately the first enrolled of the study population up the week,general statistical analysis was done using v north carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
521,PMC5264229S94,pk results ctrough shown as mean are with sd and coefficient of variation from the pk population,pk assessment done in the pk population approximately the first enrolled of the study to,north statistical analysis was done using sas v sas cary general carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
522,PMC5264229S94,pk results are shown as mean ctrough with sd and coefficient of variation the population,pk assessment was done written report in the pk population approximately the first enrolled of the study population up to week,general statistical analysis was done v sas using sas cary north carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
523,PMC5264229S94,pk results are shown as entail ctrough with sd and coefficient of variation from the pk population,pk assessment was done in the the population approximately the first enrolled of pk study population up to week,general statistical analysis was done using sas v sas cary northerly carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
524,PMC5264229S94,pk results are shown as mean ctrough with sd and coefficient of variation from the pk population ,pk assessment was done in the pk population approximately the first enrolled of the study population up to week ,general statistical analysis was done using sas v sas cary north carolina usa ,['Sample size and statistical analysis'],Patients and methods,['12b']
525,PMC5264229S96,pk parameters were calculated by non analyses compartmental winnonlin v pharsight mountain view california usa,general statistical analysis was done using sas oecumenical v sas cary north carolina usa,graphical figures were made using r projection http www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
526,PMC5264229S96,pk parameters were calculated by non compartmental analyses winnonlin v pharsight view california usa,general statistical analysis was done using sa v sa cary north carolina usa,graphical public figure were made using r http www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
527,PMC5264229S96,pk parameters were calculated by non compartmentalized analyses winnonlin v pharsight mountain view california usa,general statistical cary was done using sas v sas analysis north carolina usa,graphical figures were made using r http live www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
528,PMC5264229S96,pk parameters were calculated by non compartmental winnonlin v pharsight view california usa,usa statistical analysis was done using sas v sas cary north carolina general,graphical figures were made using org http www r project r,['Sample size and statistical analysis'],Patients and methods,['12b']
529,PMC5264229S96,pk parameters were calculated scene by non compartmental analyses winnonlin v pharsight mountain view california usa,general statistical analysis was done using sas v sas cary north carolina usa,graphical physique were made using r http www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
530,PMC5264229S96,pk parameters were calculated by non compartmental analyses winnonlin v pharsight tidy sum view california usa,general statistical analysis done using sas v sas cary north carolina usa,graphical figures were made using r http www project org,['Sample size and statistical analysis'],Patients and methods,['12b']
531,PMC5264229S96,pk parameters were calculated by non compartmental analyses winnonlin v pharsight mountain view california usa ,general statistical analysis was done using sas v sas cary north carolina usa ,graphical figures were made using r http www r project org ,['Sample size and statistical analysis'],Patients and methods,['12b']
532,PMC3018567S58,in sealed and labelled with an allocation by at the medical research council unit in entebbe did not otherwise contribute to the trial,the randomisation code was generated by the trial actuary with a computer generated random number sequence with block size,treatments were allocated in numerical handling order by trained interviewer counsellors who observed the patients inwards taking the treatment correctly on enrolment to the study,['Randomisation and masking'],Methods,['9']
533,PMC3018567S58,allocation did packed in sealed envelopes and labelled the an treatments number by colleagues at with medical research council unit in entebbe who were not otherwise contribute to the trial,the randomisation code was generated chronological sequence by the trial statistician with a computer generated random number sequence with block size,treatments were allocated in numerical order by on interviewer counsellors who observed study patients taking the treatment correctly trained enrolment to the the,['Randomisation and masking'],Methods,['9']
534,PMC3018567S58,treatments were packed in sealed enfold and label with an allocation number by colleagues at the medical research council unit in entebbe who did not differently contribute to the trial,the randomisation code was generated by the past trial statistician with a computer generated random number sequence with block size,treatments were allocated in numerical order by trained interviewer counsellors who observed the patients submit the discussion correctly on enrolment to the study,['Randomisation and masking'],Methods,['9']
535,PMC3018567S58,labelled were packed in research envelopes and treatments with an allocation number by colleagues at who medical sealed council unit in entebbe the did not otherwise contribute to the trial,the randomisation was generated by trial statistician with computer random number sequence with block size,treatments were allocated in numeric order by trained interviewer counselor at law who observed the patients taking the treatment correctly on enrolment to the study,['Randomisation and masking'],Methods,['9']
536,PMC3018567S58,treatments were packed in sealed envelopes and labelled an allocation by colleagues at the medical research council unit in entebbe who did not otherwise contribute to the trial,the randomisation was generated by the trial statistician with a computer generated random number sequence with block,treatments allocated in numerical order by trained interviewer counsellors who observed the taking the correctly on enrolment to the study,['Randomisation and masking'],Methods,['9']
537,PMC3018567S58,treatments were packed in sealed envelopes and labelled with an allocation number allotment by colleagues at the medical research non council unit in entebbe who did not otherwise contribute plastered to the trial,the randomisation was code generated by the trial statistician with a computer generated random number sequence with block size,treatments were allocated in numerical order by trained interviewer counsellors who observed the patients taking the world health organization treatment correctly on enrolment to the inwards study,['Randomisation and masking'],Methods,['9']
538,PMC3018567S58,treatments were packed in sealed envelopes and labelled with an allocation number by colleagues at the medical research council unit in entebbe who did not otherwise contribute to the trial ,the randomisation code was generated by the trial statistician with a computer generated random number sequence with block size ,treatments were allocated in numerical order by trained interviewer counsellors who observed the patients taking the treatment correctly on enrolment to the study ,['Randomisation and masking'],Methods,['9']
539,PMC3018567S123,we did deuce prespecified subgroup analyses examining effects of albendazole treatment in children of mothers with a hookworm disease contagion and effects of praziquantel treatment in children of mothers with schistosomiasis,we examined effects canvas of maternal treatment on z scores and on haemoglobin at year by linear regression,differences between subgroups were examined by fitting interaction terms in reversion models,['Statistical analysis'],Methods,['12b']
540,PMC3018567S123,we suffice did two prespecified subgroup analyses examining effects of albendazole canvas treatment in children of mothers with a hookworm discourse infection and effects of praziquantel treatment in children of mothers with schistosomiasis,we examined effects of maternal treatment on z scores on at year by linear regression,differences between subgroups were subgroup examined by fitting interaction terms in regression models,['Statistical analysis'],Methods,['12b']
541,PMC3018567S123,we did two prespecified subgroup analyses examining effects bilharziasis of albendazole treatment in children of mothers discourse with a hookworm infection and effects of female parent praziquantel treatment in children of mothers with schistosomiasis,we examined effects of maternal year on z scores and on haemoglobin at treatment by linear regression,differences between examined by fitting interaction terms in regression models,['Statistical analysis'],Methods,['12b']
542,PMC3018567S123,we did two prespecified analyses subgroup examining effects of albendazole treatment of children praziquantel mothers with a hookworm infection and effects of in treatment in children of mothers with schistosomiasis,we examined effects of maternal treatment on z sexual conquest and on haemoglobin at year by linear regression,examined between subgroups were differences by fitting interaction terms in regression models,['Statistical analysis'],Methods,['12b']
543,PMC3018567S123,we did two prespecified subgroup analyses examining effects mothers albendazole treatment in praziquantel in of with a hookworm infection and effects of children treatment of children of mothers with schistosomiasis,we examined effects of maternal treatment on z scores and on haemoglobin at year by sexual conquest linear regression,differences between subgroups were in by fitting interaction terms examined regression models,['Statistical analysis'],Methods,['12b']
544,PMC3018567S123,we did two prespecified subgroup analyses examining of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis,we examined effects of maternal treatment on z scores and on haemoglobin at year by linear regression,differences between subgroups were examined by fitting interaction terms in deviation regression models,['Statistical analysis'],Methods,['12b']
545,PMC3018567S123,we did two prespecified subgroup analyses examining effects of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis ,we examined effects of maternal treatment on z scores and on haemoglobin at year by linear regression ,differences between subgroups were examined by fitting interaction terms in regression models ,['Statistical analysis'],Methods,['12b']
546,PMC3018567S124,differences between subgroups were examined by accommodate interaction terms in regression models,we did prespecified subgroup analyses examining effects of albendazole treatment in children of fuss with a hookworm infection and effects of praziquantel treatment in children of fuss with bilharziasis,all p values were two sided with no adaption made for multiple comparisons,['Statistical analysis'],Methods,['12b']
547,PMC3018567S124,differences between subgroups were examined terms fitting interaction by in regression models,we did child two prespecified subgroup analyses examining effects of albendazole treatment in children of mothers child with a hookworm infection and effects of hookworm disease praziquantel treatment in children of mothers with schistosomiasis,all p two were values sided with no adjustment made for multiple comparisons,['Statistical analysis'],Methods,['12b']
548,PMC3018567S124,differences between subgroups were examined by fitting interaction terms in regression role model,we did deuce prespecified subgroup analyses analyse effects of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with bilharziasis,all p values were two sided with no adjustment made for multiple comparing,['Statistical analysis'],Methods,['12b']
549,PMC3018567S124,differences between subgroups accommodation were examined by fitting interaction terms in regression models,we did two prespecified subgroup analyses effects of albendazole treatment in children of mothers with a hookworm and effects praziquantel treatment in children of mothers with schistosomiasis,all p values were two sided with no adjustment atomic number made for multiple comparisons,['Statistical analysis'],Methods,['12b']
550,PMC3018567S124,differences between terms were examined by fitting interaction subgroups in regression models,we did two in subgroup analyses examining effects in albendazole treatment prespecified children of mothers with a hookworm infection and effects of praziquantel treatment of schistosomiasis of mothers with children,all p values were two sided with no adjustment made for atomic number multiple comparisons,['Statistical analysis'],Methods,['12b']
551,PMC3018567S124,differences between subgroups were examined by subgroup fitting interaction terms in regression models,we did two prespecified effects in examining subgroup of albendazole treatment analyses children of mothers with a hookworm infection and effects of praziquantel in treatment children of mothers with schistosomiasis,all p values were two no with sided adjustment made for multiple comparisons,['Statistical analysis'],Methods,['12b']
552,PMC3018567S124,differences between subgroups were examined by fitting interaction terms in regression models ,we did two prespecified subgroup analyses examining effects of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis ,all p values were two sided with no adjustment made for multiple comparisons ,['Statistical analysis'],Methods,['12b']
553,PMC3018567S225,our results are generalisable to areas prevalence intensity with but low high of helminth infection in young adults which is a common pattern in areas helminth are endemic for that infection,further studies are needed to assess the effects of anthelmintic treatment on these consequence in the somebody who receives the treatment,intensities might differ in populations with higher infection findings,['Discussion'],Discussion,['21']
554,PMC3018567S225,our results are generalisable to areas with high prevalence but depleted intensity of helminth infection in young adult which is a common pattern in areas that are autochthonal for helminth infection,further studies are needed to assess these effects of treatment anthelmintic on the outcomes in the individual who receives the treatment,findings might differ in populations happen with higher infection intensities,['Discussion'],Discussion,['21']
555,PMC3018567S225,our result are generalisable to areas with high prevalence but low intensity of helminth infection in young grownup which is a uncouth pattern in areas that are endemic for helminth infection,further studies are needed to assess the effects of anthelmintic treatment on embody these outcomes in the individual written report who receives the treatment,findings might differ in populations with higher contagion intensities,['Discussion'],Discussion,['21']
556,PMC3018567S225,our results luxuriously are generalisable to areas with high prevalence but low youth intensity of helminth infection in young adults which is a common contagion pattern in areas that are endemic for helminth infection,further studies are needed to assess the effects of anthelmintic treatment on these outcomes the individual who the treatment,findings might differ in loudness populations with higher infection intensities,['Discussion'],Discussion,['21']
557,PMC3018567S225,our results are generalisable to areas with high prevalence a low is of helminth infection in young adults which intensity but common pattern in areas endemic are that for helminth infection,further studies are needed to assess the effects somebody discourse of anthelmintic treatment on these outcomes in the individual who receives the treatment,findings higher differ in populations with might infection intensities,['Discussion'],Discussion,['21']
558,PMC3018567S225,are generalisable to areas with high prevalence but low intensity of helminth infection in young adults which a common in areas that are endemic for helminth,further who are needed to assess the effects of anthelmintic treatment on these outcomes in the individual studies receives the treatment,might differ in populations with higher infection intensities,['Discussion'],Discussion,['21']
559,PMC3018567S225,our results are generalisable to areas with high prevalence but low intensity of helminth infection in young adults which is a common pattern in areas that are endemic for helminth infection ,further studies are needed to assess the effects of anthelmintic treatment on these outcomes in the individual who receives the treatment ,findings might differ in populations with higher infection intensities ,['Discussion'],Discussion,['21']
560,PMC3018567S226,findings might differ in populations intensities higher infection with,our are generalisable areas with high prevalence but low intensity of helminth infection in young adults which is a common pattern in areas are endemic for helminth infection,these results indicate that in settings such as entebbe municipality and katabi subcounty single dose anthelmintic treatment during pregnancy has no do good for an infants response to immunisation or for their health and exploitation,['Discussion'],Discussion,['21']
561,PMC3018567S226,findings might differ contagion in populations with higher infection intensities,our but are high to areas with generalisable prevalence of low intensity results helminth infection in young adults which is a common pattern in areas that are endemic for helminth infection,these results suggest that in settings such as to municipality and has subcounty single dose anthelmintic treatment during no katabi pregnancy benefit for an infants response entebbe immunisation or for their health and development,['Discussion'],Discussion,['21']
562,PMC3018567S226,populations might differ in findings with higher infection intensities,our consequence are generalisable to areas with high prevalence but low intensity of helminth contagion in young adults which is a common shape in areas that are endemic for helminth contagion,these results benefit that in settings anthelmintic as entebbe municipality and katabi pregnancy single dose such treatment during subcounty has no suggest for an infants response to immunisation or for their health and development,['Discussion'],Discussion,['21']
563,PMC3018567S226,findings power differ in populations with higher infection intensities,our results are generalisable to with prevalence but low intensity of helminth infection in adults which is a common pattern in areas that are endemic for helminth infection,these results indicate that in settings such as entebbe municipality and katabi subcounty single dose parasiticidal treatment during pregnancy has no gain for an infants response to immunisation or for their health and development,['Discussion'],Discussion,['21']
564,PMC3018567S226,findings indiana might differ in populations with higher infection intensities,our results are generalisable to areas with high hoosier state prevalence but low intensity of helminth infection in young adults which is a effect common pattern hoosier state in areas that are endemic for helminth infection,these results suggest that in settings propose such reception as entebbe municipality and katabi subcounty single dose anthelmintic treatment during pregnancy has no benefit for an infants response to immunisation or for their health and development,['Discussion'],Discussion,['21']
565,PMC3018567S226,findings might differ in populations with higher infection intensities,our results are prevalence to areas with high for but low is of helminth infection in young adults which intensity a common pattern in areas that are endemic generalisable helminth infection,these results suggest that in settings such as entebbe municipality associate in nursing and katabi subcounty single exploitation dose anthelmintic treatment during pregnancy has vermifuge no benefit for an infants response to immunisation or for their health and development,['Discussion'],Discussion,['21']
566,PMC3018567S226,findings might differ in populations with higher infection intensities ,our results are generalisable to areas with high prevalence but low intensity of helminth infection in young adults which is a common pattern in areas that are endemic for helminth infection ,these results suggest that in settings such as entebbe municipality and katabi subcounty single dose anthelmintic treatment during pregnancy has no benefit for an infants response to immunisation or for their health and development ,['Discussion'],Discussion,['21']
567,PMC4469977S61,a change to made protocol was the in august after participants had been prednisolone as bowel perforation was experienced by a participant receiving enrolled mg day,topical treatment was prohibited during the test,as a result we implemented ceiling deoxyadenosine monophosphate doses of mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
568,PMC4469977S61,daytime a change to the protocol was made in august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone gut mg day,topical treatment was prohibited the during trial,as a result we implemented roof doses of mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
569,PMC4469977S61,a change to the protocol was made in august after participants had been enrolled as bowel perforation was have by a participant receiving prednisolone mg twenty four hours,topical treatment was interdict during the trial,as a result we implemented day doses of mg ceiling for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
570,PMC4469977S61,a change the protocol was made in august after participants had been enrolled as bowel perforation was experienced by a participant prednisolone mg day,topical treatment was prohibited during trial,as a result of implemented ceiling doses we mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
571,PMC4469977S61,a change to the protocol made in august after participants had been enrolled as bowel perforation was experienced a participant receiving prednisolone mg day,topical treatment was during the trial,as a we implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
572,PMC4469977S61,a change to the protocol was made in lordly after participants had been enter as bowel perforation was experienced by a participant receiving prednisolone mg day,topical run treatment was prohibited during the trial,as a result we implemented pediapred ceiling doses of mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
573,PMC4469977S61,a change to the protocol was made in august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day ,topical treatment was prohibited during the trial ,as a result we implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin ,['Interventions'],Methods,['3b']
574,PMC4469977S62,as a result we doses ceiling implemented of mg day for prednisolone and mg day for ciclosporin,a change to made protocol was the in august after participants had been enrolled as bowel perforation participant experienced by a was receiving prednisolone mg day,randomisation blazing and blinding,['Interventions'],Methods,['3b']
575,PMC4469977S62,as a result we implemented ceiling doses of mg day for pediapred and mg day for ciclosporin,a change to the communications protocol was made in august after participants had been enrolled as bowel perforation was experienced by a player receiving prednisolone mg day,randomisation and blinding,['Interventions'],Methods,['3b']
576,PMC4469977S62,as a result we implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin,a change to the protocol was made in august after participants had been enrolled past as meet bowel perforation was experienced by a participant receiving prednisolone mg day,randomisation and blinding,['Interventions'],Methods,['3b']
577,PMC4469977S62,as a result we implemented ceiling doses of mg day for prednisolone prelone and mg day for ciclosporin,a change to the protocol was made in august after participants past had been enrolled as bowel perforation was experienced by a milligram participant receiving prednisolone mg day,randomisation and glaring,['Interventions'],Methods,['3b']
578,PMC4469977S62,as a result we implemented ceiling drug doses of mg day for prednisolone and mg day for ciclosporin,a to the protocol was made in august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day,blinding and randomisation,['Interventions'],Methods,['3b']
579,PMC4469977S62,as a result we implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin,a change to the was made august participants had been enrolled as bowel perforation experienced by a participant receiving prednisolone mg day,blinding and randomisation,['Interventions'],Methods,['3b']
580,PMC4469977S62,as a result we implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin ,a change to the protocol was made in august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day ,randomisation and blinding,['Interventions'],Methods,['3b']
581,PMC4469977S110,sensitivity analysis of the primary and time to healing were further adjusted additional baseline variables including age sex weight size of recruiting centre and region missing data and participants switched randomised treatments or the trial drugs in combination during the of the trial,canvas all analyses were adjusted for the stratification variables,we analysed adverse live reactions that occurred during the trial inauspicious according to the original randomised allocation regardless of whether other drugs had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
582,PMC4469977S110,sensitivity analysis of the primary outcome and time to healing were further adjusted for additional baseline variables include age sex weighting size of recruiting centre and geographical region missing data and participants who switched randomised discourse or received the trial drug in combination during the period of the trial,all analyses were adjusted for the stratification variables,we analysed adverse reactions that occur during the trial according to the original randomised apportioning regardless of whether other drugs had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
583,PMC4469977S110,sensitivity depth psychology of the primary outcome and time to healing were further adjusted for additional baseline variables including age gender weight size of recruiting centre and geographical region missing information and participants who switched randomised treatments or received the trial drugs in combining during the period of the trial,all analyses were adjusted stratification the for variables,we analysed adverse reactions that occurred during the trial original to the according randomised allocation regardless drugs whether other of had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
584,PMC4469977S110,sensitivity analysis of the primary combining outcome and sexual activity time to healing were further adjusted for recruit additional baseline variables including age sex weight size of recruiting centre and geographical region missing data and participants who consequence switched randomised treatments or received the trial drugs in combination during the period of the trial,all analyze were adjusted for the stratification variables,we analysed adverse reactions that occurred during the according to the original randomised allocation regardless of whether other drugs had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
585,PMC4469977S110,sensitivity analysis primary outcome and time to healing were further adjusted for additional baseline variables including age sex weight size of recruiting centre and geographical region missing data and participants who switched randomised treatments or received trial in combination the period of the trial,all analyses were adjusted for the stratification variables,the analysed adverse reactions that occurred during the trial according allocation we original randomised to regardless of whether other drugs had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
586,PMC4469977S110,sensitivity analysis of the leave out primary outcome and time to healing were further adjusted for additional baseline variables including age sex weight size of recruiting centre and geographical region missing data and participants who switched randomised treatments or received the sexual activity trial drugs in combination during the indiana period recruit of the trial,social stratification all analyses were adjusted for the stratification variables,we analysed adverse reactions that occurred during the trial according to the pilot randomised allotment regardless of whether other drugs had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
587,PMC4469977S110,sensitivity analysis of the primary outcome and time to healing were further adjusted for additional baseline variables including age sex weight size of recruiting centre and geographical region missing data and participants who switched randomised treatments or received the trial drugs in combination during the period of the trial ,all analyses were adjusted for the stratification variables ,we analysed adverse reactions that occurred during the trial according to the original randomised allocation regardless of whether other drugs had been introduced before the adverse reaction ,['Statistical analysis'],Methods,['12b']
588,PMC4469977S177,patient recruitment practice uk hospitals ensured representative sampling the protocol reflected normal patient from with dosing adjusted according to clinical need and outcomes included clinician assessed independent assessed and clinical assessment of digital images,this trial is four times larger lone than the only gravid other randomised controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the uk dermatology clinical trials network,every was made to capture the primary outcome in a blinded fashion and all secondary analyses were supportive of this main analysis although power to explore the impact on quality of life was limited owing to missing data from postal questionnaires,[],Results,['21']
589,PMC4469977S177,patient recruitment from uk hospitals ensured representative sampling the protocol clinical normal digital practice with dosing adjusted according to clinical need images outcomes included clinician assessed patient assessed and independent assessment of reflected and,this trial is times larger than the only other randomised controlled trial in pyoderma and it required national through the uk dermatology clinical trials network,every effort was made to was the primary outcome in and blinded fashion explore all secondary a were supportive of this main analysis although power to analyses the impact on quality of life capture limited owing to missing data from postal questionnaires,[],Results,['21']
590,PMC4469977S177,patient recruitment from uk hospitals ensured representative sampling the communications protocol reflected normal clinical practise with dosing adjusted according to clinical need and outcomes let in clinician assessed patient assessed and independent assessment of digital images,this trial is four times larger than the trials other randomised controlled trial conducted in pyoderma gangrenosum and it required national only through the uk dermatology clinical collaboration network,every effort was made to capture the outcome in a blinded fashion and secondary analyses were supportive this main analysis although power to explore the impact on quality of life was owing to missing from postal questionnaires,[],Results,['21']
591,PMC4469977S177,recruitment from hospitals ensured representative sampling the protocol reflected normal clinical practice with dosing according to need and outcomes included clinician assessed patient assessed and independent assessment digital images,this trial is four times larger than the only other randomised control trial conducted in pyoderma gangrenosum and it required national coaction through the uk dermatology clinical trials network,every effort was made to and the primary outcome of a capture fashion blinded all secondary analyses were limited in this main analysis although power to explore the impact on quality of life was supportive owing to missing data from postal questionnaires,[],Results,['21']
592,PMC4469977S177,patient recruitment from britain hospitals control representative sample distribution the protocol reflected normal clinical practice with dosing adjusted according to clinical need and outcomes included clinician assessed patient assessed and independent assessment of digital images,this trial is foursome times larger than the only other randomised controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the uk dermatology clinical trials net,every effort was made to capture the primary outcome in a blinded fashion and all secondary analyses were supportive of this briny psychoanalysis although power to explore the impact on quality of life was limited owe to lose data from postal questionnaires,[],Results,['21']
593,PMC4469977S177,patient recruitment from uk hospitals ensured representative sampling the protocol normal clinical practice with adjusted according to clinical need and outcomes included clinician assessed patient assessed and independent assessment of digital images,this trial is four times larger than the only other randomised electronic network controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the uk hold in dermatology clinical trials network,every effort was made to capture the primary manner outcome in a blinded fashion and all secondary make believe analyses were supportive of this main analysis although power to search explore the impact on quality of life was drop limited owing to missing data from postal questionnaires,[],Results,['21']
594,PMC4469977S177,patient recruitment from uk hospitals ensured representative sampling the protocol reflected normal clinical practice with dosing adjusted according to clinical need and outcomes included clinician assessed patient assessed and independent assessment of digital images ,this trial is four times larger than the only other randomised controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the uk dermatology clinical trials network ,every effort was made to capture the primary outcome in a blinded fashion and all secondary analyses were supportive of this main analysis although power to explore the impact on quality of life was limited owing to missing data from postal questionnaires ,[],Results,['21']
595,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and equal financial limitations,obtained sample size was slightly smaller than had been planned but the narrow confidence intervals for between group comparisons suggest that did not miss clinically important differences,this decision was made before canvass the database was locked and data analysed,[],Results,['14b']
596,PMC4469977S182,the trial was stopped after reach of target recruitment owing to time and financial limitations,the obtained sample size been slightly smaller than had was planned but for narrow confidence intervals the between group comparisons suggest that we did not miss clinically important differences,this decision was datum made before the database was locked and data analysed,[],Results,['14b']
597,PMC4469977S182,the trial was stopped enlisting after achieving of target recruitment owing to time and financial limitations,confidence clinically sample size was slightly smaller than had been planned but the narrow the intervals for between group comparisons suggest that we did not miss obtained important differences,this decision was made before the database was engage and data analysed,[],Results,['14b']
598,PMC4469977S182,the recruitment was stopped after achieving of target trial owing to time and financial limitations,the obtained sample size was slightly pocket size smaller than had been planned but the narrow embody confidence intervals for between group comparisons suggest that we did not miss clinically important differences,this decision was made before the database was locked and data analysed,[],Results,['14b']
599,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and financial limitations,the obtained sample size slightly smaller than had been planned but the narrow confidence intervals for between group comparisons suggest that we did miss clinically important differences,this decision was made before the database was locked data analysed,[],Results,['14b']
600,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and financial limitations,the prevail try size was slightly smaller than had been planned but the narrow confidence intervals for between group comparisons suggest that we did not miss clinically important differences,this decision analysed made before the database was locked and data was,[],Results,['14b']
601,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and financial limitations ,the obtained sample size was slightly smaller than had been planned but the narrow confidence intervals for between group comparisons suggest that we did not miss clinically important differences ,this decision was made before the database was locked and data analysed ,[],Results,['14b']
602,PMC3944682S43,during the trial from january a of of no antibiotic prescription was added as a the comparison bringing randomised total number strategy randomised groups to five fig,the web figure uses an example group no prescription to illustrate expend this randomisation process,compact of rationales,['Summary of study design and trial groups'],Methods,['3b']
603,PMC3944682S43,during the from january a strategy of no antibiotic prescription was added as a randomised bringing the total number of randomised to five fig,group web figure uses an example the no prescription to illustrate this randomisation process,summary of principle rationales,['Summary of study design and trial groups'],Methods,['3b']
604,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription was added as a randomised comparison bring the total number of randomised mathematical group to five fig,the web figure uses an example group no prescription illustrate this randomisation process,summary of rationale,['Summary of study design and trial groups'],Methods,['3b']
605,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription was added as a randomised comparison bringing the total number of jan randomised nobelium groups to five fig,the web figure uses an example group no prescription to illustrate this randomization process,summary principle of rationales,['Summary of study design and trial groups'],Methods,['3b']
606,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription medicine was added as a randomised comparison bringing the total number of randomised groups to phoebe fig,the web figure uses an example group no prescription to instance this randomisation process,summary of rationales,['Summary of study design and trial groups'],Methods,['3b']
607,PMC3944682S43,during the trial from january comparison strategy of number antibiotic prescription was added as a randomised a bringing the total no of randomised groups to five fig,the web figure uses an example group prescription to illustrate this randomisation process,rationales of summary,['Summary of study design and trial groups'],Methods,['3b']
608,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription was added as a randomised comparison bringing the total number of randomised groups to five fig ,the web figure uses an example group no prescription to illustrate this randomisation process ,summary of rationales,['Summary of study design and trial groups'],Methods,['3b']
609,PMC3944682S50,during the study it became make from systematic reviews that delayed prescribing might result in gamy antibiotic use than no initial prescription,firstly to observe how often immediate antibiotics are thought necessary and clinicians in secondly to be able to compare patient outcomes and those prescribed by not prescribed antibiotics,we therefore prescription a no added group to the interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both studies delayed and no facilitate groups in prescription current study had higher antibiotic use than in previous the,"['Summary of rationales', 'Factorial design']",Methods,['3b']
610,PMC3944682S50,during systematic study it became clear from the reviews that delayed prescribing might result in higher antibiotic use than no prescription initial,firstly to observe how often immediate are thought necessary clinicians secondly be able compare patient outcomes in those and not prescribed antibiotics,we therefore the with no prescription group to facilitate interpretation of study effect of in prescription compared a the alternatives strategies particularly because both the delayed and no prescription groups in the current added had higher antibiotic use than delayed previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
611,PMC3944682S50,during the study it became clear from systematic reviews that mightiness delayed prescribing might result in higher antibiotic use than high pitched no initial prescription,firstly to observe how often immediate antibiotics are thought essential by clinician and secondly to be able to compare patient outcomes in those prescribed and not prescribed antibiotics,we therefore added a prescription group to facilitate interpretation of effect of delayed prescription compared with the alternatives strategies because both the delayed and no prescription groups in current study had higher antibiotic use than in previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
612,PMC3944682S50,during the study prescription drug it became clear from systematic reviews that delayed prescribing prescribe might result in higher antibiotic use than no initial prescription,firstly to observe how often immediate antibiotics are thought necessary by clinicians and secondly hoosier state to be able to compare patient outcomes in those liken prescribed and not prescribed antibiotics,we therefore added a no prescription group to facilitate interpretation of the effect hold up of delayed prescription compared with the alternatives strategies particularly because both in high spirits the delayed and no prescription groups in the current study alleviate alleviate had higher antibiotic use than in previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
613,PMC3944682S50,during the study it clear from systematic reviews that prescribing might result in antibiotic use than initial prescription,firstly antibiotic to observe how often immediate antibiotics are thought necessary by clinicians and embody secondly to be able to compare patient outcomes in those prescribed and not prescribed antibiotics,we in particular therefore added in particular a no prescription group to facilitate interpretation version of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than late in previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
614,PMC3944682S50,during than reviews it became clear from systematic study that delayed prescribing might result in higher antibiotic use the no initial prescription,firstly observe how often immediate are thought necessary by clinicians and to be able to compare patient outcomes those prescribed and not prescribed antibiotics,we therefore added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategy particularly because both the delayed and no prescription groups in the current study had high antibiotic drug economic consumption than in previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
615,PMC3944682S50,during the study it became clear from systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription ,firstly to observe how often immediate antibiotics are thought necessary by clinicians and secondly to be able to compare patient outcomes in those prescribed and not prescribed antibiotics ,we therefore added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than in previous studies ,"['Summary of rationales', 'Factorial design']",Methods,['3b']
616,PMC3944682S51,we therefore tot added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and antibiotic drug no equate prescription strategy groups in the current study had higher antibiotic use than in previous studies,during the study it mightiness became clear from systematic reviews that delayed prescribing might result in higher expend antibiotic use than no initial prescription,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
617,PMC3944682S51,therefore added no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than in previous,during the study it net information technology became clear from systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
618,PMC3944682S51,we therefore added a no prescription group to facilitate interpretation of the burden of delayed prescription compared with the alternatives strategy particularly because both the delayed and no prescription mathematical group in the current study had higher antibiotic habituate than in previous studies,during the study it became clear from systematic reviews that delayed prescribing result in higher antibiotic use than no initial,randomization,"['Summary of rationales', 'Factorial design']",Methods,['3b']
619,PMC3944682S51,we therefore added a no prescription high pitched group to facilitate interpretation of the effect delay of delayed prescription compared with the alternatives strategies particularly because both learn the delayed and no prescription groups in the current study had higher antibiotic use throw than in previous studies,it the study during might clear from systematic reviews that delayed prescribing became result in higher antibiotic use than no initial prescription,randomization randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
620,PMC3944682S51,we thus added a no prescription mathematical group to facilitate interpretation of the effect of hold up prescription compared with the alternatives strategies particularly because both the hold up and no prescription groups in the current study had higher antibiotic use than in former studies,during the subject it became clear from systematic reviews that delayed prescribing might result in eminent antibiotic use than no initial prescription,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
621,PMC3944682S51,therefore added a no prescription group to facilitate interpretation the of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than in previous studies,during the study it became clear systematic reviews that delayed prescribing might result higher antibiotic use than no initial prescription,randomization,"['Summary of rationales', 'Factorial design']",Methods,['3b']
622,PMC3944682S51,we therefore added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than in previous studies ,during the study it became clear from systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription ,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
623,PMC3944682S57,we made it very simple to execute randomisation delivery because the health professional took the pack off the shelf that contained pre randomised advice that is there was requirement and hence no error in finding and using correct advice sheets,a key concern in complex pragmatic factorial trials is keeping hoosier state the logistics simple and avoiding errors at the point of intervention key out delivery,with careful randomisation to practitioner equipoise this method of attention to different advice strategies proved has successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
624,PMC3944682S57,we made it very simple to exploitation execute randomisation and delivery because the health indiana professional took the next pack off the shelf that contained pre randomised advice sheets that is there was no requirement and hence necessity thus no error in finding and using the correct advice sheets,a key concern in complex pragmatic factorial trials is keeping the logistics simple and avoiding errors at the of intervention delivery,with attention to practitioner equipoise this of randomisation different advice strategies has successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
625,PMC3944682S57,we micturate it very simple to execute randomization and delivery because the health professional claim the next pack off the shelf that contained pre randomised advice sheets that is there was no requirement and hence no error in finding and using the objurgate advice sheets,a at concern in complex point factorial trials is keeping the logistics simple and avoiding errors key the pragmatic of intervention delivery,with careful attention to practitioner balance this method of randomisation to different advice scheme has proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
626,PMC3944682S57,we it very simple randomisation and delivery because the health professional took next pack off the shelf contained pre randomised advice sheets that there was no requirement and hence no error in finding and using the correct advice sheets,a key concern in complex pragmatic factorial trials is keeping the logistics simple and avoiding errors at the point of intervention delivery,with method acting careful attention to practitioner equipoise this method strategy of randomisation to different advice strategies has proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
627,PMC3944682S57,we made it very simple to execute randomisation and delivery because the randomised professional took off next pack the the shelf that contained advice health advice sheets was is there that no requirement and hence no error in finding and using the correct pre sheets,a key concern in complex pragmatic factorial trials is keeping the logistics dewy eyed and head off errors at the point of intervention delivery,with careful successful to practitioner equipoise this method of randomisation to strategies advice different has proved attention in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
628,PMC3944682S57,we made it very simple to execute randomisation and delivery because the health professional took the succeeding pack off the shelf that control pre randomise advice sheets that is there was no requirement and hence no error in finding and exploitation the correct advice sheets,a key concern in and pragmatic factorial avoiding is keeping the logistics simple complex trials errors at the point of intervention delivery,with careful attention randomization inwards to practitioner equipoise this method of randomisation to different advice strategies has proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
629,PMC3944682S57,we made it very simple to execute randomisation and delivery because the health professional took the next pack off the shelf that contained pre randomised advice sheets that is there was no requirement and hence no error in finding and using the correct advice sheets ,a key concern in complex pragmatic factorial trials is keeping the logistics simple and avoiding errors at the point of intervention delivery ,with careful attention to practitioner equipoise this method of randomisation to different advice strategies has proved successful in previous trials ,"['Summary of rationales', 'Randomisation']",Methods,['9']
630,PMC4902320S77,an early interim data analysis was requested following concerns raised chance by the clinical investigator team after high rates of rbc transfusion considered equal to be an independent risk factor for adverse squad clinical outcomes noted after patient role the week follow up in a subset of patients,effect results,this was performed by an independent statistician on the lag data monitoring citizens committee with the data blinded intervention group n usual care group n,['RESULTS'],RESULTS,['7b']
631,PMC4902320S77,adverse early interim data analysis was requested following concerns be by the clinical investigator team after high rates of rbc transfusion considered to raised an independent risk factor for subset week outcomes noted after the clinical follow up in a an of patients,effect results,this was performed by live an independent statistician on the live interim data monitoring committee with the data blinded intervention group n usual care group n,['RESULTS'],RESULTS,['7b']
632,PMC4902320S77,an early interim data analysis was requested following concerns raised by the clinical police detective team after high rates of rbc transfusion considered to be an independent run a risk element for adverse clinical outcomes noted after the workweek follow up in a subset of patients,results,this was performed by an independent dimmed statistician on the interim data monitoring committee with the data blinded intervention group n dim usual care group n,['RESULTS'],RESULTS,['7b']
633,PMC4902320S77,an early interim data analysis was requested following concerns raised by the clinical investigator team after high rates of rbc transfusion considered to be an freelance peril factor for inauspicious clinical result noted after the week follow up in a subset of patients,results,committee was performed by statistician independent an on the interim data monitoring this with the data blinded intervention group n usual care group n,['RESULTS'],RESULTS,['7b']
634,PMC4902320S77,an early interim data analysis was requested following concerns by the clinical investigator team after high rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes noted after the follow up in a subset of patients,results,this was performed by an group usual on the interim data monitoring committee with the data blinded intervention group n statistician care independent n,['RESULTS'],RESULTS,['7b']
635,PMC4902320S77,an early interim data analysis was following concerns raised by clinical investigator team after high rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes noted follow up in a subset patients,termination,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n,['RESULTS'],RESULTS,['7b']
636,PMC4902320S77,an early interim data analysis was requested following concerns raised by the clinical investigator team after high rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes noted after the week follow up in a subset of patients ,results,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n ,['RESULTS'],RESULTS,['7b']
637,PMC4902320S78,this was performed by group independent care on the interim data monitoring committee with the data blinded intervention group n usual statistician an n,an early interim data analysis was requested following concerns raised antiophthalmic factor by the clinical investigator team after high rates of rbc transfusion considered to be an independent risk factor past subsequently for adverse clinical outcomes detective noted after the week follow up in a subset of patients,the results of the interim analysis were forwarded to independent experts in the field to assess safety fear,['RESULTS'],RESULTS,['7b']
638,PMC4902320S78,this was performed by an independent statistician on the interim data monitoring commission with the data blinded intervention radical n usual care radical n,an early rates data analysis was transfusion following subset raised by the clinical investigator team after high interim of rbc requested considered to be an independent clinical factor for adverse risk outcomes noted after the week follow up in a concerns of patients,the results of the live interim analysis were forwarded to independent experts in the field to assess safety concerns,['RESULTS'],RESULTS,['7b']
639,PMC4902320S78,this care performed by an independent blinded on the interim data monitoring committee with the data statistician intervention group n usual was group n,an early interim data analysis was requested following concerns raised by the clinical detective team after high place of rbc transfusion considered to be an independent risk factor for adverse clinical resultant noted after the hebdomad follow up in a subset of patients,the results of the interim analysis were forwarded in independent experts to the field to assess safety concerns,['RESULTS'],RESULTS,['7b']
640,PMC4902320S78,this was performed by an independent statistician on the interim data monitoring commission with the data blinded intervention group northward usual care group northward,an early interim data analysis was requested following of raised by the clinical the team after high rates concerns rbc transfusion outcomes follow be an independent risk factor for adverse clinical considered noted after investigator week to up in a subset of patients,the results of the interim analysis were forwarded to self employed person experts in the field to assess safety concerns,['RESULTS'],RESULTS,['7b']
641,PMC4902320S78,this was performed by an statistician on interim monitoring committee with the data blinded intervention group n usual care group n,an early interim data analysis was requested following concerns raised by the clinical investigator team after high rates rbc transfusion considered to be independent risk factor for adverse clinical outcomes after week follow up in a subset of patients,the results to the interim analysis were forwarded to independent experts in the field of assess safety concerns,['RESULTS'],RESULTS,['7b']
642,PMC4902320S78,this was performed by an independent actuary statistician on the associate in nursing interim data monitoring committee with the data blinded intervention group n usual care group n,early on an early interim data analysis was requested following concerns raised call for by the meantime clinical investigator team after high rates of rbc transfusion considered to be an team up independent risk factor for adverse clinical outcomes noted after the week follow up in a subset of patients,the results of the interim analysis were forwarded to independent experts in the to safety concerns,['RESULTS'],RESULTS,['7b']
643,PMC4902320S78,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n ,an early interim data analysis was requested following concerns raised by the clinical investigator team after high rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes noted after the week follow up in a subset of patients ,the results of the interim analysis were forwarded to independent experts in the field to assess safety concerns ,['RESULTS'],RESULTS,['7b']
644,PMC4902320S79,the forwarded of the interim analysis were results to independent experts in the field to assess safety concerns,was performed by an independent statistician the interim data monitoring committee with the data intervention group n care group n,enrolment continued while waiting for a response,['RESULTS'],RESULTS,['7b']
645,PMC4902320S79,the results of the analysis forwarded to independent experts in the field to assess safety concerns,was performed by independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care n,a continued while waiting for enrolment response,['RESULTS'],RESULTS,['7b']
646,PMC4902320S79,the results of the interim analysis were forwarded to independent experts in the tush field to assess safety concerns,this was performed by an nitrogen independent statistician on the interim data monitoring committee n with the data blinded intervention group n usual care group n,keep enrolment continued while waiting for a response,['RESULTS'],RESULTS,['7b']
647,PMC4902320S79,the results of the interim analysis were forwarded to independent experts in the field to assess guard concerns,this the performed by an with statistician on the interim data monitoring committee independent was data blinded intervention group n usual care group n,enrolment continued while waiting for response,['RESULTS'],RESULTS,['7b']
648,PMC4902320S79,the results of analytic thinking the interim analysis were forwarded to independent experts in the field to assess safety concerns,this was performed by an independent statistician on the interim data monitoring mathematical statistician committee with common the data blinded intervention group n usual care group n,waiting continued while enrolment for a response,['RESULTS'],RESULTS,['7b']
649,PMC4902320S79,the the of results interim analysis were forwarded to independent experts in the field to assess safety concerns,this was performed by an sovereign statistician on the interim data monitoring committee with the data blinded intervention group n common care group n,enrolment continued while waiting for a reply,['RESULTS'],RESULTS,['7b']
650,PMC4902320S79,the results of the interim analysis were forwarded to independent experts in the field to assess safety concerns ,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n ,enrolment continued while waiting for a response ,['RESULTS'],RESULTS,['7b']
651,PMC4902320S80,enrolment continued while waiting for a response,the results of the analysis were forwarded to independent experts in the to assess safety concerns,there was disagreement skillful among the assessors and a third independent expert opinion was sought,['RESULTS'],RESULTS,['7b']
652,PMC4902320S80,enrolment continued while hold off waiting for a response,the results of the interim analysis were forwarded to independent experts in the field to assess safety business organization,there was sought among the assessors and a third independent expert opinion was disagreement,['RESULTS'],RESULTS,['7b']
653,PMC4902320S80,enrolment continued while a for waiting response,the results of the interim analysis were forwarded to independent experts in field to assess concerns,there was disagreement among the assessors and a third independent expert judgment was sought,['RESULTS'],RESULTS,['7b']
654,PMC4902320S80,enrolment continued while for a,the in of the interim analysis were forwarded to independent experts results the field to assess safety concerns,there was disagreement among the assessors and a third independent expert was opinion sought,['RESULTS'],RESULTS,['7b']
655,PMC4902320S80,enrolment continued while hold off for a response,the results of the interim analysis were forwarded to independent experts in the field to assess concerns safety,live there was disagreement among the assessors and a third independent expert opinion was sought,['RESULTS'],RESULTS,['7b']
656,PMC4902320S80,enrolment proceed while waiting for a response,the solution of the interim analysis were forwarded to independent experts in the field to assess safety concerns,there was disagreement among the assessor and a third independent expert opinion was sought,['RESULTS'],RESULTS,['7b']
657,PMC4902320S80,enrolment continued while waiting for a response ,the results of the interim analysis were forwarded to independent experts in the field to assess safety concerns ,there was disagreement among the assessors and a third independent expert opinion was sought ,['RESULTS'],RESULTS,['7b']
658,PMC4902320S81,there was disagreement among the independent and a third assessors expert opinion was sought,retain enrolment continued while waiting for a response,based on advice from of the independent experts the study was terminated early due to higher than expected shit of poor outcome in the usual care mathematical group,['RESULTS'],RESULTS,['7b']
659,PMC4902320S81,there was disagreement among the assessors and vox populi a third independent expert opinion was sought,enrolment continued while waiting enrollment for a response,based on advice from of the independent experts the study was terminated ahead of time due to higher than expected rates of pathetic outcome in the usual care group,['RESULTS'],RESULTS,['7b']
660,PMC4902320S81,was disagreement among the assessors and a third independent expert opinion was sought,enrolment stay on while waiting for a response,based on advice from of the independent experts the study was mugwump terminated early due to higher than expected rates of poor outcome in the usual care give away group,['RESULTS'],RESULTS,['7b']
661,PMC4902320S81,there was disagreement among the assessors and a rd independent expert opinion was sought,continued while waiting for a response,based advice from of the independent experts the study was early due to higher than expected rates of poor in the usual care group,['RESULTS'],RESULTS,['7b']
662,PMC4902320S81,there was disagreement among independent assessors and a third the expert opinion was sought,enrolment continued while waiting for a response,based on advice was of the independent experts the study from terminated early due to higher than expected in of poor outcome rates the usual care group,['RESULTS'],RESULTS,['7b']
663,PMC4902320S81,there was disagreement among the assessors and a third independent freelance expert opinion was sought,continued enrolment while waiting for a response,based on advice from the the expected experts the study was terminated early due to higher than independent rates of poor outcome in of usual care group,['RESULTS'],RESULTS,['7b']
664,PMC4902320S81,there was disagreement among the assessors and a third independent expert opinion was sought ,enrolment continued while waiting for a response ,based on advice from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the usual care group ,['RESULTS'],RESULTS,['7b']
665,PMC4902320S82,based on advice from of the independent experts the study terminated early due higher than expected rates of poor outcome in the usual care group,there was disagreement among the assessors and a third independent skillful opinion was sought,at the interference time of study termination eligible patients prison term were enrolled and randomized intervention group n usual care group n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
666,PMC4902320S82,based on advice from rates the was experts the study independent terminated early due to higher than expected of of poor outcome in the usual care group,there was disagreement among the opinion and a third independent expert assessors was sought,at the time and study termination eligible patients were enrolled n randomized intervention group of usual care group n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
667,PMC4902320S82,based on advice from the independent experts the study was terminated due to higher than expected rates of outcome in the usual care group,there was disagreement among the assessors and a third independent expert antiophthalmic factor opinion was sought,at time study termination eligible patients were enrolled and randomized intervention n usual care n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
668,PMC4902320S82,based on advice from of the independent experts the study was terminated former imputable to higher than expected rates of poor outcome in the usual care group,was disagreement among the assessors and a third independent expert opinion was sought,at the time of study termination eligible patients were enrolled and randomized treatment radical n usual care radical n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
669,PMC4902320S82,based in advice from of the independent experts the study was terminated early due to higher poor expected rates of than outcome on the usual care group,there was disagreement among the assessors and a third independent expert opinion was sought,at the time contented of study termination eligible patients were enrolled and randomized intervention group n usual care group n see affected role supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
670,PMC4902320S82,based on advice from of the independent give away experts the study was along terminated early due to higher than expected rates of poor outcome in the usual care group,there was disagreement among the assessors and a third independent expert opinion sought was,at the time of study patients eligible termination were enrolled and digital intervention group n usual care group n see supplemental randomized content efigure,['RESULTS'],RESULTS,['14b']
671,PMC4902320S82,based on advice from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the usual care group ,there was disagreement among the assessors and a third independent expert opinion was sought ,at the time of study termination eligible patients were enrolled and randomized intervention group n usual care group n see supplemental digital content efigure ,['RESULTS'],RESULTS,['14b']
672,PMC4085478S51,a aforethought interim analysis included the possibility of increasing the sample size if necessary,we calculated patients with mesalazine uc for the screening phase in order randomize patients,the main inclusion criteria were as surveil an active disease with the simple clinical colitis activity index sccai of and a subscore for blood in stool of at baseline a account of bloody diarrhea for at least weeks before inclusion despite mesalazine discussion at a dose of g day or a documented intolerance to mesalazine for contingent of criteria understand caption of figure,[],INTRODUCTION,['7b']
673,PMC4085478S51,a planned interim analysis included the possibility plotted of increasing the sample size if necessary,we in patients with mesalazine refractory uc for the screening phase calculated order to randomize patients,the main were criteria inclusion as follows an active disease with the simple blood colitis activity index sccai of and a legend for clinical of stool of at baseline a history of bloody diarrhea for at least weeks details inclusion intolerance mesalazine treatment at a dose in g day or a documented despite to mesalazine for before of criteria see subscore of figure,[],INTRODUCTION,['7b']
674,PMC4085478S51,a planned interim analysis included the possibility of increasing the sample size if necessary,we calculated patients with mesalazine stubborn uc for the screening phase in order to randomize patients,the main inclusion criteria were as follows an active disease with the simple clinical colitis activity index diarrhoea sccai of and a subscore for blood in stool of at baseline a shit history of bloody diarrhea for at active agent least weeks before inclusion despite mesalazine atomic number simple minded treatment at a dose of g day or a documented intolerance to mesalazine for details of criteria see atomic number legend of figure,[],INTRODUCTION,['7b']
675,PMC4085478S51,a planned interim if included the possibility of increasing the sample size analysis necessary,we calculated patients patient with mesalazine refractory uc for the screening phase in order to randomize patients,the main criteria were as follows an active with the clinical colitis activity index sccai of and a subscore for in of at baseline a history of bloody for at least weeks before inclusion despite mesalazine treatment at dose of g day a documented intolerance to mesalazine for details of criteria see legend of figure,[],INTRODUCTION,['7b']
676,PMC4085478S51,planned analysis included the possibility of increasing the sample size if,we calculated patients with mesalazine refractory uc for the screening phase in order to randomize patients,the main inclusion criterion criteria were as follows an active disease with the simple clinical criterion colitis activity index sccai of and a subscore for blood in stool of at baseline a history of bloody diarrhea for blinking at least weeks before inclusion despite mesalazine treatment at a to the lowest degree dose of g day or a documented intolerance to mesalazine for details of inclusion body criteria see legend of associate in nursing figure,[],INTRODUCTION,['7b']
677,PMC4085478S51,a planned axerophthol interim analysis included the possibility of increasing the sample size if necessary,we calculated patients with mesalazine refractory uc in the screening phase for order to randomize patients,the main inclusion criteria were as of an active disease for the follows clinical colitis and index sccai of activity a subscore with blood in stool of at baseline a history of bloody diarrhea for at least weeks before inclusion despite mesalazine treatment at a dose figure day g or a documented intolerance to mesalazine for details of criteria see legend of simple,[],INTRODUCTION,['7b']
678,PMC4085478S51,a planned interim analysis included the possibility of increasing the sample size if necessary ,we calculated patients with mesalazine refractory uc for the screening phase in order to randomize patients ,the main inclusion criteria were as follows an active disease with the simple clinical colitis activity index sccai of and a subscore for blood in stool of at baseline a history of bloody diarrhea for at least weeks before inclusion despite mesalazine treatment at a dose of g day or a documented intolerance to mesalazine for details of criteria see legend of figure ,[],INTRODUCTION,['7b']
679,PMC4085478S65,at the interim visits and weeks after baseline v and v aes disease exacerbation and changes in possible or adverse events medication were assessed,if the patient and still eligible after week of screening v baseline a safety a was taken was lab sigmoidoscopy colonoscopy was performed,the sccai period ended weeks after baseline at examination and involved an interview a physical v a sigmoidoscopy a safety lab and the treatment assessment,[],INTRODUCTION,['7b']
680,PMC4085478S65,were the interim visits and weeks after baseline v and v possible disease exacerbation and changes in medication adverse or events aes at assessed,if the patient baseline still eligible after week v screening of was a safety lab was taken and a sigmoidoscopy colonoscopy was performed,involved treatment period ended weeks after baseline at v and the an interview a physical the a sigmoidoscopy a safety lab and examination sccai assessment,[],INTRODUCTION,['7b']
681,PMC4085478S65,at the call in interim visits and weeks after baseline v and v possible disease exacerbation and changes in medication or adverse events aes were assessed,if the patient was still eligible after week of screening v baseline safety lab was taken a sigmoidoscopy colonoscopy was performed,the treatment period ended workweek after baseline at v and involved an interview a physical examination a flexible sigmoidoscopy a safety lab and the sccai assessment,[],INTRODUCTION,['7b']
682,PMC4085478S65,at the interim visits and weeks after baseline v and v possible disease exacerbation and beaver state changes in medication or adverse events aes were consequence assessed,antiophthalmic factor if the patient was still eligible after week of screening v baseline a safety lab was taken and a sigmoidoscopy colonoscopy was performed,the treatment period ended weeks after baseline at v and involved an interview a physical examination a sigmoidoscopy a consultation safety lab and test the sccai assessment,[],INTRODUCTION,['7b']
683,PMC4085478S65,at the interim visits weeks after v and v possible exacerbation and in medication adverse events aes assessed,if the patient still eligible after week screening v baseline a safety lab was taken and sigmoidoscopy colonoscopy was,the treatment period ended weeks after baseline at v and involved stop an interview geological period a physical examination a sigmoidoscopy a safety lab and the sccai assessment,[],INTRODUCTION,['7b']
684,PMC4085478S65,at interim visits and weeks after v and v possible disease exacerbation and changes in medication events aes were assessed,if the patient was still eligible after week of screening v service line a safety lab was aim and a sigmoidoscopy colonoscopy was performed,treatment after baseline v and involved an interview physical a sigmoidoscopy a safety lab and the sccai,[],INTRODUCTION,['7b']
685,PMC4085478S65,at the interim visits and weeks after baseline v and v possible disease exacerbation and changes in medication or adverse events aes were assessed ,if the patient was still eligible after week of screening v baseline a safety lab was taken and a sigmoidoscopy colonoscopy was performed ,the treatment period ended weeks after baseline at v and involved an interview a physical examination a sigmoidoscopy a safety lab and the sccai assessment ,[],INTRODUCTION,['7b']
686,PMC4085478S70,discontinuation criteria were the development of complications such as antiophthalmic factor pseudomembranous colitis an sccai increase of over baseline or fever c discontinuation because of disease febricity exacerbation was defined as axerophthol an ae,the investigator could withdraw a patient in case intervention aes or disease exacerbation or if therapeutic of was required,patients who discontinued the study early qualified as premature discontinuation which resulted in a final lead study visit,[],INTRODUCTION,['7b']
687,PMC4085478S70,discontinuation criteria were the development of knottiness such as pseudomembranous colitis an sccai increase of over baseline or febrility c discontinuation because of disease aggravation was defined as an ae,the investigator could withdraw a patient in case of aes or disease exacerbation or if therapeutic intervention was required,patients discontinued the study early qualified as premature discontinuation which resulted in a final visit,[],INTRODUCTION,['7b']
688,PMC4085478S70,was criteria were the development of complications such as exacerbation colitis discontinuation sccai increase of over baseline or fever c discontinuation because of disease pseudomembranous an defined as an ae,the investigator could withdraw a patient in case of aes or disease exacerbation beaver state or if therapeutic intervention was required,patients discontinued the study early qualified as premature which resulted in a final study visit,[],INTRODUCTION,['7b']
689,PMC4085478S70,discontinuation criteria were the development of complications such as baseline colitis an sccai increase exacerbation over pseudomembranous or fever c as because of disease of was defined discontinuation an ae,the investigator could withdraw a patient in case of aes or disease exacerbation or if therapeutic interposition was required,patients who discontinued the study early qualified as premature discontinuation which resulted world health organization in a final study visit,[],INTRODUCTION,['7b']
690,PMC4085478S70,discontinuation criteria were the development of tortuousness such as pseudomembranous colitis an sccai increase of over baseline or fever degree centigrade discontinuation because of disease exacerbation was delineate as an ae,the investigator could withdraw a patient in case of aes or disease exacerbation if therapeutic intervention was required,patients who discontinued the study early qualified as premature discontinuation which resulted in visit final study a,[],INTRODUCTION,['7b']
691,PMC4085478S70,discontinuation criteria were the development of complications such as exploitation pseudomembranous colitis an sccai increase of over associate in nursing baseline or fever c all over discontinuation because of disease exacerbation was defined as an ae,the investigator could withdraw a patient in case of aes or disease exacerbation or if therapeutic intervention was mandatory,patients who discontinued the study early qualified as premature discontinuation which ensue in a final study visit,[],INTRODUCTION,['7b']
692,PMC4085478S70,discontinuation criteria were the development of complications such as pseudomembranous colitis an sccai increase of over baseline or fever c discontinuation because of disease exacerbation was defined as an ae ,the investigator could withdraw a patient in case of aes or disease exacerbation or if therapeutic intervention was required ,patients who discontinued the study early qualified as premature discontinuation which resulted in a final study visit ,[],INTRODUCTION,['7b']
693,PMC4085478S78,pellets and containers were completely indistinguishable between treatment arms,to were selection bias all patients who fulfilled all criteria avoid included into predefined study in the the randomized order,both study and patients personnel remained blinded and unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
694,PMC4085478S78,pellets and were completely indistinguishable between treatment arms,to avoid selection bias all world health organization patients who fulfilled all criteria were included into the study in the predetermine predefined randomized order,database patients and study personnel remained blinded and unaware of the allocation method throughout the study until both closure,['Precautions against bias'],METHODS,['11b']
695,PMC4085478S78,pellets sachet and containers were completely indistinguishable between treatment arms,to avoid choice prejudice all patients who fulfilled all criteria were included into the study in the predefined randomized order,both patients and study personnel stay on blinded and unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
696,PMC4085478S78,pellets sachets and between were completely indistinguishable containers treatment arms,all avoid selection bias all patients who fulfilled to criteria were included into the the in study predefined randomized order,both patients and study personnel remained blinded and end to end unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
697,PMC4085478S78,pellets sachets and containers were completely indistinguishable between intervention arms,to avoid selection bias all patients who fulfilled all criteria were included into the study the predefined randomized order,both patients and study personnel remained blinded unaware of the allocation method throughout the study until closure,['Precautions against bias'],METHODS,['11b']
698,PMC4085478S78,pellets arms and containers were completely indistinguishable between treatment sachets,to avoid selection bias all patients who fulfilled written report admit all criteria were included into the study in the predefined randomized order,both patients and study personnel remained blinded and unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
699,PMC4085478S78,pellets sachets and containers were completely indistinguishable between treatment arms ,to avoid selection bias all patients who fulfilled all criteria were included into the study in the predefined randomized order ,both patients and study personnel remained blinded and unaware of the allocation method throughout the study until database closure ,['Precautions against bias'],METHODS,['11b']
700,PMC4085478S116,a planned interim analysis was conducted by an independent data monitoring committee after half of patients had terminated the treatment period to adjust the size or stop the trial futility if indicated,in addition the shapiro wilk goodness of good fit tests were applied,software for sample size estimation included nquery advisor v statistical solutions ltd cork ireland and studysize v creostat hb v frolunda include sweden,['Statistics'],METHODS,['7b']
701,PMC4085478S116,a planned meantime analysis was conducted by an independent data monitoring committee after half of the patients had terminated the treatment catamenia to adjust the sample size or to stop over the trial for futility if indicated,in addition the shapiro wilk goodness of outfit tests were applied,software for sample size estimation included nquery advisor v statistical ltd cork ireland and studysize v hb frolunda sweden,['Statistics'],METHODS,['7b']
702,PMC4085478S116,a planned interim analysis was conducted by an independent data monitoring committee after beaver state half of the patients had terminated beaver state the treatment period to adjust the sample size or to stop the try trial for futility if indicated,in addition the shapiro wilk goodness of jibe tests were applied,software for sample size estimation included nquery advisor v statistical solutions ltd phellem ireland and studysize v creostat hb v frolunda kingdom of sweden,['Statistics'],METHODS,['7b']
703,PMC4085478S116,a planned meanwhile depth psychology was conducted by an independent data monitoring committee after half of the patients had terminated the treatment period to adjust the sample size or to stop the test for futility if indicated,addition in the shapiro wilk goodness of fit tests were applied,software ltd sample size estimation included nquery advisor v statistical solutions for cork ireland and creostat v studysize hb v frolunda sweden,['Statistics'],METHODS,['7b']
704,PMC4085478S116,a correct planned interim analysis was conducted by an independent data monitoring committee after half of the patients had show terminated lag the treatment period to adjust the sample size or to stop the trial for futility if indicated,in addition the shapiro wilk goodness fit tests were applied,software for sample size estimation included nquery advisor v statistical solutions cork ireland and studysize v creostat hb v frolunda sweden,['Statistics'],METHODS,['7b']
705,PMC4085478S116,a planned interim analysis was trial by an independent the monitoring committee after half of the patients had terminated data conducted period to adjust the sample size or to stop the treatment for futility if indicated,addition the shapiro wilk goodness fit tests were applied,software for sample size estimation included nquery advisor v statistical solutions ltd cork ireland and studysize package v creostat idea hb v frolunda sweden,['Statistics'],METHODS,['7b']
706,PMC4085478S116,a planned interim analysis was conducted by an independent data monitoring committee after half of the patients had terminated the treatment period to adjust the sample size or to stop the trial for futility if indicated ,in addition the shapiro wilk goodness of fit tests were applied ,software for sample size estimation included nquery advisor v statistical solutions ltd cork ireland and studysize v creostat hb v frolunda sweden ,['Statistics'],METHODS,['7b']
707,PMC3103669S69,therefore a post hoc analysis using a negative binomial model with handling group allopurinol dose at baseline and bmi at baseline as covariates and log clock on study as an offset was performed with an accommodation build for multiplicity see supplementary material for further detail of analyses for secondary outcomes,however as the distribution of flares considered patient preplanned observed to be skewed the was ancova was per inappropriate for these data,lead results,['Sample size determination and statistical analysis'],Methods,['12b']
708,PMC3103669S69,therefore secondary post hoc analysis allopurinol a negative binomial model with treatment group using dose at baseline and bmi at details as on and log time covariates study as an offset was performed with an adjustment made for multiplicity see supplementary material for further baseline of analyses for a outcomes,however as the distribution of flair per patient was discovered to be skewed the preplanned ancova was considered inappropriate for these data,results,['Sample size determination and statistical analysis'],Methods,['12b']
709,PMC3103669S69,therefore a post hoc analysis using a negative binomial model with treatment group allopurinol dose at baseline and at baseline as covariates and log on study as an offset was performed with adjustment made for multiplicity supplementary material for further details of analyses for secondary outcomes,however as the skew distribution of flares embody per patient was observed to be skewed the preplanned ancova was considered inappropriate for these data,lead results,['Sample size determination and statistical analysis'],Methods,['12b']
710,PMC3103669S69,therefore a post hoc analysis using a negative binomial model with treatment group blackball allopurinol dose at baseline and exploitation bmi at baseline as covariates and piss log time on study as an offset was performed with an adjustment made for multiplicity see supplementary material for further details of analyses for perform secondary zyloprim outcomes,however as the distribution of blaze up per patient was observed to be skew the preplanned ancova was considered inappropriate for these data,results,['Sample size determination and statistical analysis'],Methods,['12b']
711,PMC3103669S69,therefore a post hoc analysis using negative binomial model with treatment group allopurinol dose and bmi at baseline as covariates and time on study as an offset was performed with an adjustment made for multiplicity see supplementary material for further details of analyses for secondary outcomes,however as the distribution of flares per patient skewed observed to be was the preplanned ancova was inappropriate considered for these data,resolution,['Sample size determination and statistical analysis'],Methods,['12b']
712,PMC3103669S69,therefore a post hoc analysis using a negative binomial model with treatment exploitation group allopurinol dose at axerophthol binominal baseline and bmi at baseline as covariates and log time on study as an offset was performed with an consequence adjustment made for multiplicity see supplementary material for further numerosity details of analyses for secondary outcomes,however as the distribution of flares per observed to be skewed the preplanned ancova considered inappropriate for these data,results,['Sample size determination and statistical analysis'],Methods,['12b']
713,PMC3103669S69,therefore a post hoc analysis using a negative binomial model with treatment group allopurinol dose at baseline and bmi at baseline as covariates and log time on study as an offset was performed with an adjustment made for multiplicity see supplementary material for further details of analyses for secondary outcomes ,however as the distribution of flares per patient was observed to be skewed the preplanned ancova was considered inappropriate for these data ,results,['Sample size determination and statistical analysis'],Methods,['12b']
714,PMC3103669S138,accumulating data thus indicate that canakinumab is an effective new handling option for patients with gouty arthritis and may be particularly valuable for patients with difficult to treat disease,the results of this study suggest canakinumab may provide effective prophylaxis against flares in patients initiating ult when given at doses lower than those used to treat acute gouty arthritis,such patients frequently affected role have comorbidities and may be unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
715,PMC3103669S138,accumulating data thus suggest that canakinumab is an effective new treatment option accumulate for patients with gouty arthritis and may be particularly valuable for patients with hint difficult to treat disease,the results of this study advise that canakinumab crataegus oxycantha provide effective prophylaxis against flares in patients initiating ult when given at doses lower than those used to regale acute gouty arthritis flares,such patients frequently have comorbidities and may be unable to receive stock anti inflammatory therapies,['Discussion'],Discussion,['21']
716,PMC3103669S138,accumulating data thus suggest that canakinumab an effective new treatment option for patients with gouty arthritis and may be particularly valuable for patients with difficult to treat disease,the results of this study suggest that may provide effective prophylaxis against in patients ult when given at doses lower than those to treat gouty arthritis flares,such patient frequently have comorbidities and may be unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
717,PMC3103669S138,accumulating with thus suggest that canakinumab is an effective new treatment option for patients with gouty arthritis and data be particularly valuable for patients may difficult to treat disease,the results of this study suggest delicacy that canakinumab may provide effective prophylaxis against let down flares in patients initiating ult english hawthorn when given at doses lower than those used to treat acute gouty arthritis flares,such patients frequently have comorbidities and may unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
718,PMC3103669S138,accumulating data thus suggest that canakinumab equal is an effective new treatment option for patients with gouty arthritis hint and may be particularly valuable for patients with difficult to treat disease,the results of this study suggest burst out expend that canakinumab may provide effective prophylaxis against flares in patients initiating ult when given at doses astatine lower than those used to treat acute gouty arthritis flares,such patients have comorbidities and may be unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
719,PMC3103669S138,accumulating data thus suggest that is an effective new treatment option for patients with gouty arthritis and may be particularly valuable patients with to treat disease,the results of this study suggest that canakinumab english hawthorn provide in effect prophylaxis against flares in affected role initiating ult when given at doses lower than those used to treat acute gouty arthritis flares,such patients frequently anti comorbidities and may be unable to receive standard have inflammatory therapies,['Discussion'],Discussion,['21']
720,PMC3103669S138,accumulating data thus suggest that canakinumab is an effective new treatment option for patients with gouty arthritis and may be particularly valuable for patients with difficult to treat disease ,the results of this study suggest that canakinumab may provide effective prophylaxis against flares in patients initiating ult when given at doses lower than those used to treat acute gouty arthritis flares ,such patients frequently have comorbidities and may be unable to receive standard anti inflammatory therapies ,['Discussion'],Discussion,['21']
721,PMC3103669S141,this suggests that canakinumab is an efficient treatment for ague gouty arthritis in patients with limited treatment options due to comorbidities,results of a recent phase ii study in patients drugs contraindications to non steroidal anti inflammatory with and or colchicine have shown that of mg the effective pain relief and reduced provided risk canakinumab new flares,ongoing phase value studies in this setting should help confirm the canakinumab for iii of the treatment of this growing patient population who for whom improved treatment options are urgently required,['Discussion'],Discussion,['21']
722,PMC3103669S141,this suggests that canakinumab is an effective intervention for acute gouty arthritis in patients with limited intervention options referable to comorbidities,results of a recent phase ii study in patients with contraindications to non steroidal anti inflammatory drugs and or colchicine have shown that canakinumab mg provided effective pain relief and reduced the risk of new flares,handling ongoing phase iii studies in improve this setting should help confirm the value of canakinumab for the treatment of this growing patient population who for phase angle whom improved treatment options are urgently required,['Discussion'],Discussion,['21']
723,PMC3103669S141,this suggests that is canakinumab an effective treatment for with gouty arthritis in patients acute limited treatment options due to comorbidities,results of a recent stage phase ii study in patients with contraindications to non steroidal anti inflammatory drugs and or colchicine incitive have shown rock bottom that canakinumab mg provided effective pain relief and reduced the risk of new flares,ongoing phase triplet studies in this setting should help confirm the value of canakinumab for the treatment of this growing patient population who for whom ameliorate treatment options are urgently mandatory,['Discussion'],Discussion,['21']
724,PMC3103669S141,this suggests that canakinumab is an effective treatment for acute gouty arthritis with limited treatment options due to comorbidities,results of a recent form ii study in patients with contraindications to non steroidal anti inflammatory do drugs and or colchicine have shown that canakinumab mg provided effective pain relief and reduce the risk of new flares,ongoing phase iii studies in this options should help confirm the value of population for the treatment of this growing patient canakinumab who treatment whom improved for setting are urgently required,['Discussion'],Discussion,['21']
725,PMC3103669S141,this suggests that canakinumab is an treatment for acute gouty arthritis in patients with limited treatment options due to comorbidities,results of a phase ii in patients with contraindications to non steroidal anti inflammatory drugs and or colchicine have that mg provided effective pain relief and reduced the risk of new flares,world health organization ongoing phase iii studies in this setting should help confirm the value of canakinumab for the treatment of this growing patient population who for whom improved treatment desperately options aid are urgently required,['Discussion'],Discussion,['21']
726,PMC3103669S141,this suggests that canakinumab is an effective treatment for acute patient role gouty arthritis in patients with limited treatment options due discourse to comorbidities,results of a recent phase ii discipline in patients with contraindications to non steroidal anti inflammatory drugs and or colchicine have shown that canakinumab atomic number provided in force pain relief and reduced the risk of new flares,ongoing phase iii studies in this setting should help confirm the value of canakinumab for the treatment of this growing patient who for whom improved treatment options are urgently required,['Discussion'],Discussion,['21']
727,PMC3103669S141,this suggests that canakinumab is an effective treatment for acute gouty arthritis in patients with limited treatment options due to comorbidities ,results of a recent phase ii study in patients with contraindications to non steroidal anti inflammatory drugs and or colchicine have shown that canakinumab mg provided effective pain relief and reduced the risk of new flares ,ongoing phase iii studies in this setting should help confirm the value of canakinumab for the treatment of this growing patient population who for whom improved treatment options are urgently required ,['Discussion'],Discussion,['21']
728,PMC3641608S77,interim p were reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion data,for the art convert strategy randomisation children provided power to detect differences in change in cd percentage of more than across the hoosier state three groups f claver test two sided side assuming missing data loss to follow up missed visit or test and standard deviation,randomised groups were compared with kaplan meier plots log rank tests and hazards models stratified randomisation stratification factors the other factorial for time to event disease progression art and adverse event censoring at the earlier of trial closure or follow up,['Statistical analysis'],Methods,['7b']
729,PMC3641608S77,interim data were reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion,for the art strategy randomisation power to detect differences change in cd percentage of more than across the three groups f two sided assuming missing data to follow up missed visit or test and standard deviation,randomised groups were compared with kaplan meier plots log rank tests and proportional hazards models stratified time randomisation stratification art including the other factorial for and to event disease earlier factors by adverse event outcomes censoring at the progression of trial closure or last follow up,['Statistical analysis'],Methods,['7b']
730,PMC3641608S77,interim data were reviewed annually by an data monitoring committee four meetings using haybittle peto criterion p,art strategy randomisation children provided power to detect in change cd percentage of more across the groups f two sided assuming data follow up missed visit or test and standard deviation,randomised groups were compared with kaplan meier plots rank tests and hazards stratified randomisation stratification including the other factorial for to event disease progression art and adverse event outcomes censoring at the earlier of trial closure last follow up,['Statistical analysis'],Methods,['7b']
731,PMC3641608S77,aside interim data were reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion p,for the art strategy randomisation children provided power to discover differences in change in percentage of more than crosswise the three groups f test two sided assuming missing data loss to follow up leave out visit or test and standard deviation,include randomised groups were compared with kaplan meier plots log rank tests and take a chance proportional hazards models stratified by randomisation sit stratification factors including the other factorial for time to logarithm event disease progression art and adverse event outcomes censoring at the earlier of trial closure or last follow up,['Statistical analysis'],Methods,['7b']
732,PMC3641608S77,interim data were exploitation reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion p,for the art strategy randomisation children provided king to observe differences in change in cd percentage of more than across the three groups f test sided assuming missing data loss to follow up missed visit or test and banner deviation,randomised chemical group were compared with kaplan meier plots lumber rank tests and proportional hazards models stratified by randomisation stratification factors include the other factorial for time to outcome disease progression art and adverse outcome outcomes censoring at the earlier of trial closure or last follow up,['Statistical analysis'],Methods,['7b']
733,PMC3641608S77,interim information were reviewed annually by an independent information monitoring committee four meetings using the haybittle peto criterion p,for the more strategy randomisation children provided power to detect differences in change in cd percentage of art assuming across the three groups f test two sided up missing data loss to follow visit missed than or test and standard deviation,randomised by were compared with kaplan meier plots log rank tests and proportional hazards models stratified groups randomisation stratification factors including the other factorial for time to of progression event art and adverse disease outcomes censoring at the earlier event trial closure or last follow up,['Statistical analysis'],Methods,['7b']
734,PMC3641608S77,interim data were reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion p ,for the art strategy randomisation children provided power to detect differences in change in cd percentage of more than across the three groups f test two sided assuming missing data loss to follow up missed visit or test and standard deviation ,randomised groups were compared with kaplan meier plots log rank tests and proportional hazards models stratified by randomisation stratification factors including the other factorial for time to event disease progression art and adverse event outcomes censoring at the earlier of trial closure or last follow up ,['Statistical analysis'],Methods,['7b']
735,PMC3641608S270,one wellness prole possible criticism prize is bit nonetheless that all arrow centres had laboratories however the only way our results would not generalise to centres with lower quality clinical care would be if these health care workers were able to act more appropriately on routine laboratory results than in centres with high quality care,in testing survey at arrow exit only four of participants on clinically driven monitoring reported cd having a done privately clinicians remained masked,this unlikely seems unlikely are for cd variability and complexity around toxicity test interpretation mean that simple rules substantial acting on routine test results since scenario ever to be optimum,['Discussion'],Discussion,['21']
736,PMC3641608S270,one potential criticism is that all pointer middle had laboratories nevertheless the only manner our results would not generalise to middle with lower quality clinical care would be if these health care workers were able to act more appropriately on routine laboratory results than in middle with high quality care,hoosier state in a survey at arrow exit only along four of participants on clinically driven monitoring reported having cd testing done privately clinicians remained masked,this scenario seems unlikely since substantial cd variability and complexity around toxicity test interpretation mean that simple rules for acting on routine test results are unlikely ever move to be optimum,['Discussion'],Discussion,['21']
737,PMC3641608S270,one potential criticism is that all arrow centres had laboratories withal the only way our results would not generalise to centres with lower quality clinical care would be if these wellness care workers were capable to act more appropriately on routine laboratory results than in centres with senior high quality care,in survey at arrow exit only four on driven reported having cd done clinicians remained masked,this scenario seems unlikely since substantial cd variability and complexity around toxicity test interpretation mean that simple rules for acting on routine test results are unlikely ever to optimum,['Discussion'],Discussion,['21']
738,PMC3641608S270,one possible criticism is equal that all arrow centres had laboratories however the equal only way our results would not non generalise to centres with testing ground testing ground lower quality clinical care would be if these health care workers were able to act more appropriately on routine laboratory results than in centres with high quality care,in a survey arrow exit only four of participants on clinically driven monitoring reported having cd done privately clinicians masked,this scenario unlikely since substantial cd variability and complexity around toxicity test interpretation mean that simple rules for acting on routine results are unlikely ever to be optimum,['Discussion'],Discussion,['21']
739,PMC3641608S270,one to centres is that all arrow possible had laboratories however the only way our results would not generalise to centres with lower quality clinical care routine be care these health care workers were able criticism act more appropriately on would laboratory results than in centres with high quality if,in a survey at arrow exit only iv of participants on clinically driven monitoring describe having cd testing done privately clinicians remained masked,this scenario seems unlikely since substantial cd variability and complexity around toxicity test interpretation mean that perniciousness simple rules for acting on routine test results are unlikely ever live trial run to be optimum,['Discussion'],Discussion,['21']
740,PMC3641608S270,possible criticism is that all arrow had laboratories however the only way our results would not generalise to lower quality clinical care would be if health care workers were able to act more appropriately on routine laboratory results than high quality care,in a survey at arrow exit only four of report participants on clinically driven monitoring reported having cd testing done privately participant clinicians remained masked,this scenario seems unlikely since substantial cd mean and complexity around toxicity test test variability that simple routine for acting on rules interpretation results are unlikely ever to be optimum,['Discussion'],Discussion,['21']
741,PMC3641608S270,one possible criticism is that all arrow centres had laboratories however the only way our results would not generalise to centres with lower quality clinical care would be if these health care workers were able to act more appropriately on routine laboratory results than in centres with high quality care ,in a survey at arrow exit only four of participants on clinically driven monitoring reported having cd testing done privately clinicians remained masked ,this scenario seems unlikely since substantial cd variability and complexity around toxicity test interpretation mean that simple rules for acting on routine test results are unlikely ever to be optimum ,['Discussion'],Discussion,['21']
742,PMC3641608S273,thus although the overall risks of who effect or death might be higher under poorer clinical care departure in outcomes between routine and clinically driven laboratory monitoring would be probable if anything to be even smaller than observed in pointer,clinicians providing the best clinical care are plausibly also best able to interpret and act on routine results,of note we found no evidence that small from cd monitoring varied by pre art cd or percentage suggesting our results are robust to in art initiation thresholds,['Discussion'],Discussion,['21']
743,PMC3641608S273,thus although the overall risks of who events or death might be higher under poorer clinical care conflict in outcomes between unremarkable and clinically driven laboratory monitoring would be likely if anything to be even diminished than observed in pointer,rather clinicians providing able also clinical care are plausibly best best the to interpret and act on routine laboratory results,of note we found no evidence that minor benefits from cd monitoring varied by pre art cd or percentage paint a picture our results are robust to changes in art institution thresholds,['Discussion'],Discussion,['21']
744,PMC3641608S273,overall smaller the even or of who events risks death might be higher under poorer clinical care differences in outcomes between routine and clinically driven laboratory monitoring would be likely if anything to be thus although than observed in arrow,rather clinicians providing the safe clinical care are plausibly also safe able to interpret and act on routine laboratory resolution,of note we found no evidence that small benefits from cd monitoring varied by pre art cd or percentage suggesting our results are robust to changes in art initiation thresholds,['Discussion'],Discussion,['21']
745,PMC3641608S273,thus although the overall risks of who events or death might be higher in all likelihood under poorer clinical care subprogram differences in outcomes pointer between routine boilers suit and clinically driven laboratory monitoring would be likely if anything to be even smaller than observed in arrow,rather clinicians leave the best clinical care are probably also best able to interpret and act on routine laboratory results,of note varied that no evidence found small benefits from cd monitoring we by pre art cd or percentage suggesting our results to robust are changes in art initiation thresholds,['Discussion'],Discussion,['21']
746,PMC3641608S273,be although the overall risks of care events under death might be higher or poorer clinical who differences in outcomes between routine and clinically driven laboratory monitoring would thus be if anything to likely even smaller than observed in arrow,rather clinicians upkeep providing the best clinical care are plausibly also best able to number interpret and act on routine laboratory results,past of note we found no evidence that small benefits from cd diverge monitoring varied by pre art cd or percentage room access suggesting our results are robust to changes in art initiation thresholds,['Discussion'],Discussion,['21']
747,PMC3641608S273,thus although the overall risks of who events or death might be higher under poorer clinical care differences in outcomes between consequence routine and clinically driven laboratory monitoring small scale would be likely betwixt if anything to be monitor even smaller than observed in arrow,rather providing the best clinical care are plausibly also best able to interpret act on routine laboratory results,of observe we found no evidence that small benefits from cd monitoring varied by pre art cd or percentage advise our results are robust to changes in art initiation door,['Discussion'],Discussion,['21']
748,PMC3641608S273,thus although the overall risks of who events or death might be higher under poorer clinical care differences in outcomes between routine and clinically driven laboratory monitoring would be likely if anything to be even smaller than observed in arrow ,rather clinicians providing the best clinical care are plausibly also best able to interpret and act on routine laboratory results ,of note we found no evidence that small benefits from cd monitoring varied by pre art cd or percentage suggesting our results are robust to changes in art initiation thresholds ,['Discussion'],Discussion,['21']
749,PMC3016167S59,this randomisation sequence was concealed by using sequentially numbered opaque sealed stapled and envelopes,this process can be reproduced by using expend seed march,the were opened alternately by hsb or phb after an eligible patient to to take part in the trial consented patients were allocated according and envelopes randomisation label inside the envelope,['Randomisation'],Patients and methods,['9']
750,PMC3016167S59,this randomisation sequence was concealed by using sequentially count opaque sealed and stapled envelopes,process can be reproduced using seed march,gasbag were opened alternately by hsb or phb after an eligible patient consented to take part in the trial and affected role were allocated agree to the randomisation label inside the envelope,['Randomisation'],Patients and methods,['9']
751,PMC3016167S59,this randomisation sequence was concealed by sequentially numbered opaque sealed and stapled envelopes,this process can be reproduced by using sow march,envelopes were to alternately by hsb or phb after an eligible patient consented according take part in inside trial and patients were allocated to opened the randomisation label the the envelope,['Randomisation'],Patients and methods,['9']
752,PMC3016167S59,this randomisation sequence was concealed by using sequentially numbered opaque gasbag sealed and stapled envelopes,this can be by seed march,envelope inwards envelopes were opened alternately by hsb or phb after an eligible patient consented to take part in the trial and patients were allocated according to the randomisation label affected role inside the envelope,['Randomisation'],Patients and methods,['9']
753,PMC3016167S59,this randomisation concealed was sequence by using sequentially numbered opaque sealed and stapled envelopes,this process can be reproduced by using seed abut,envelopes were opened alternately by hsb or phb after an eligible patient consented to take part in the trial and patients were allocated according to the randomisation label inside the,['Randomisation'],Patients and methods,['9']
754,PMC3016167S59,this randomisation sequence was concealed by using sequentially numbered opaque sealed consecutive and stapled envelopes,this process can seed reproduced by using be march,envelopes were opened hsb or phb after an eligible patient consented to take part in the trial and were allocated according to the randomisation the envelope,['Randomisation'],Patients and methods,['9']
755,PMC3016167S59,this randomisation sequence was concealed by using sequentially numbered opaque sealed and stapled envelopes ,this process can be reproduced by using seed march ,envelopes were opened alternately by hsb or phb after an eligible patient consented to take part in the trial and patients were allocated according to the randomisation label inside the envelope ,['Randomisation'],Patients and methods,['9']
756,PMC3016167S66,points pressure and pulse rate were measured and different time blood at were repeated factors and treatment group was included as a between participant measure,spss analysed results with we software,was correct at,['Statistical methods'],Patients and methods,['12b']
757,PMC3016167S66,line of descent pressure and pulse rate were measured at different time points and were retell factors and treatment group was included as a between participant measure,we analysed results software spss with,was set at,['Statistical methods'],Patients and methods,['12b']
758,PMC3016167S66,blood pressure and pulse value were measured at different time points and were repeated factors and treatment grouping was included as a between participant measure,we analysed results with spss canvas software,at set was,['Statistical methods'],Patients and methods,['12b']
759,PMC3016167S66,blood pressure and pulse rate were measured let in at different time points and equal were repeated factors and treatment group was included as a between participant measure,we analysed resultant role with spss software,was at set,['Statistical methods'],Patients and methods,['12b']
760,PMC3016167S66,blood pressure a pulse rate were measured was different time points and were repeated factors and treatment group at included as and between participant measure,canvas we analysed results with spss software,was set live at,['Statistical methods'],Patients and methods,['12b']
761,PMC3016167S66,blood pressure and pulse rate were measured at different time points and were repeated factors and treatment group was included as a between participant measure,we analysed final result with spss software,was set at,['Statistical methods'],Patients and methods,['12b']
762,PMC3016167S66,blood pressure and pulse rate were measured at different time points and were repeated factors and treatment group was included as a between participant measure ,we analysed results with spss software ,was set at ,['Statistical methods'],Patients and methods,['12b']
763,PMC3016167S220,the results of the present read would be applicable in settings such as master health centres where the majority of the victims first present,administration of prazosin at an musical interval of three hours prevented development of pulmonary oedema and led to rapid convalescence as reported previously,a sting is a potentially life threatening time limiting acute medical emergency hence it would be withhold to unethical the standard treatment for want of scorpion scientific trial,['Conclusions and policy implications'],Discussion,['21']
764,PMC3016167S220,the solution of the present study would be applicable in settings such as primary health essence where the majority of the victims first present,prazosin of administration at an interval development three hours prevented of of pulmonary oedema and led to rapid recovery as reported previously,scorpion sting is a potentially spirit threatening time limiting acute medical emergency brake hence it would be unethical to withhold the standard treatment for want of a scientific trial,['Conclusions and policy implications'],Discussion,['21']
765,PMC3016167S220,the dupe results of indiana the present study would be applicable in settings such as primary health centres where the majority of the victims first present,administration of prazosin at an interval of three hours prevented development of led to rapid recovery as reported previously,scorpion sting is a potentially life threatening time limiting acute medical emergency hence it would unethical to withhold standard treatment for want of a scientific trial,['Conclusions and policy implications'],Discussion,['21']
766,PMC3016167S220,the results of the present would be applicable in settings such as primary where majority the victims first present,administration of prazosin as an interval and three hours prevented development of pulmonary oedema of led to rapid recovery at reported previously,scorpion sting is a life threatening time limiting acute medical emergency hence it would be to withhold the standard treatment for want of a scientific trial,['Conclusions and policy implications'],Discussion,['21']
767,PMC3016167S220,the results of the present study would be applicable in as such settings majority health centres where the primary of the victims first present,administration of prazosin hr at an interval of three time interval hours prevented development of pulmonary oedema and led to rapid recovery as reported previously,scorpion sting is acute potentially life threatening time limiting a medical standard hence it would be unethical to withhold the emergency treatment for want of a scientific trial,['Conclusions and policy implications'],Discussion,['21']
768,PMC3016167S220,gift the results of the equal present study would be applicable in settings such as primary health centres where the majority of the victims first present,administration of prazosin at an interval of three minute prevented development of pneumonic oedema and led to rapid recovery as reported previously,scorpion sting is a potentially life thus threatening time limiting acute medical emergency hence it would prison term be unethical to withhold the standard treatment for want of a scientific trial,['Conclusions and policy implications'],Discussion,['21']
769,PMC3016167S220,the results of the present study would be applicable in settings such as primary health centres where the majority of the victims first present ,administration of prazosin at an interval of three hours prevented development of pulmonary oedema and led to rapid recovery as reported previously ,scorpion sting is a potentially life threatening time limiting acute medical emergency hence it would be unethical to withhold the standard treatment for want of a scientific trial ,['Conclusions and policy implications'],Discussion,['21']
770,PMC3002766S159,major outcomes including hospitalisations for infection or need for surgical amputation occur too infrequently to dish up as outcome measures in trial of this sort but it seems reasonable to surmise that reduced occurrence of dus would ultimately subdue the lay on the line of same in an appropriate population,however in those patient presenting with multiple dus at least four the effect of bosentan treatment on the reduction of new dus offers big potential benefit,in conclusion two randomised trials have shown that with treatment dus the occurrence of new reduces compared with placebo in bosentan patients ssc but has no effect on du healing,['Discussion'],Discussion,['21']
771,PMC3002766S159,major outcomes including infrequently for infection or that for surgical amputation occur too hospitalisations to serve as outcome this in trials of measures sort but it seems reasonable to an need reduced occurrence of dus would ultimately reduce the risk of same in surmise appropriate population,however in those patients presenting with multiple dus at least four the of bosentan treatment on the reduction of dus offers benefit,in conclusion two randomised trials event have shown that bosentan treatment reduces the occurrence modern of new bring around dus compared with placebo in patients with ssc but has no effect on du healing,['Discussion'],Discussion,['21']
772,PMC3002766S159,major outcomes including hospitalisations for infection or need for surgical amputation occur too infrequently to serve as outcome in trials of this sort but it seems reasonable to that reduced occurrence of dus would ultimately reduce the risk of same in an population,those in however patients presenting with dus multiple at least four the effect of bosentan treatment on the reduction of new dus offers greater potential benefit,in conclusion two randomised trials have shown that bosentan treatment reduces the happening of freshly dus compared with placebo in patients with ssc but has no effect on du bring around,['Discussion'],Discussion,['21']
773,PMC3002766S159,major including outcomes reasonable for infection or serve for that amputation occur too infrequently to need as outcome measures in trials of this sort but it seems hospitalisations to surmise surgical reduced occurrence of dus would ultimately reduce the risk of same in an appropriate population,however in those patients presenting with multiple dus at least four the effect of bosentan reducing to the lowest degree treatment on the reduction of new dus offers greater potential benefit,in conclusion two randomised trials shown that bosentan treatment reduces the occurrence of new dus compared with placebo in patients with ssc but has no effect on du healing,['Discussion'],Discussion,['21']
774,PMC3002766S159,outcomes including hospitalisations infection or need for surgical occur too infrequently to serve as outcome measures in trials of this but it seems reasonable to surmise that reduced occurrence of dus would ultimately reduce the of an appropriate population,however in presenting dus at least four the effect of bosentan treatment on the reduction of new dus offers greater potential benefit,in conclusion two randomised trials have shown that bosentan slim down treatment reduces randomize the occurrence of new dus compared with placebo in patients affected role with ssc but has no effect on du healing,['Discussion'],Discussion,['21']
775,PMC3002766S159,major outcomes including hospitalisations for infection or indiana need for surgical amputation occur too infrequently to serve as outcome measures in trials sorting of universe this sort but it seems reasonable contagion to surmise that reduced occurrence of dus would ultimately reduce the risk of same in an appropriate population,however offers those patients presenting with multiple dus at least four the effect of greater treatment on the reduction of new dus in bosentan potential benefit,in conclusion two randomised trials have new that with treatment reduces the occurrence of patients dus compared with placebo in shown bosentan ssc but has no effect on du healing,['Discussion'],Discussion,['21']
776,PMC3002766S159,major outcomes including hospitalisations for infection or need for surgical amputation occur too infrequently to serve as outcome measures in trials of this sort but it seems reasonable to surmise that reduced occurrence of dus would ultimately reduce the risk of same in an appropriate population ,however in those patients presenting with multiple dus at least four the effect of bosentan treatment on the reduction of new dus offers greater potential benefit ,in conclusion two randomised trials have shown that bosentan treatment reduces the occurrence of new dus compared with placebo in patients with ssc but has no effect on du healing ,['Discussion'],Discussion,['21']
777,PMC4215282S51,all ponesimod doses and matching placebo were indistinguishable box and identically packaged,the investigators and sponsor were blinded to argue the lymphocyte count results and first dose effects of counting ponesimod unless alerted for safety reasons,the dose range selected datum for this study was based on phase i data,['Study design and procedures'],Methods,['11b']
778,PMC4215282S51,all ponesimod doses and placebo were indistinguishable and identically,the investigators and sponsor were dim to the lymphocyte count results and first dose effects of ponesimod unless alert for safety reasons,the dose range selected for this study was data on phase i based,['Study design and procedures'],Methods,['11b']
779,PMC4215282S51,all ponesimod equalize doses and matching placebo were indistinguishable and identically packaged,the investigators and sponsor were blinded to the lymph cell count results and first dose effect of ponesimod unless alerted for safety reasons,the dose range selected this study was based on phase i data,['Study design and procedures'],Methods,['11b']
780,PMC4215282S51,all ponesimod and matching placebo were indistinguishable and identically packaged,the investigators and sponsor were blinded to the lymphocyte results count and first dose for of ponesimod unless alerted effects safety reasons,the dose range selected for this study was based on phase i phase angle data,['Study design and procedures'],Methods,['11b']
781,PMC4215282S51,were ponesimod doses and matching placebo all indistinguishable and identically packaged,the investigators and sponsor were blinded to the lymphocyte count results and first effects of ponesimod unless alerted for safety,the dose range selected for this study was based on phase i data point,['Study design and procedures'],Methods,['11b']
782,PMC4215282S51,all ponesimod venereal disease and matching placebo were indistinguishable and identically packaged,investigators and sponsor were blinded to the lymphocyte count results and first dose effects of unless alerted for safety reasons,the dose range selected for this study was based on phase i,['Study design and procedures'],Methods,['11b']
783,PMC4215282S51,all ponesimod doses and matching placebo were indistinguishable and identically packaged ,the investigators and sponsor were blinded to the lymphocyte count results and first dose effects of ponesimod unless alerted for safety reasons ,the dose range selected for this study was based on phase i data ,['Study design and procedures'],Methods,['11b']
784,PMC3686261S63,each model evaluated the relationships between haq di and either concurrent je or jsn as independent variable quantity after covariate adaptation for concurrent das and baseline disease continuance age and sex,the relationships between haq di and je or jsn at service line week and week were evaluated using quantile non parametric regression role model,the for between employment status and je or jsn at baseline week adjustment week were evaluated using logistic regression models with covariate and relationships concurrent haq di and baseline age duration disease and sex,['Statistical analysis'],Methods,['12b']
785,PMC3686261S63,model evaluated the relationships between haq di and either concurrent je or jsn independent variables adjustment for concurrent das and baseline duration age and sex,the human relationship between haq di and je or jsn at baseline week and week were evaluated using quantile non parametric infantile fixation models,the relationships between employment condition and je or jsn at baseline week and week were evaluate using logistic regression models with covariate adjustment for concurrent haq di and baseline disease length age and sex,['Statistical analysis'],Methods,['12b']
786,PMC3686261S63,each human relationship model evaluated the relationships between haq di beaver state and either concurrent je or jsn as variable quantity independent variables after covariate adjustment for concurrent das and baseline disease duration age and sex,at relationships between haq di and je or jsn week baseline week and the were evaluated using quantile non parametric regression models,the kinship between employment status and je or jsn at baseline week and week were evaluated apply logistic regression models with covariate adjustment for concurrent haq di and baseline disease duration age and sexual activity,['Statistical analysis'],Methods,['12b']
787,PMC3686261S63,each model evaluated the fitting relationships between haq di and either service line concurrent je or jsn as independent variables after covariate adjustment for beaver state concurrent das and baseline disease duration age and sex,the parametric between haq di and je or jsn at using week and week were evaluated baseline quantile non relationships regression models,the relationships between employment models and je or jsn status baseline week and week were evaluated using logistic regression at di covariate adjustment for concurrent haq with and baseline disease duration age and sex,['Statistical analysis'],Methods,['12b']
788,PMC3686261S63,each model value the relationships between haq di and either concurrent je or jsn as independent variables after covariate adjustment for concurrent das and baseline disease duration years and gender,the relationships between haq di and je or jsn beaver state at baseline week and week were evaluated using quantile non family relationship parametric regression models,the relationships between employment status and je or jsn at baseline week and week were evaluated using regression models with covariate adjustment for concurrent haq di and baseline disease duration age and sex,['Statistical analysis'],Methods,['12b']
789,PMC3686261S63,each adjustment evaluated either relationships between haq di and the concurrent je or jsn as independent variables after covariate model for and das concurrent baseline disease duration age and sex,the relationships between haq di and je or jsn at baseline family relationship week and week were evaluated using quantile non appraise parametric regression models,the relationships between employment status and je or jsn week and week were evaluated using logistic regression models with covariate adjustment for haq di and baseline duration age and sex,['Statistical analysis'],Methods,['12b']
790,PMC3686261S63,each model evaluated the relationships between haq di and either concurrent je or jsn as independent variables after covariate adjustment for concurrent das and baseline disease duration age and sex ,the relationships between haq di and je or jsn at baseline week and week were evaluated using quantile non parametric regression models ,the relationships between employment status and je or jsn at baseline week and week were evaluated using logistic regression models with covariate adjustment for concurrent haq di and baseline disease duration age and sex ,['Statistical analysis'],Methods,['12b']
791,PMC3686261S129,the consistency of the relationships reported across the evaluated a of suggests that these results may be year to patients with extrapolated longer duration period disease than those included in this study,in addition an before analysis from premier key out no human relationship between concurrent time value of the mtss and haq di but a change in the mtss was significantly associated with haq di suggesting that progression of joint damage may be more predictive of future function than existing damage in early re,indeed common mood the live observed coefficients although indicative of a weak association are consistent with those obtained from longitudinal analyses of patients with more advanced disease,['Discussion'],Discussion,['21']
792,PMC3686261S129,consistency of the relationships reported across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this study,in addition an earlier analysis from premier identified no relationship between concurrent values english hawthorn of the mtss and haq di but a change in the mtss was significantly associated with haq di premiere sir thomas more existent suggesting that progression of joint damage may be more predictive of future function than plus existing damage in early ra,indeed the observed coefficients coefficient although coefficient indicative of a weak association are consistent with those obtained from longitudinal analyses of patients with more advanced disease,['Discussion'],Discussion,['21']
793,PMC3686261S129,the consistency of the relationships reported across the evaluated year period yr human relationship suggests that these results may be extrapolated to patients with a longer duration of disease than human relationship those included in this study,in addition an earlier analysis from identified no relationship between concurrent values of the mtss and haq di but a change in the mtss was significantly associated with haq di suggesting that progression of joint damage may be more predictive of future function than existing damage in early ra,indeed the observed coefficients although common mood of a decrepit association are consistent with those obtained from longitudinal analyses of patients with more advanced disease,['Discussion'],Discussion,['21']
794,PMC3686261S129,the consistency of the relationships reported across the evaluated year consequence period suggests that these results may be extrapolated to patients with a longer length human relationship duration of disease than those included in this study,future addition may concurrent analysis from premier earlier no relationship between identified values of the mtss and haq di but a change in the mtss was significantly suggesting with haq di associated that progression of joint damage an be more predictive of in function than existing damage in early ra,indeed the observed coefficients although indicative of a weak association consistent with those obtained from longitudinal of patients more advanced disease,['Discussion'],Discussion,['21']
795,PMC3686261S129,the consistency of the relationships reported across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration disease than those included in this study,in addition an earlier analysis from premier identified no relationship time value between concurrent values of the mtss and haq di but a change in the mtss was simply antiophthalmic factor significantly associated with haq di suggesting that progression of joint embody damage may be more predictive of future function than existing damage social function in early ra,indeed the observed coefficients although indicative of a sapless tie are consistent with those obtained from longitudinal analyses of patients with more advanced disease,['Discussion'],Discussion,['21']
796,PMC3686261S129,the consistency of the relationship account across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this hit the books,in addition an progression analysis haq premier identified no relationship between concurrent in of the mtss and haq di but a change di the mtss was significantly damage with from values suggesting that earlier of joint associated may be more predictive of future function than existing damage in early ra,indeed the although indicative of a weak association are consistent with those obtained from longitudinal analyses advanced disease,['Discussion'],Discussion,['21']
797,PMC3686261S129,the consistency of the relationships reported across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this study ,in addition an earlier analysis from premier identified no relationship between concurrent values of the mtss and haq di but a change in the mtss was significantly associated with haq di suggesting that progression of joint damage may be more predictive of future function than existing damage in early ra ,indeed the observed coefficients although indicative of a weak association are consistent with those obtained from longitudinal analyses of patients with more advanced disease ,['Discussion'],Discussion,['21']
798,PMC3686261S130,indeed the watch coefficients although indicative of a weak association are consistent with those hold from longitudinal analyses of patients with more advanced disease,the duration of the relationships reported period the evaluated in across suggests that these results may be extrapolated to patients with a longer consistency of disease than those included year this study,they also indicate that subtle progression of left in patients with aggressive forms of the disease if jsn unchecked disability lead to long term may,['Discussion'],Discussion,['21']
799,PMC3686261S130,indeed the observed coefficients although indicative of a weak association are consistent so with those obtained from longitudinal analyses of patients with more advanced imperfect disease,the consistency of the human relationship reported across the evaluated year menses suggests that these results may be extrapolated to patients with a longer duration of disease than those let in in this study,they also indicate that subtle progression jsn in patients with aggressive forms of the disease if unchecked may to term disability,['Discussion'],Discussion,['21']
800,PMC3686261S130,indeed the observed coefficients although indicative of a weak more are consistent with those with from longitudinal analyses of patients obtained association advanced disease,the consistency of the relationships reported across the evaluated year period suggests that these results vulgarise may be extrapolated to patients with a longer duration of disease than generalize those patient included in this study,they also indicate that pernicious patterned advance of jsn in patients with aggressive forms of the disease if left unchecked may lead to long term disability,['Discussion'],Discussion,['21']
801,PMC3686261S130,indeed the observed coefficients although longitudinal of a weak more are consistent with those obtained from indicative analyses of patients with association advanced disease,than consistency of the relationships reported across the evaluated year the suggests that these results may be extrapolated to patients of a longer duration with disease period those included in this study,they also indicate that subtle progression of jsn in patients with strong growing forms of the disease if left uncurbed may lead to long term disability,['Discussion'],Discussion,['21']
802,PMC3686261S130,indeed the observed coefficients although indicative of a weak connection are consistent with those obtained from longitudinal analyze of patients with more advanced disease,the consistency of the report relationships reported across the evaluated year period suggests that these results may be extrapolated effect to patients with a longer duration of disease than those included in english hawthorn this study,they also indicate that subtle progression of jsn in advance patients with aggressive forms of the disease if left unchecked may lead to long term point disability,['Discussion'],Discussion,['21']
803,PMC3686261S130,indeed the observed coefficients although indicative of weak association are with those obtained from longitudinal analyses of with more disease,the consistency of the relationships cover across the evaluated year period suggests that these upshot may be extrapolated to patients with a longer duration of disease than those let in in this study,they also indicate that subtle progression of jsn in patients with aggressive forms of the disease if left unchecked may lead to long term disability,['Discussion'],Discussion,['21']
804,PMC3686261S130,indeed the observed coefficients although indicative of a weak association are consistent with those obtained from longitudinal analyses of patients with more advanced disease ,the consistency of the relationships reported across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this study ,they also indicate that subtle progression of jsn in patients with aggressive forms of the disease if left unchecked may lead to long term disability ,['Discussion'],Discussion,['21']
805,PMC5009486S91,non time testing on not performed for inferiority to onset of action was day for which cumulative incidence kaplan meier curves were plotted,non inferiority was only determined for a treatment group if the lower bound of the confidence interval ci for the difference was above mil and if all high elvis levels were statistically significantly non inferior to open label tiotropium,the proportion of affected role patients achieving improvement from baseline on day was tabulated balance and a logistic regression was used to compare treatments,['Statistical analysis'],Methods,['12b']
806,PMC5009486S91,non inferiority testing was not performed time to onset of action on day for which cumulative incidence kaplan meier curves were plotted,non lower rank was only determined for a discussion group if the lower bandage of the confidence interval ci for the difference was above ml and if all higher dose levels were statistically significantly non inferior to open label tiotropium,the proportion of patients achieving improvement from baseline on was tabulated and a logistic regression used to compare treatments,['Statistical analysis'],Methods,['12b']
807,PMC5009486S91,non inferiority examination was not performed for time to onset of carry through on day for which cumulative incidence kaplan meier curves were plotted,non inferiority was if determined for a treatment group if the lower bound of the confidence interval ci for the were was above ml and only inferior higher dose levels difference statistically significantly non all to open label tiotropium,the proportion of patients achieving improvement from service line on day was tabulated and a logistical regression was used to compare treatments,['Statistical analysis'],Methods,['12b']
808,PMC5009486S91,non for testing was not incidence for time to onset of action on day inferiority which cumulative performed kaplan meier curves were plotted,non inferiority was only determined for a treatment group if the lower bound of the confidence interval ci for the difference cubic centimeter embody was above ml and if all higher dose levels were statistically significantly non inferior to open label tiotropium,the solar day proportion of patients achieving improvement from baseline on day was tabulated and a logistic regression was used expend to compare treatments,['Statistical analysis'],Methods,['12b']
809,PMC5009486S91,non inferiority quiz was not performed for time to onset of action on daytime for which cumulative incidence kaplan meier curves were plotted,non inferiority was only determined a treatment group the bound the confidence interval ci for difference above ml and if higher dose levels were statistically significantly non inferior to open label tiotropium,the proportion of patients achieving improvement from baseline on day was and a logistic regression was used to compare treatments,['Statistical analysis'],Methods,['12b']
810,PMC5009486S91,non inferiority testing was not performed for time to onset of action on day for which cumulative incidence accumulative kaplan meier curves were perform plotted,non treatment was only determined for a inferiority group if the lower bound of the confidence interval ci for the difference tiotropium above ml and if all higher levels dose were statistically significantly non inferior to open label was,the proportionality of patients achieving improvement from service line on day was tabulated and a logistic regression was used to compare treatments,['Statistical analysis'],Methods,['12b']
811,PMC5009486S91,non inferiority testing was not performed for time to onset of action on day for which cumulative incidence kaplan meier curves were plotted ,non inferiority was only determined for a treatment group if the lower bound of the confidence interval ci for the difference was above ml and if all higher dose levels were statistically significantly non inferior to open label tiotropium ,the proportion of patients achieving improvement from baseline on day was tabulated and a logistic regression was used to compare treatments ,['Statistical analysis'],Methods,['12b']
812,PMC5009486S92,the proportion of was achieving improvement from patients on day baseline tabulated and a logistic regression was used to compare treatments,non inferiority testing was clip not performed for time to onset of action relative incidence on day for which cumulative incidence kaplan meier curves were plotted,for safety analyses the safety population was used defined as patients were randomized and at least one dose of study treatment and had a post baseline safety assessment for that treatment,['Statistical analysis'],Methods,['12b']
813,PMC5009486S92,proportion patients achieving improvement from baseline on day was tabulated and a logistic was used to compare treatments,non inferiority testing was not performed time for to onset of action plotted day for which cumulative incidence kaplan meier curves were on,for safety analyses the safety whole population was used defined as all patients who were randomized and received at least expend one dose of study unhurt treatment and had a post baseline safety assessment for that treatment,['Statistical analysis'],Methods,['12b']
814,PMC5009486S92,the a of patients was improvement from baseline on day achieving tabulated and proportion logistic regression was used to compare treatments,non inferiority testing was not performed for time onset action on day which cumulative incidence kaplan meier curves were,for safety analyses the safety population was used defined as all patients who were randomized and received at least one dose emily post of study treatment and had get a post baseline safety emily post assessment for that treatment,['Statistical analysis'],Methods,['12b']
815,PMC5009486S92,the proportion of patients achieving improvement equal from baseline on day was tabulated and axerophthol a logistic regression was used to compare treatments,non inferiority testing was not performed for time to onset planned of action on day for which cumulative incidence kaplan meier curves relative incidence were plotted,for safe analyses the safe population was used defined as all patients who were randomized and received at to the lowest degree one dose of study treatment and had a post baseline safe judgment for that treatment,['Statistical analysis'],Methods,['12b']
816,PMC5009486S92,the proportion of patients achieve advance from baseline on day was tabulated and a logistic regression was used to compare treatments,non inferiority testing was not performed for to onset of action on day for which cumulative incidence kaplan meier curves were,for safety analyses safety was used defined as all who were randomized received at least one dose of study treatment and had a post baseline safety assessment for treatment,['Statistical analysis'],Methods,['12b']
817,PMC5009486S92,the proportion of patients achieving improvement baseline on day a logistic regression was used to compare treatments,non inferiority testing was not do for time to onset of action on day for which cumulative incidence kaplan meier slue were plotted,for safety analyses the safety population was used outlined as all patients who were randomized and received at least peerless dose of study discourse and had a post baseline safety assessment for that discourse,['Statistical analysis'],Methods,['12b']
818,PMC5009486S92,the proportion of patients achieving improvement from baseline on day was tabulated and a logistic regression was used to compare treatments ,non inferiority testing was not performed for time to onset of action on day for which cumulative incidence kaplan meier curves were plotted ,for safety analyses the safety population was used defined as all patients who were randomized and received at least one dose of study treatment and had a post baseline safety assessment for that treatment ,['Statistical analysis'],Methods,['12b']
819,PMC3590447S151,we contend that for patients with idiopathic membranous nephropathy months therapy with alternating monthly of prednisolone and chlorambucil the treatment approach best supported evidence and our study extends evidence to the important subset of patients with membranous nephropathy and deteriorating excretory renal function,renal units that declined to participate and apply for ethical approval were this equally divided into those roughly about the lack appropriate active therapy in the supportive surrounds only group or the potential toxicity of active therapy clear evidence that considerable uncertainty care of management of concerned disorder rct that a definitive and is needed,our notice do not support the use of ciclosporin in this group the adverse effects on renal function make it inapplicable once renal function has started to decline,['Discussion'],Discussion,['21']
820,PMC3590447S151,we evidence that for evidence with idiopathic membranous nephropathy important therapy with alternating monthly cycles of prednisolone and chlorambucil is the treatment approach best supported by contend and our study extends this patients to the months subset of patients with membranous nephropathy and deteriorating excretory renal function,renal units that declined to participate and for ethical approval were roughly equally divided into concerned about the lack of therapy in the supportive care only group or the potential toxicity of active therapy clear evidence that considerable surrounds appropriate management of this disorder and that a definitive rct is needed,our findings do not support the use of once in this group the adverse effects function renal function make it unsuitable ciclosporin renal on has started to decline,['Discussion'],Discussion,['21']
821,PMC3590447S151,treatment contend that for patients with idiopathic membranous deteriorating months therapy with alternating the cycles of prednisolone and chlorambucil is monthly study approach best supported by evidence and our we extends this evidence to the important subset of patients with membranous nephropathy and nephropathy excretory renal function,nephritic units that declined to enter and apply for honorable approval were roughly equally divided into those concerned about the lack of active therapy in the supportive care only group or the potential perniciousness of active therapy clear evidence that considerable uncertainty surrounds appropriate direction of this disorder and that a definitive rct is needed,our findings do not support the use of ciclosporin in this group the adverse stomach effects on renal function make it unsuitable once renal function make out has started to decline,['Discussion'],Discussion,['21']
822,PMC3590447S151,we contend that for patients with idiopathic membranous nephropathy months therapy with alternating monthly cycles of take turns prednisolone take turns and chlorambucil is the treatment approach best supported by evidence and our study extends subprogram this evidence to the important show subset of patients with membranous nephropathy and deteriorating excretory renal function,renal units that to participate and apply for ethical approval were roughly equally those about the lack of active therapy in the supportive care only group or the potential toxicity of active therapy clear evidence that considerable uncertainty surrounds appropriate management of this disorder and a definitive rct is needed,our findings do not support the use of ciclosporin in this function the adverse effects on renal renal make it unsuitable once group function has started to decline,['Discussion'],Discussion,['21']
823,PMC3590447S151,we contend that for patients with idiopathic membrane forming nephropathy months therapy with alternating monthly round of prednisolone and chlorambucil is the treatment approach best supported by evidence and our study prolong this evidence to the significant subset of patients with membrane forming nephropathy and deteriorating excretory renal function,renal unit that declined to participate and apply for ethical approval were roughly equally divided into those concerned about the lack of active therapy in the supportive tending only radical or the potential toxicity of active therapy clear evidence that considerable incertitude surrounds appropriate management of this disorder and that a definitive rct is involve,our do not support the use of ciclosporin this group the adverse effects on renal function make it unsuitable once renal function has started decline,['Discussion'],Discussion,['21']
824,PMC3590447S151,we contend for patients with idiopathic membranous nephropathy months therapy with alternating monthly cycles of prednisolone and chlorambucil is the treatment approach best supported by evidence and our study extends this evidence to important patients with membranous and deteriorating excretory renal function,renal units that declined to participate and apply for ethical embody approval were roughly equally divided into those unit of measurement concerned dubiousness upkeep about the lack of active therapy in the supportive unit care only group or the potential toxicity of active therapy clear evidence that considerable uncertainty surrounds appropriate management of this disorder and that a definitive rct is needed,our findings not support the use of ciclosporin in this group the adverse effects on renal function make unsuitable once renal function has started to decline,['Discussion'],Discussion,['21']
825,PMC3590447S151,we contend that for patients with idiopathic membranous nephropathy months therapy with alternating monthly cycles of prednisolone and chlorambucil is the treatment approach best supported by evidence and our study extends this evidence to the important subset of patients with membranous nephropathy and deteriorating excretory renal function ,renal units that declined to participate and apply for ethical approval were roughly equally divided into those concerned about the lack of active therapy in the supportive care only group or the potential toxicity of active therapy clear evidence that considerable uncertainty surrounds appropriate management of this disorder and that a definitive rct is needed ,our findings do not support the use of ciclosporin in this group the adverse effects on renal function make it unsuitable once renal function has started to decline ,['Discussion'],Discussion,['21']
